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ABSTRACT 
 
Bacteria precisely coordinate DNA replication and chromosome segregation with 
cell division; accurate regulation of each of these processes is critical to genome 
inheritance and thus reproductive success. During fast growth, Bacillus subtilis carries 
out multi-fork replication and maintains multiple partial copies of the genome. However, 
during the developmental process of sporulation, B. subtilis shuts down DNA replication 
initiation and maintains only two copies of the chromosome. SirA (Sporulation inhibitor 
of replication A), is a protein produced only during sporulation that has been shown to 
inhibit new rounds of DNA replication by interacting directly with the initiator protein 
DnaA. Apart from inhibiting replication, I discovered that SirA acts in the same pathway 
as Soj to facilitate capture of the origin of segregation (oriC) in the forespore 
compartment during sporulation. I identified residues in both SirA and DnaA that are 
important for mediating the SirA-DnaA interaction and demonstrate that the two 
functions of SirA (replication inhibition and oriC segregation) are genetically separable. 
My data support the model that SirA interacts with DnaA Domain I to inhibit DNA 
replication initiation and with DnaA Domain III to promote oriC segregation. 
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CHAPTER I 
INTRODUCTION 
 
In both prokaryotes and eukaryotes, successful reproduction requires precise 
regulation of DNA replication and chromosome segregation. Under conditions of rapid 
division, many bacteria, including Bacillus subtilis and Escherichia coli, are unable to 
finish a complete round of chromosome replication before cell division occurs and 
therefore must initiate a new round of DNA replication before the first round is 
complete. This form of growth is very different from eukaryotes, in which chromosome 
replication and segregation occur in a different phase of the cell cycle than cytokinesis. 
Bacteria tightly coordinate chromosome segregation with cell division, segregating 
newly synthesized origins of replication (oriCs) toward cell poles (or future cell poles in 
rapidly growing cells undergoing multifork replication) shortly after initiation (1). The 
process of oriC segregation happens with very high fidelity, even in the absence of 
known chromosome organizing factors (2, 3). Failure to properly initiate replication or 
to properly segregate replicated chromosomes has numerous detrimental effect on the 
cell including abnormal cell growth (4), guillotining and breakage of chromosomes 
during cell division (5, 6), generation of anucleate cells (7), and cell death (8). Despite 
the critical nature of genome inheritance to viability, our understanding of the 
mechanisms underlying chromosome dynamics in bacteria remains incomplete. 
Fundamental questions related to how bacteria accurately regulate chromosome 
replication and segregation and, coordinate chromosome dynamics with other essential 
processes such as cell growth and cell division, remain outstanding. In this thesis, I 
address these fundamental questions utilizing the well-studied Gram positive bacterial 
model organism B. subtilis.  
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1.1 Bacillus subtilis 
 
Bacillus subtilis is a rod-shaped, non-pathogenic bacterium, which belongs to the 
endospore-forming phylum Firmicutes. This phylum includes a number of important 
Gram positive pathogens and commensals, including Staphylococcus, Clostridia, and 
Listeria, as well as organisms important in food production, such as the Lactobacillus. B. 
subtilis is the most characterized Gram positive bacterium, and has served as a model 
organism for over fifty years. B. subtilis is also widely used in industry for the 
commercial production of enzymes and detergents (9). One of the most widely used B. 
subtilis strains in the laboratory is strain B. subtilis 168, a tryptophan auxotroph. The B. 
subtilis 168 strain was isolated by Paul Burkholder and Norman Giles, who used X-rays 
to mutagenize the Marburg strain (10). Another Marburg strain, NCIB3610, more 
closely resembles the original wild-type isolates and is more widely used in studies 
related to multicellular behavior, including biofilm and fruiting body formation, and 
swarming motility. In contrast, B. subtilis 168 is defective in these functions (11), and is 
thus considered a “domesticated” strain. In this study, we used both strain 168 and 
another closely related domesticated strain PY79, which has been cured of the 
conjugative transposon ICEBs1 (12) as well as a prophage called SPβ (13). Compared to 
the NCIB3610 strain, both B. subtilis 168 and PY79 are more competent and thus easier 
to manipulate genetically. In both of these organisms, the genome can be easily modified 
with insertions, deletions, and point mutations. B. subtilis 168 also has the richest 
repository of genome-level resources available for any Gram positive bacterium. These 
resources include a BioCyc database collection (BsubCyc), a barcoded, clean deletion 
library, and over 250 condition-dependent transcriptomic datasets (14). 
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1.2 Sporulation 
 
Bacterial cell differentiation is a specialized cellular process that undergone by 
some bacteria to generate a new cell type that is phenotypically distinct from the parent 
cell. These changes can be morphological but may also only be physiological and result 
in the production of a daughter cell with distinct function or roles (15). B. subtilis 
sporulation is a paradigm system for studying cell differentiation in bacteria, including 
the coordination between gene expression and morphological change.  
During vegetative growth, B. subtilis replicates DNA, grows, and divides 
actively, sometimes possessing cells with 2, 4, or even 8 partial copies of the genome 
(16). When Bacillus cells experience nutrient stress, they are capable of entering into a 
developmental process called sporulation that ultimately results in the production of a 
metabolically inert, heat and desiccation resistant cell type called a spore (17, 18). 
During sporulation, the cell reduces its chromosome copy number to two, as each 
sporulating cell only needs two copies of the chromosome for spore formation (7). New 
rounds of DNA replication are prevented by production of a sporulation specific protein 
called SirA (7). The chromosomes undergoes a dramatic structural change and become 
stretched across the entire cell in an elongated structure called an axial filament that (19), 
with the origins of replication anchored to the cell poles (20). After axial filament 
formation, the sporulating cell forms a septum at one of the cell quarter positions, 
dividing the cell into a smaller compartment called the forespore and a larger 
compartment called the mother cell. At the time of polar septum formation, only one 
quarter of one copy of the chromosome is present in the forespore, creating an initial 
genetic asymmetry between the mother cell and forespore compartments. Successful 
spore production requires that oriC be located on the forespore side of septum (21). This 
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positioning somehow allows the remainder of the chromosome to be directionally 
pumped into the forespore by the FtsK-like DNA translocase, SpoIIIE (22, 23). At this 
point, the septal peptidoglycan is partially degraded and the membranes present on the 
mother cell side of the septum start to migrate around the forespore in a process called 
engulfment. The engulfment stage is completed when the engulfing membrane fuse. At 
this point, the forespore is bound by two sets of membranes (24). Over time, the 
peptidoglycan surrounding the forespore is thickened and modified (25), water inside the 
spore is replaced with dipocolonic acid (SP), and the spore is encapsulated by a protein-
based spore coat (26). Eventually the mother cell lyses, releasing the mature endospore 
into the environment (Fig 1.1)(27-29).  
B. subtilis sporulates in response to adverse environmental conditions, especially 
nutrient deprivation. The spore protects the genome until favorable growth conditions 
return. The process of spore formation is time-consuming, energy-expensive and 
becomes irreversible sometime after the completion of polar septum formation even if 
nutrients become available (30, 31). Therefore, successful sporulation provides B. 
subtilis with a distinct advantage during conditions of environmental stress. 
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Fig. 1.1.  Bacillus subtilis sporulation. During sporulation, B. subtilis reduces its 
chromosome copy number to two and stretches the chromosomes along the cell length in 
an elongated structure called the axial filament. Septation then occurs near one pole, 
initially capturing only a portion of one chromosome in the forespore compartment. The 
rest of this chromosome will be pumped into the forespore later by DNA translocase, 
SpoIIIE. The septum is then degraded, triggering the membrane migration around both 
sides of the forespore until fuses at the cell pole, releasing the forespore into the mother 
cell as a protoplast. Finally, peptidoglycan layers and spore coat are formed and when 
the spore is mature, it is released into the environment following mother cell lysis. 
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1.2.1 Spo0A 
 
The master regulator of sporulation is a DNA-binding protein called Spo0A. 
Spo0A is expressed even during vegetative growth, but increases in copy number during 
stationary phase (32). When conditions become favorable for sporulation, Spo0A is 
converted into its active phosphorylated form, Spo0A-P (33, 34). Phosphorylation of 
Spo0A is highly regulated by a complex phosphorelay that integrates environmental 
signals with the developmental decision to sporulate (35). Spo0A-P can either activate or 
repress transcription by binding to the so-called spo0A box, which has the 7-bp 
consensus sequence, TGNCGAA (36). spo0A boxes are generally found in promoter 
regions recognized by the vegetative sigma factor σA and the stationary phase sigma 
factor σH (37-39). Accumulation of Spo0A-P is correlated with changes in gene 
expression for more than 500 genes (40), ~25% have been shown to be directly regulated 
by Spo0A-P binding; one-third of these are positively regulated by Spo0A-P, while the 
remainder are negatively regulated (36). Spo0A-P activates genes required for 
downregulation of DNA replication (7), anchoring of oriC at the distal cell poles (20) 
and redistribution of FtsZ from midcell toward the cell pole for polar septum formation 
(41-43), as well as other sporulation-specific processes (44). In addition to Spo0A-P, the 
stationary phase sigma factor σH is also required for sporulation initiation. σH regulates a 
number of phosphorelay genes including upregulation of spo0A itself (32). σH also 
regulates a number of other factors, some of which are important for the later steps of 
sporulation (45).  
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1.3 DNA replication 
 
For both prokaryotes and eukaryotes, DNA replication is the basis for biological 
inheritance and therefore must be carefully regulated to ensure that daughter cells inherit 
complete copies of the genome (46). During replication, the double stranded DNA is 
melted. Each original single strand then serves as a template for the production of a new 
daughter strand, a process referred to as semiconservative replication (47). Cellular 
proofreading and error-checking mechanisms ensure near perfect fidelity for DNA 
replication (48). DNA replication, just like the other biological polymerization 
processes, also includes three steps, initiation, elongation and termination (49). 
 
1.3.1 Replication initiation 
 
In both prokaryotes and eukaryotes, chromosome replication starts at a site called 
the origin of replication (oriC). The origin site needs to be unwound before other 
components of the replication machinery can be assembled onto the DNA. In both 
prokaryotes and eukaryotes, initiator proteins are required for this melting process, 
which is proceeded by the loading of the rest of replisome components including 
helicase and DNA polymerase (46, 50). 
 
1.3.1.1 Initiation in eukaryotes 
 
Eukaryotic cells, which typically have much larger genomes than their 
prokaryotic counterparts, have multiple replication origins. To initiate DNA replication, 
multiple replicative proteins assemble on and then dissociate from these replicative 
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origins (50). DNA replication is tightly controlled in the context of the cell cycle (51-
54). Activation of replication origins occurs as a two-step process during G1 phase (55). 
First, pre-replication complexes (pre-RC) are formed in a process called licensing. Then, 
when the appropriate cell cycle cues are received, initiation from pre-RCs begins (56). 
Tight regulation of assembly and dissociation of pre-RC complexes helps ensure that the 
initiation of DNA replication only occurs once per cell cycle, and only from designated 
origins (57-59). 
In order to form pre-RC, multiple proteins and/or protein complexes need to be 
assembled orderly, such as ORC (origin recognition complex), Cdc6 (cell division cycle 
6), Cdt1 (chromatin licensing and DNA replication factor 1) and Mcm 
(minichromosome maintenance proteins)(60). CDK (cyclin-dependent kinase) and DDK 
(Dbf4-dependent kinase), which phosphorylate the Cdc6 and the Mcm proteins 
respectively, then activate the pre-RC (52). Phosophorylation leads to the release of 
Cdc6 and the subsequent formation of the initiation complex, for instance, the 
interaction between Mcm and Cdc45 (cell division cycle 45)(61). Once formed, the 
initiation complex leads to the ordered loading of other initiation factors that unwind the 
DNA and promote the recruitment of DNA polymerases (Fig 1.2)(50). 
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Fig. 1.2.  Chromosome replication initiation in budding yeast. (A) Formation of the pre-
RC. (B) CDK/DDK-dependent pre-RC activation and origin unwinding. (C) DNA 
polymerase loading and replication initiating. See text for details. 
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1.3.1.2 Initiation in prokaryotes 
 
In prokaryotes, chromosomes are generally circular and the origin of replication 
on the chromosome is called oriC. oriC is typically AT rich and the length of oriC is 
around 250 base pairs (62). The oriC region also possesses multiple sites containing 9-
bp motifs called dnaA boxes with the consensus sequence 5′-TTATNCACA-3’ (63), 
which are bound by the initiator protein DnaA (64). During replication initiation, DnaA 
binds to and oligomerizes at oriC, generating conformational changes that result in local 
unwinding of the AT-rich DNA unwinding element (DUE) followed by assembly of 
other replication machinery components (63, 65).  
In E. coli, DUE unwinding is proceeded by recruitment of the helicase loader, 
DnaC, and loading of the helicase DnaB (66, 67). Helicase loading is followed by the 
sequential assembly of DnaG primase and the DNA polymerase III holoenzyme on 
single stranded DNA (68-70).  
In B. subtilis and other low GC content Gram positive bacteria, different naming 
conventions are used, and loading of the replicative helicase (DnaC in B. subtilis), 
requires three additional proteins, DnaD, DnaB and DnaI (71). After DnaA binds to 
oriC, DnaD is recruited, followed by the membrane-associated protein DnaB (72). DnaI, 
also a AAA+ ATPase, then mediates DnaC loading onto the DNA (73). Primase and 
DNA polymerase are then recruited, leading to the initiation of DNA replication (Fig 
1.3). 
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1.3.1.2.1 DnaA, the bacterial initiator 
 
The initiation protein DnaA is highly conserved in bacteria and has four 
functional and structural domains (74). The N-terminal domain, Domain I, is known to 
be important for DnaA self-dimerization and helicase loading, as well as recruitment of 
other proteins required for initiation (75, 76). Domain I is also critical for interacting 
with other replication regulators such as DiaA in E. coli and SirA in B. subtilis 
(regulators are discussed more below)(77-81). The self-dimerization of DnaA Domain I 
is necessary for initiating DNA replication because it is essential for the cooperative 
binding of DnaA at oriC that leads to melting of the origin region (82, 83). Domain II is 
poorly conserved and flexible (84). Domain III carries the AAA+ ATPase motif for ATP 
binding/hydrolysis and oligomerization of DnaA when it is bound to ATP (74, 85). The 
C-terminal domain, Domain IV, possesses the helix-turn-helix motif responsible for 
binding to DNA (Fig 1.4)(65, 74). 
In addition to DnaA Domain IV, which harbors the helix-turn-helix motif 
responsible for direct interaction with DNA, Domain III is also important for DNA 
binding. In the DNA-free DnaA crystal structure, the orientations of Domain III and 
Domain IV exhibit a steric clash with DNA when the DNA molecule is modeled into the 
structure. Therefore, it has been proposed that in the DNA-bound form, DnaA Domain 
III and Domain IV must exist in a different conformation (65, 86). In its DNA-free form, 
DnaA Domain IV is only loosely tethered to Domain III, thus it has been suggested that 
flexibility in this region is important for assembly of the DnaA oligomer on DNA (86). 
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Fig. 1.3.  DNA replication initiation in B. subtilis. During replication initiation, the 
initiator protein DnaA binds to oriC, forms an oligomer and unwinds the DUE element. 
For simplicity, the cartoon depicts DnaA on only one strand of DNA. DnaD then binds 
to DnaA, and is recruited to DnaB at the cytoplasmic membrane. This step is followed 
by recruitment of the helicase loader (DnaI), helicase (DnaC), primase (not shown) and 
DNA polymerase III. 
 
 
 
 
 
 
 
 13 
 
 
 
 
Fig. 1.4.  Cartoon representation of DnaA’s elongated four domain structure. Domain I 
is N-terminal while Domain IV is C-terminal.  
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In bacterial cells, DnaA has two different nucleotide-bound forms: ADP bound 
DnaA (ADP-DnaA) and ATP bound DnaA (ATP-DnaA). However, only ATP-DnaA is 
capable of initiating DNA replication (46, 68, 87). During replication, ATP-DnaA binds 
cooperatively to dnaA boxes at oriC and forms an ATP-DnaA-oriC complex (74, 88). 
For duplex opening at the AT-rich DNA unwinding element (DUE), enhanced 
supercoiling is required by DnaA oligomer to bind to DNA (64), which causes a ~28° 
kink of the local DNA at multiple sites (65), thus promoting unwinding of DUE (63). 
In addition to its primary role in replication initiation, DnaA also binds to 
additional sites around the chromosome, some far distal to oriC (89). Many of these 
secondary sites are in promoter regions, consistent with studies demonstrating that in 
addition to its role in DNA replication initiation, DnaA can also function as a 
transcription factor (90, 91). DnaA regulates the transcription of several genes (including 
its own) by acting as both an activator and a repressor (89-95). DnaA’s function as a 
transcription factor is more active when replication stress is induced by DNA damage, 
the inhibition of DNA replication elongation, or the inactivation of other replication 
initiation proteins (89, 91). 
 
1.3.1.2.2 Regulation of initiation 
 
DNA replication is carefully regulated to ensure both daughter cells inherit a 
copy of the genome. Tight regulation of DNA replication initiation not only determines 
the overall frequency of DNA synthesis, but also helps to ensure that DNA replication is 
properly timed during the cell cycle (46, 96). In most bacteria, DNA replication 
initiation is largely regulated by controlling both the availability and activity of the 
replication initiation protein DnaA (46, 88, 97). 
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In E. coli, there are at least four regulatory systems to regulate DNA replication 
initiation (98). E. coli methylates DNA at adenine residues at the motif GATC through 
the activity of the enzyme DNA adenine methylase (Dam)(99). GATC motifs are 
enriched in the origin-proximal region of the chromosome, and there are eleven GATC 
sites around the oriC region, including one in the promoter region of dnaA (100). The 
newly synthesized DNA strand is unmethylated, thus after initiation, the new oriC 
region is temporarily hemimethylated. The membrane-associated protein SeqA 
preferentially binds to hemimethylated GATC sites, and temporarily sequesters them 
from ATP-DnaA binding, thus delaying replication initiation (101-103). Once the strand 
becomes methylated again, ATP-DnaA can once again compete for binding, thus 
promoting replication initiation (104, 105). In this way, SeqA and Dam prevent the 
immediate re-initiation of replication (106, 107). SeqA binding in the dnaA promoter 
region also acts to repress dnaA expression further contributing to the delay in initiation 
(100).  
Two additional systems negatively regulate DnaA activity by stimulating ATP 
hydrolysis of ATP-DnaA (98). The first system is called regulatory inactivation of DnaA 
(RIDA). RIDA prevents immediate re-initiation by promoting ATP (bound to DnaA) 
hydrolysis after initiation, yielding ADP-DnaA (108, 109). RIDA activity is dependent 
on the sliding clamp subunit of DNA polymerase III and an associated protein called 
Hda (98). Hda possesses a AAA+ ATPase domain and is bound to the clamp in its ADP-
bound form (109, 110). Recent studies suggest that Hda-clamp complex interacts with 
DNA-bound DnaA at Domain I and that the AAA+ ATPase domain of Hda interacts 
with DnaA Domain III (111-113). The RIDA system is conserved in other Gram 
negative bacteria as well. In Caulobacter crescentus, the Hda ortholog HdaA, has been 
shown to colocalize with the sliding clamp and inhibit replication (114).  
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In addition to the RIDA system, the pool of ATP-DnaA available to bind oriC is 
also controlled by titration of ATP-DnaA at a chromosomal locus called datA (115-117). 
The datA locus, which resides near oriC, contains five dnaA boxes (118). Deletion of the 
datA sites does not cause re-initiation of replication, but does give asynchrony phenotype 
as rifampin-resistant replication initiation (118). In addition to titrating available ATP-
DnaA, the datA locus contributes to ATP-DnaA hydrolysis in a manner that is still being 
investigated (119).  
DnaA activity is also regulated by positive control mechanisms. The DARS 
(DnaA re-activating sequence) system has been described to reactivate initiation by 
stimulating DnaA binding to ATP (120). DARS is a 70-bp DNA fragment containing 
one dnaA box and two dnaA box-like sequences which have the opposite orientation as 
the dnaA box (120). In this system, ADP-DnaA binds to DARS and thereby causes 
disassociation of ADP from DnaA, makes DnaA free to re-associate with ATP (121). 
Another positive regulator in E. coli called DiaA, has been shown to stimulate the 
cooperative binding of ATP-DnaA on DNA (78, 122). DiaA forms a homotetramer and 
is able to bind to multiple DnaA molecules simultaneously. DiaA is hypothesized to 
stimulate conformational changes in DnaA molecule that allow assembly of the ATP-
DnaA oligomer on DNA at oriC (80). Homologs of E. coli DiaA, have been described in 
several other Gram negative bacteria including Caulobacter crescentus and Helicobacter 
pylori (123-126). 
Unlike E. coli, regulators of DnaA’s nucleotide bound state have yet to be 
identified in B. subtilis or other Gram positives. It is possible that at least some of these 
regulators have yet to be identified. Another hypothesis is that intrinsic differences in the 
ADP-DnaA exchange rate in Gram positives (at least the ones that have been examined) 
makes additional factors unnecessary. This hypothesis is based on the observation that in 
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E. coli, the half-life of ADP-DnaA is ~40 min, whereas the half-life of ADP-DnaA in B. 
subtilis and several other Gram-positive bacteria is ~ 5 min (127). In rapidly growing B. 
subtilis, it is estimated that 90% of DnaA molecules are bound by ATP (85, 128). This 
high nucleotide exchange rate suggests that DnaA in B. subtilis is less likely to be 
regulated by ATP binding and hydrolysis. 
Although sufficient ATP-DnaA levels are required for replication initiation, 
recent data suggests that increasing ATP-DnaA levels alone cannot account for origin 
firing and other cues are required (129). In B. subtilis and other Gram positive bacteria, 
other regulators have been described that control DnaA activity through nucleotide-
independent mechanisms.  
One of the best studied regulators of DnaA activity in B. subtilis is YabA. YabA 
was identified based on its ability to interact with both DnaA and the sliding clamp, 
DnaN (130). Overproduction of YabA causes decreased replication initiation and a yabA 
mutant overinitiates (131, 132). In vitro, purified YabA alters binding of ATP-DnaA to 
DNA by inhibiting the cooperativity of DnaA oligomerization, but does not affect either 
ATP binding or hydrolysis (133). In vivo, YabA associates with DnaA and decreases 
DnaA occupancy at oriC (127, 133). Another initiation protein DnaD, which is essential 
for helicase loading (72) and thus replication initiation. In vitro, DnaD, like YabA, has 
also been shown to interfere with the cooperative association of DnaA into its oligomer 
form, again without affecting ATP binding or hydrolysis (127). 
Another protein found to be important in the regulation of DnaA activity in B. 
subtilis is called Soj (ParA). soj is located in an operon with the gene encoding DNA-
binding protein Spo0J (ParB), which is involved in chromosome condensation in 
B.subtilis (134). ParAB proteins were originally described to be involved in plasmid 
partitioning (135); however, parAB operons are present in bacterial genomes throughout 
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the eubacteria (136) and have also been implicated in chromosome segregation in 
several bacteria (136-138).  
Genetic and biochemical studies suggest that monomeric Soj acts as a negative 
regulator of DNA replication initiation, while dimeric Soj permits replication initiation 
(139-141). Scholefield et al. have shown that Spo0J promotes the conversion of dimeric 
Soj into monomeric Soj by stimulating Soj’s ATPase activity (142). To inhibit 
replication, Soj interacts with Domain III (127). In vitro, similar to DnaD and YabA 
(143), Soj has been shown to inhibit DnaA oligomerization without affecting DnaA’s 
ability to bind and hydrolyze ATP (127).  
Spo0J and Soj act together to inhibit replication initation. How Spo0J itself is 
regulated remains an important outstanding question. One possibility is that Spo0J and 
Soj activity depend on a close association with oriC and that movement of Spo0J and/or 
Soj away from this site could allow enough ATP-DnaA oligomerization to promote 
loading of other replisome components, or at least DnaA-oriC membrane association. 
Intriguingly, Soj has been shown to interact with MinD at nascent cell division sites 
(144). Thus, the early steps in the assembly of the cell division complex could serve as a 
trigger to release the inhibitory hold on DnaA activity. Such a mechanism would also be 
an elegant way to coordinate the initation of DNA replication with cell division. 
 
1.3.2 Replication elongation and termination 
 
During replication, the origin region is unwound by helicase, a motor protein that 
is loaded on at the origin region and moves directionally to separate the double-stranded 
DNA to single-stranded DNA (145). Primase, a DNA-dependent RNA polymerase, next 
adds small RNA primers to both strands of the DNA template (146). High processivity 
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DNA polymerase (Pol III in bacteria, Pol δ and Pol ε in eukaryotes) then synthesizing 
the new daughter strand in the 5’ to 3’ direction away from the primer using the parent 
as template during the successive addition of nucleotides (147-149). Since only one 
primer is added to the leading strand but multiple primers are added to the lagging 
strand, the leading strand replicates continuously whereas the lagging strand is replicated 
discontinuously, thus creating Okazaki fragments (150, 151). The RNA primers are 
degraded and a low processivity DNA polymerase fills in the gaps left behind (152, 
153). Finally, the nicks present following the gap-filling step are ligated by DNA ligase 
(154, 155). 
DNA replication terminates when the replication fork is blocked. In order to 
terminate replication, a termination protein bound at its cognate binding site is required 
(156, 157). The termination protein is able to physically block the replication fork, and 
for both E. coli and B. subtilis, the region where this blockage takes place is called ter 
(158). In bacteria with circular chromosomes, replication initiates at the origin region 
and creates two replication forks that move bi-directionally. The two replication forks 
meet each other at ter, located on the opposite side of the chromosome as oriC (159, 
160). In E. coli, termination occurs when a protein called Tus binds to termination 
sequences, preventing the faster replication fork from proceeding (161). This ensures 
that the slower replication fork reaches the stalled one in the termination region (162). In 
contrast, eukaryotes initiate replication at multiple sites along the length of a linear 
chromosome and therefore must also terminate at multiple sites (163, 164). 
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1.4 Chromosome segregation 
 
For both prokaryotes and eukaryotes, proper chromosome segregation is critical 
for successful reproduction. After replication, the duplicated chromosomes need to be 
segregated away from each other and the site of cell division to ensure that each 
daughter cell will inherit a genome. Not surprisingly, chromosome segregation is a 
tightly regulated process (16, 165). 
 
1.4.1 Chromosome segregation in eukaryotes 
 
In the S phase of the cell cycle, the two identical sister chromatids (produced 
after DNA replication) are held together by highly conserved protein complexes called 
cohesins (166). Cohesins contains two SMCs (structural maintenance of chromosome) 
called Smc1 and Smc3, and a “kleisin” subunit called Scc1/Mcd1 (167). SMC proteins 
are found across all domains of life, from bacteria and archaea to yeast and higher 
eukaryotes (168-170). SMC proteins contain globular N and C-termini seperated by two 
coiled-coil domains bearing a central hinge domain (Fig 1.5A)(171). The N and C-
termini interact with each other, causing the protein to fold over upon itself with a bend 
at the hinge region. Two subunits then associate at both the hinge region to form a 
wishbone-shaped structure (Fig 1.5B)(172). Scc1 (the kleisin subunit) interacts with both 
the C-terminus of Smc1 and the N-terminus of Smc3, acting as a bridge to connect Smc1 
and Smc3, thus forming a ring-like structure capable of encircling multiple strands of 
double stranded DNA (Fig 1.5B)(167). 
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Fig. 1.5.  Structure of SMC protein and the cohesin complex. (A) Domain structure of 
SMC proteins. SMC proteins contain a globular N-terminal domain, coiled-coil domain 
I, a hinge domain, coiled-coil domain II and a globular C-terminal domain. (B) Structure 
of the cohesin complex. The N and C-termini of SMC protein associate, causing the 
SMC protein to fold over on itself. The hinge regions of Smc1 and Smc3 interact with 
each other to create the SMC dimer. Scc1 interacts with the C-terminus of Smc1 and the 
N-terminus of Smc3 to form a ring-like structure. 
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In mitosis, microtubules attach to the kinetochore on the chromatids which are 
held together by cohesions (173). In budding yeast, each kinetochore only binds to a 
single microtubule (174). The kinetochore geometry and the error correction system 
ensure that the sister chromatids attach to microtubules from opposite poles (175, 176). 
Following attachment, the chromatids are then separated and finally segregate to the cell 
pole (165). The sister chromatids can then be segregated equally into each daughter cell 
(177). When all the chromosomes have properly attached to microtubules, the 
chromatids are ready to fall apart. The anaphase promoting complex, or cyclosome 
(APC/C)(178), targets the anaphase inhibitor securin for ubiquitnation and degradation 
by the 26S proteasome (179). Since securin binds to and inhibits the separase (180), this 
ubiquitination process actually releases the inhibition for separase. Separase is a cysteine 
protease that cleaves the Scc1 subunit of cohesin, allowing the cohesins to be released 
from the DNA (Fig 1.6)(181). Once seperated, the chromatids segregate to opposite cell 
poles (165). 
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Fig. 1.6.  Eukaryotic chromosome segregation during mitosis. In pro-metaphase, the 
sister chromatids are held together by cohesins. In metaphase, microtubules attach to the 
kinetochore, only stably associating when the kinteochores of sister chromatids are 
separately attached to microtubules emanating from opposite cell poles. Separase is still 
inactivated by securin. In anaphase, APC/C binds to securin, causing it to be ubiquinated 
and degraded by the 26S proteasome. This leaves separase free to cleave Scc1, releasing 
DNA held together by the SMC complex. The sister chromatids then separate and 
segregate to opposite cell poles.  
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1.4.2 Chromosome segregation in bacteria 
 
Different from eukaryotes, bacteria lack microtubules and appear to rely heavily 
on chromosome compaction and oriC dynamics to help ensure chromosomes are 
properly segregated to future daughter cells. In all bacteria for which oriC dynamics 
have been examined, newly synthesized replication origins are segregated toward a cell 
pole (or future cell pole in cells with multi-fork replication) shortly after DNA 
replication initiation, even while the remainder of the chromosome is being replicated 
(1). In other words, DNA replication and chromosome segregation are concurrent (182, 
183). Three systems, ParAB-parS, SMC complexes, and FtsK-like translocation, have 
been implicated in partitioning bacterial chromosomes to daughter cells (184, 185). The 
ParAB-parS and SMC proteins help ensure efficient oriC segregation, especially during 
conditions of rapid growth when cells have multiple partial copies of the chromosome 
(16, 186), while FtsK translocase acts preferentially at the terminus of the chromosome 
to segregate DNA away from the site of cytokinesis or septation. 
 
1.4.2.1 Par proteins 
 
The ParAB-parS system is conserved across the members of the eubacteria 
(136), although, it is notably absent from the model organism E. coli. In B. subtilis, the 
Par system is not essential during vegetative growth (139); however, both ParA and 
ParB play roles in oriC segregation during sporulation (see below)(187). In Vibrio 
cholerae, there are two chromosomes, chrI and chrII, each containing par loci. ChrII 
encoded Par system is important for its own segregation, while chrI encoded system is 
not required for chrI segregation, but instead, moves the origin from the cell pole toward 
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mid-cell (188). Caulobacter crescentus is the only known organism that requires a 
functional ParAB-parS chromosomal system for viability (189).  
The parS sites on the chromosome were first identified in B. subtilis (190). There 
are eight parS sites located around the origin region with the consensus sequence 5′-
TGTTNCACGTGAAACA-3′, each with an imperfect 8-bp inverted repeat (190). 
Chromosomal parS sites in other bacteria are very similar to the ones in B. subtilis, not 
only in sequence, but also in oriC-proximal location (191-195), strongly suggesting that 
this location is important for parS function. ParB binds to parS sites and forms a 
centromere-like nucleoprotein complex favorable for oriC segregation (139, 196), 
whereas ParA interacts with ParB to help oriC partition (197-199).  
The exact mechanisms of how ParAB-parS system work in different bacteria are 
still largely unclear, and several sometimes conflicting models have been proposed. In C. 
crescentus, there are two major models describing possible mechanism for ParAB-parS 
dependent segregation of oriC (198, 199). The first model is called the “burnt-bridge 
Brownian ratchet model” (198). This model is partly based on the observation in vitro 
that ATP-ParA can oligomerize to form a spindle-like structure (198). In vivo, ParA 
bound to a fluorescent fusion appears to form oscillating clouds near the new cell that 
coalesce into an elongated structure by high resolution epifluorsecence microscopy. The 
authors of this study propose that ParB interacts with ParA, stimulating ParA’s ATPase 
activity and depolymerization. This depolymerization somehow causes ParA to “retract” 
and “pull” the ParB-parS-oriC complex towards the new cell pole (198). The other 
model is called the “DNA-relay model” (199). This model is based on the observation 
that the chromosome is elastic (200, 201). In this model, the newly synthesized oriC is 
bound by ParB. ParA, which is bound to DNA, can move with the same elasticity as the 
chromosome, but is constrained to the nucleoid surface and therefore the movement is 
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different from random diffusion (199). To reach its target at the opposite cell pole, ParB 
interacts with ParA and stimulates its ATPase activity. This causes ParA dimers to be 
released from the DNA, where they bind again following dimerization. The ParB-oriC 
complex is biased to move in the same direction as the ParA gradient due to interactions 
between ParB and ParA. What biases ParA to move toward the new pole is unclear in 
this model, although the gradient is observed experimentally (199). When the ParB-
parS-oriC complex reaches the pole, it is anchored by a protein called PopZ, thus 
preventing its diffusion away (198).  
In B. subtilis, ParA and ParB are more often referred to as Soj and Spo0J, 
respectively. Both Soj and Spo0J are non-essential, although a spo0J mutant produces a 
small number (1-2%) of anucleate cells (202). Instead of being required for chromosome 
segregation during vegetative growth (139), B. subtilis Soj regulates DNA replication 
initiation by interacting directly with DnaA (see section above, on regulation of 
initiation)(140, 143). ATP-Soj binds to DNA as a dimer, and this form permits DNA 
replication initiation (203). After initiation, Spo0J stimulates the ATPase activity of Soj 
causing a shift toward the monomer form (142). Monomeric Soj inhibits DnaA activity, 
by interacting with DnaA Domain III and disrupting DnaA oligomerization (143). 
 
1.4.2.2 SMC complex 
 
SMC proteins are conserved in both prokaryotes and eukaryotes (see text above 
for details on SMC structure). In bacteria, SMC proteins play important roles in 
chromosome compaction and segregation (204). In B. subtilis, smc null mutant is lethal 
for rapidly growing cells (in rich media at higher temperatures). Although cells are 
viable when growing at lower temperatures or in minimal media, approximately 10% of 
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the cells are anucleate, and most cells possess nucleoids of irregular morphology and 
origin localization (168, 204-206). Similarly, a C. crescentus smc mutant is nonviable in 
rich medium regardless of temperature, and can only grow at lower temperatures in 
minimal medium. Like B. subtilis, abnormal nucleoid morphology and origin 
localization defect has also been observed in the C. crescentus smc mutant; however, 
very few anucleate cells are produced (207). Instead of SMC, E. coli and some of its γ-
proteobacterial relatives utilize a functionally equivalent, but evolutionarily distinct 
protein complex called MukBEF (5). In E. coli, mukBEF mutants are also temperature 
sensitive, producing 5% anucleate cells under permissive conditions (208, 209).  
Under conditions of rapid growth, B. subtilis can possess more than 8 partial 
copies of the chromosome. Since smc null mutant possesses decondensed chromosome, 
one idea is that the lethality is related to the difficulty in disentangling and partitioning 
the large mass of chromosomal DNA (168, 210). Consistent with this hypothesis, 
viability can be restored under non-permissive conditions when cells possess mutations 
that slow DNA replication (210). 
In B. subtilis, SMC is enriched around the oriC region and this association is 
mediated by interaction with the ParB-parS complex (134, 187). Similarly, in E. coli, 
MukB is shown to generally colocalize with oriC (211). Recent data suggest that E. coli 
MukBEF is also briefly associated with the ter site of the chromosome, suggesting that 
MukBEF might also play a role in segregation of the terminus region of the chromosome 
(212). 
Although the mechanisms of how SMC/MukBEF precisely contribute to 
chromosome segregation remain elusive, there is no doubt that these complexes 
performs important roles in this process. Moreover, if both SMC and another 
segregation-important protein complex are impaired, the phenotypes are much more 
 28 
 
severe. In B. subtilis, smc parA double mutant produced more anucleate cells compared 
to the single mutant (139), while smc parB mutant showed a severe oriC segregation 
defect (213). There is likely an intimate relationship between the initiation of replication, 
oriC segregation, and chromosome condensation, as SMC needs to be loaded shortly 
after new DNA is synthesized, and newly synthesized oriC needs to be segregated 
shortly after initiation; moreover, in B. subtilis, ParB regulates aspects of both DnaA 
replication (142) and apparently, SMC loading at oriC (134). 
 
1.4.2.3 FtsK-like DNA translocases 
 
Apart from the two systems mentioned above, the DNA translocase FtsK and its 
orthologs also play important roles in chromosome decantenation and partitioning in 
various bacterial species (214, 215). FtsK is not only required for chromosomal dimer 
resolution during Xer-dif recombination, but also for positioning the dif site to the cell 
division site where FtsK acts (214, 216). At midcell, FtsK facilitates the segregation of 
any chromosomal DNA located in the division plane toward the future daughter cell, 
thus preventing chromosome guillotining during cell division (217). In addition, FtsK is 
also present in such bacteria like Streptomyces coelicolor and Borrelia, which instead of 
having circular chromosomes, contain linear chromosomes and thus have no need for 
dimer resolution (218, 219). 
B. subtilis possesses two FtsK-like translocases, SftA and SpoIIIE (220, 221). A 
double knockout of sftA and spoIIIE is viable, indicating that the genes perform 
functions that are not essential during normal vegetative growth (222). SpoIIIE was first 
identified because of its essential role during B. subtilis sporulation (6). During 
sporulation, when the polar septum is formed, initially only a quarter of one 
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chromosome is trapped into the forespore compartment, the other three quarters remain 
in the mother cell (see Sporulation, above). SpoIIIE is assembled around DNA 
transversing the septum (223, 224) and it is responsible for pumping the remainder of the 
forespore-destined chromosome into the forespore compartment using the energy 
produced by ATP hydrolysis (225). Burton et al. have shown that the two arms of the 
chromosome are pumped simultaneously (23), although the exact pumping mechanism 
remains unknown. 
 The SpoIIIE recognition site (SRS) is an 8-bp consensus sequence, 5′-
GAGAAGGG-3′, and the orientation of this sequence is proposed to affect the 
directionally of DNA translocation (226). However, the chromosome is ultimately 
released into the cell compartment possessing oriC, and cells that fail to capture oriC in 
the forespore fail to generate spores (21). 
 
1.5 Developmental regulation of DnaA activity and oriC segregation during B. 
subtilis sporulation 
 
During B. subtilis sporulation, when the chromosome copy number is maintained 
at two, new rounds of DNA replication are at least partially prevented by SirA 
(sporulation inhibitor of replication A), another negatively regulator of DnaA (7, 227). 
sirA (formerly called yneE) is under the positive control of Spo0A-P and is expressed 
during the earliest stages of sporulation (36). SirA inhibits new rounds of DNA 
replication during sporulation by targeting DnaA activity (7, 81). Misexpression of SirA 
during vegetative growth prevents colony formation on plates and produced anucleate 
cells in liquid medium, phenocopying depletion of the initiator protein DnaA (7). SirA 
inhibits DNA replication in a DnaA-dependent manner, as SirA has no effect on the 
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strain which does not require DnaA to initiate replication (7). Genetic, cell biological, 
biochemical, and structural studies have shown that SirA targets DnaA Domain I directly 
to inhibit replication initiation (7, 79, 81).  
In bacteria, DNA replication and chromosome segregation occur concurrently 
(182, 183). In C. crescentus, DnaA is able to bind to the centromere region and thereby 
segregates the chromosome (228). During B. subtilis sporulation, Sullivan et al. have 
shown that a soj mutant fails to segregate ~20% oriC into the forespore compartment 
(187). Since Soj is indicated to act as a negative regulator of DnaA activity (127), like 
SirA, all the above results suggest that SirA may also play an important role in oriC 
segregation during B. subtilis sporulation.  
In this thesis, I address the mechanism by which SirA inhibits DnaA activity and 
report a second, genetically distinct function for SirA in ensuring proper oriC 
segregation during B. subtilis sporulation.  
 
  
*Reprinted with permission from “The DnaA inhibitor SirA acts in the same pathway as Soj (ParA) to 
facilitate oriC segregation during Bacillus subtilis sporulation” by Duan, Y., Huey J.D. and Herman J.K., 
2016. Molecular Microbiology, 102(3):530-544. Copyright 2016 by John Wiley & Sons, Inc. 
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CHAPTER II 
THE DnaA INHIBITOR SirA ACTS IN THE SAME PATHWAY AS Soj (ParA) 
TO FACILITATE oriC SEGREGATION DURING Bacillus subtilis 
SPORULATION* 
 
2.1 Introduction 
 
In all bacteria for which origin of replication (oriC) dynamics have been 
examined, newly synthesized replication origins are segregated toward a cell pole (or 
future cell pole in cells with multi-fork replication) shortly after DNA replication 
initiation (3, 16, 182, 183, 213, 229). oriC segregation happens with high fidelity and is 
aided by chromosome condensing and partitioning complexes that include MukBEF, 
SMC, and ParABS (186, 230). The MukBEF and SMC complexes include condensin 
proteins that compact the chromosome lengthwise (230), while ParA and ParB orthologs
have been found to stabilize the partitioning of both low copy-number plasmids and 
bacterial chromosomes (137). 
In B. subtilis, ParA and ParB are most often referred to as Soj and Spo0J, 
respectively. Spo0J binds to parS sites and forms a centromere-like nucleoprotein 
complex favorable for oriC segregation (139, 196). Spo0J-parS complexes are also 
important for SMC enrichment around the oriC-proximal region of the chromosome and 
cohesion of the chromosomal arms following their replication (134, 187, 231). A spo0J 
mutant exhibits a slight increase in the frequency of anucleate cells (202) and is 
important for oriC segregation in the absence of a functional SMC complex (213). Soj, 
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which is encoded in the same operon as Spo0J, is not required for chromosome 
segregation during vegetative growth (139). Instead, Soj’s described function is to 
regulate DNA replication by interacting directly with the bacterial DNA initiator protein 
DnaA (140, 143). During replication initiation, DnaA binds to and oligomerizes at oriC. 
Soj binds to DNA as an ATP-dependent dimer, and directly stimulates DnaA to activate 
DNA replication initiation (203). Following replication initiation, the monomeric form 
of Soj acts as an inhibitor of initiation by preventing DnaA oligomerization (143). Spo0J 
promotes Soj’s ATPase activity, and thus also appears to function as a negative regulator 
of replication initiation in vivo (Fig. 2.1)(142). 
DNA replication and oriC dynamics are also highly regulated during bacterial 
development. For example, during sporulation, B. subtilis reduces its chromosome copy 
number to two and stretches the chromosomes along the cell length in an oriC-ter-ter-
oriC arrangement called the axial filament (19, 24). The number of chromosomes in 
sporulating cells is regulated by nutrient status, a checkpoint protein called Sda (92, 96), 
and by SirA, a protein expressed early in sporulation that directly targets DnaA activity 
(7). SirA ensures that new rounds of DNA replication are not initiated, thus preserving a 
diploidy state in the sporulating cell (7). Once the axial filament forms, septation occurs 
near one pole, initially capturing only a portion of one chromosome in the future spore 
(forespore) compartment (138, 187, 232). The remainder of the chromosome is 
eventually pumped into the forespore, but only if the chromosome’s oriC region is 
captured on the forespore side of the polar septum (22). Therefore, the position of oriC 
at the time of polar septation is important for successful sporulation. 
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Fig. 2.1.  Cartoon representation of chromosome segregation in B. subtilis. (Top) 
Following DNA replication initiation, newly synthesized oriCs are repositioned at cell 
quarters and future cell quarters. Spo0J stimulates formation of Soj monomers, delaying 
new rounds of DNA replication initiation until an unknown cell cycle cue is received. 
(Bottom) During sporulation, oriC is repositioned from the cell quarter toward the 
extreme cell pole in a manner that depends on DivIVA (black triangles), RacA (grey 
squares), MinD, ComN, MinJ, Spo0J, and Soj. In the absence of factors important for 
oriC repositioning during sporulation, a subset of cells fail to capture oriC in the 
forespore compartment following polar septation. 
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Several proteins have been implicated in oriC capture in the forespore (20, 138, 
187). Spo0J condenses the oriC-proximal region into a centromere-like element 
favorable for chromosome segregation during both vegetative growth and sporulation 
(196). Another protein, RacA, contributes by tethering the oriC-proximal region to the 
distal cell pole via interactions with the polar organizing protein DivIVA (Fig 2.1)(20, 
138, 233). The DnaA regulator Soj is also important, as a Δsoj mutant fails to capture 
oriC in ~20% of sporulating cells (Fig 2.1)(187). Genetic and cell biological data 
indicate that Soj’s importance is amplified in the absence of a functional RacA tethering 
system, suggesting that these two systems contribute in independent ways (138); the 
precise role of Soj in oriC capture is unknown. Recently, Kloosterman et al. 
demonstrated that ComN, MinJ, and MinD, proteins that like RacA utilize DivIVA for 
localization (234-236), also act in the same pathway as Soj to facilitate oriC capture (Fig 
2.1)(144). The authors propose that during sporulation, a complex of proteins that 
includes DivIVA, ComN, MinJ, and MinD relocalizes from the cell quarter to the 
extreme cell pole, and that this relocalization is important for Soj-dependent oriC 
capture (144). 
Here we show that the sporulation protein SirA, which also regulates DnaA 
activity, is also required for high-fidelity oriC capture in the forespore (7, 79, 81, 227). 
More specifically we show that SirA and Soj act in the same pathway to segregate oriC 
in 10% of sporulating cells. Residues in the N-terminus of SirA interact directly with 
DnaA Domain I to inhibit replication (79), and SirA inhibits new rounds of DNA 
replication initiation during sporulation (7). Surprisingly, we found that SirA’s ability to 
inhibit DNA replication is not required for its role in oriC capture, indicating that these 
functions are distinct and separable. Using SirA-DnaA gain of interaction screens, we 
identified additional residues near the C-terminus of SirA and in DnaA Domain III, 
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which are also important for mediating interaction between the two proteins. Moreover, 
we isolated one C-terminal substitution in SirA, P141T, which inhibits DNA replication, 
yet is unable to support SirA-dependent oriC capture. These unexpected results suggest 
that SirA may target two distinct domains of DnaA: Domain I, to inhibit DNA 
replication, and Domain III to facilitate Soj-dependent oriC segregation. 
2.2 Materials and methods 
2.2.1 General methods 
All B. subtilis strains were derived from B. subtilis 168 or PY79. E. coli and B. 
subtilis strains utilized in this study are listed in Table 2.1. Plasmids are listed in Table 
2.2. Oligonucleotide primers are listed in Table 2.3. All cloning was carried out in E. 
coli DH5α. E. coli strain DHP1 was used for assaying interaction in the B2H. 
Sporulation was induced by resuspension at 37°C according to the Sterlini-Mandelstam 
method (237). For microscopy experiments, all samples were grown in 25 ml CH (237) 
in 250 ml baffled flasks at 37°C in a shaking waterbath set at 280 rpm. For 
transformation of E. coli, antibiotics were included at the following concentrations when 
indicated: 100 µg/ml ampicillin, and 25 µg/ml kanamycin. For transformation and 
selection of B. subtilis, antibiotics, when required, were included at the following 
concentrations: 100 µg/ml spectinomycin, 7.5 µg/ml chloramphenicol, 0.8 µg/ml 
phleomycin, 10 µg/ml tetracycline, 10 µg/ml kanamycin and 1 µg/ml erythromycin with 
25 µg/ml lincomycin. 
 36 
 
Table 2.1.  Strains used in Chapter II. 
 
Strain Description Reference 
Parental   
B. subtilis 
PY79 
Bacillus subtilis laboratory strain (238) 
B. subtilis 
168 
Bacillus subtilis laboratory strain 168 trpC2  BGSC (1A866) 
E. coli 
DH5α 
F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR 
nupG Φ80dlacZΔM15 Δ(lacZYA-argF)U169, 
hsdR17(rK
- mK
+), λ–  
 
E. coli 
DHP1 
F-, cya-99, araD139, galE15, galK16, rpsL1 
(Strr), hsdR2, mcrA1,mcrB1; 
Tom Bernhardt 
B. subtilis 
PY79  
  
BJH015 spoIIIE36, yycR::PspoIIQ-yfp (phleo), 
amyE::PspoIIQ-cfp (cat), sirA::tet, yvbj::sirA (erm) 
This study 
BJH090 spoIIIE36, yycR::PspoIIQ-yfp (phleo), 
amyE::PspoIIQ-cfp (cat), sirA::tet 
This study 
BJH103 spoIIIE36, yycR::PspoIIQ-yfp (phleo), 
amyE::PspoIIQ-cfp (cat) 
This study 
BKE25690 sda::erm BGSC 
BYD067 spoIIIE36, yycR::PspoIIQ-yfp (phleo), 
amyE::PspoIIQ-cfp (cat), sirA::sirAY51A 
This study 
BYD073 spoIIIE36, yycR::PspoIIQ-yfp (phleo), 
amyE::PspoIIQ-cfp (cat), dnaA::dnaAF49Y 
This study 
BYD116 spoIIIE36, yycR::PspoIIQ-yfp (phleo), 
amyE::PspoIIQ-cfp (cat),  
D(soj, spo0J)::spec,  pelB::soj- spo0J+ (kan) 
This study 
BYD117 spoIIIE36, yycR::PspoIIQ-yfp (phleo), 
amyE::PspoIIQ-cfp (cat), sirA::tet 
D(soj, spo0J)::spec,  pelB::soj- spo0J+ (kan) 
This study 
BYD299 spoIIIE36, yycR::PspoIIQ-yfp (phleo), 
amyE::PspoIIQ-cfp (cat), sirA::sirAP141T 
This study 
BYD302 spoIIIE36, yycR::PspoIIQ-yfp (phleo), 
amyE::PspoIIQ-cfp (cat), sirA::sirAF14A 
This study 
BYD303 spoIIIE36, yycR::PspoIIQ-yfp (phleo), 
amyE::PspoIIQ-cfp (cat), dnaA::dnaAA50V 
This study 
BYD306 spoIIIE36, yycR::PspoIIQ-yfp (phleo), 
amyE::PspoIIQ-cfp (cat), sirA::sirAA111V 
This study 
BYD308 spoIIIE36, yycR::PspoIIQ-yfp (phleo), 
amyE::PspoIIQ-cfp (cat), sirA::sirAE144A 
This study 
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Table 2.1.  Continued. 
Strain Description Reference 
BYD310 spoIIIE36, yycR::PspoIIQ-yfp (phleo), amyE::PspoIIQ-
cfp (cat), sirA::sirAS123C 
This study 
BYD470 spoIIIE36, yycR::PspoIIQ-yfp (phleo), amyE::PspoIIQ-
cfp (cat),  
D(soj, spo0J)::spec,  pelB::soj- spo0J+ (kan), 
sda::erm 
This study 
BYD471 spoIIIE36, yycR::PspoIIQ-yfp (phleo), amyE::PspoIIQ-
cfp (cat),  
D(soj, spo0J)::spec,  pelB::soj- spo0J+ (kan), 
sirA::tet, sda::erm 
This study 
BYD472 spoIIIE36, yycR::PspoIIQ-yfp (phleo), amyE::PspoIIQ-
cfp (cat),  
sirA::tet, sda::erm 
This study 
BYD498 spoIIIE36, yycR::PspoIIQ-yfp (phleo), amyE::PspoIIQ-
cfp (cat), sirA::sirAT113M 
This study 
BYD499 spoIIIE36, yycR::PspoIIQ-yfp (phleo), amyE::PspoIIQ-
cfp (cat), sirA::sirAV118M  
This study 
BYD500 spoIIIE36, yycR::PspoIIQ-yfp (phleo), amyE::PspoIIQ-
cfp (cat), sirA::sirAK121N 
This study 
BYD533 spoIIIE36, yycR::PspoIIQ-yfp (phleo), amyE::PspoIIQ-
cfp (cat), sirA::sirAI103V  
This study 
B. subtilis 
168 
BAM075 amyE::Phy (spec) This study 
BYD036 amyE::Phy-sirA (spec) This study 
BYD283 amyE::Phy-sirAP141T (spec) This study 
BYD285 amyE::Phy-sirAQ30L (spec) This study 
BYD286 amyE::Phy-sirAQ41H (spec) This study 
BYD287 amyE::Phy-sirAL69F (spec) This study 
BYD288 amyE::Phy-sirAA111V (spec) This study 
BYD291 amyE::Phy-sirAI83K (spec) This study 
BYD292 amyE::Phy-sirAE144A (spec) This study 
BYD293 amyE::Phy-sirAR64P (spec) This study 
BYD294 amyE::Phy-sirAF115Y (spec) This study 
BYD295 amyE::Phy-sirAS123C (spec) This study 
BYD296 amyE::Phy-sirAP124L (spec) This study 
BYD297 amyE::Phy-sirAS106P (spec) This study 
BYD298 amyE::Phy-sirAL28P (spec) This study 
BYD462 amyE::Phy-sirAF14A (spec) This study 
BYD463 amyE::Phy-sirAY51A (spec) This study 
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Table 2.1.  Continued. 
Strain Description Reference 
BYD464 amyE::Phy-sirA (spec), dnaA∷dnaAF49Y This study 
BYD465 amyE::Phy-sirA (spec), dnaA∷dnaAA50V This study 
BYD549 amyE::Phy-sirAI103V (spec) This study 
BYD550 amyE::Phy-sirAT113M (spec) This study 
BYD551 amyE::Phy-sirAV118M (spec) This study 
BYD552 amyE::Phy-sirAK121N (spec) This study 
BYD574 amyE::Phy-sirA (spec), D(soj, spo0J)::cat, 
pelB::soj- spo0J+ (kan)   
This study 
BYD575 amyE::Phy (spec), D(soj, spo0J)::cat,  pelB::soj- 
spo0J+ (kan)   
This study 
E. coli 
DHP1 
CYD050 dnaA-T25 (kan), sirA-T18 (amp) This study 
CYD051 dnaA-T25 (kan), sirAY51A-T18 (amp) This study 
CYD053 dnaAF49Y-T25 (kan), sirA-T18 (amp) This study 
CYD055 dnaAA50V-T25 (kan), sirA-T18 (amp) This study 
CYD060 dnaA-T25 (kan), empty-T18 (amp) This study 
CYD061 empty-T25 (kan), sirA-T18 (amp) This study 
CYD062 empty-T25 (kan), sirAY51A-T18 (amp) This study 
CYD064 dnaAF49Y-T25 (kan), empty-T18 (amp) This study 
CYD066 dnaAA50V-T25 (kan), empty-T18 (amp) This study 
CYD168 dnaAA50V-T25 (kan), sirAI103V-T18 (amp) This study 
CYD169 dnaAA50V-T25 (kan), sirAT113M-T18 (amp) This study 
CYD172 dnaAA50V-T25 (kan), sirAV118M-T18 (amp) This study 
CYD173 dnaAA50V-T25 (kan), sirAK121N-T18 (amp) This study 
CYD175 dnaAA50V-T25 (kan), sirAP141T-T18 (amp) This study 
CYD286 T25-soj (kan), sirA-T18 (amp) This study 
CYD306 T25-soj (kan), empty-T18 (amp) This study 
CYD307 T25-empty (kan), sirA-T18 (amp) This study 
CYD602 dnaAT116N-T25 (kan), sirAY51A-T18 (amp) This study 
CYD605 dnaAF120S-T25 (kan), sirAY51A-T18 (amp) This study 
CYD608 dnaAI122T-T25 (kan), sirAY51A-T18 (amp) This study 
CYD611 dnaAH130D-T25 (kan), sirAY51A-T18 (amp) This study 
CYD626 dnaAV136A-T25 (kan), sirAY51A-T18 (amp) This study 
CYD629 dnaAK197N-T25 (kan), sirAY51A-T18 (amp) This study 
CYD632 dnaAD215V-T25 (kan), sirAY51A-T18 (amp) This study 
CYD635 dnaAP255L-T25 (kan), sirAY51A-T18 (amp) This study 
CYD638 dnaAG268R-T25 (kan), sirAY51A-T18 (amp) This study 
CYD711 T25-soj (kan), sirAP141T-T18 (amp) This study 
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Table 2.1.  Continued. 
Strain Description Reference 
CYD715 T25-soj (kan), sirAT113M-T18 (amp) This study 
CYD716 T25-soj (kan), sirAV118M-T18 (amp) This study 
CYD717 T25-soj (kan), sirAK121N-T18 (amp) This study 
CYD718 T25-empty (kan), sirAP141T-T18 (amp) This study 
CYD722 T25-empty (kan), sirAT113M-T18 (amp) This study 
CYD723 T25-empty (kan), sirAV118M-T18 (amp) This study 
CYD724 T25-empty (kan), sirAK121N-T18 (amp) This study 
CYD736 T25-soj (kan), sirAE144A-T18 (amp) This study 
CYD737 T25-empty (kan), sirAE144A-T18 (amp) This study 
CYD742 T25-soj (kan), sirAA111V-T18 (amp) This study 
CYD743 T25-empty (kan), sirAA111V-T18 (amp) This study 
CYD765 T25-soj (kan), sirAS123C-T18 (amp) This study 
CYD770 T25-empty (kan), sirAS123C-T18 (amp) This study 
CYD823 dnaA-T25 (kan), sirAF14A-T18 (amp) This study 
CYD824 empty-T25 (kan), sirAF14A-T18 (amp) This study 
CYD1050 T25-soj (kan), sirAI103V-T18 (amp) This study 
CYD1055 T25-empty (kan), sirAI103V-T18 (amp) This study 
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Table 2.2.  Plasmids used in Chapter II. 
 
Plasmid Description Reference 
pCH363 empty-T18 (amp) Tom Bernhardt 
pDR111 amyE::Phy-empty (spec) David Z. Rudner 
pKNT25 empty-T25 (kan) Tom Bernhardt 
pKT25 T25-empty (kan) Tom Bernhardt 
pminiMAD oriBsTs (amp)(erm) (239)  
pYD009 sirA-T18 (amp) This study 
pYD011 dnaA-T25 (kan) This study 
pYD040 dnaAF49Y-T25 (kan) This study 
pYD042 dnaAA50V-T25 (kan) This study 
pYD059 sirAY51A-T18 (amp) This study 
pYD081 pminiMAD-dnaAF49Y (amp) This study 
pYD096 T25-soj (kan) This study 
pYD101 pminiMAD-sirAY51A (amp) This study 
pYD102 amyE::Phy-sirA (amp)  This study 
pYD125 amyE::Phy-sirAP141T (amp)  This study 
pYD126 amyE::Phy-sirAQ30L (amp)  This study 
pYD127 amyE::Phy-sirAI83K (amp)  This study 
pYD128 pminiMAD-sirAP141T (amp) This study 
pYD129 pminiMAD-sirAF14A (amp)  This study 
pYD130 pminiMAD-dnaAA50V (amp)  This study 
pYD131 amyE::Phy-sirAQ41H (amp) This study 
pYD132 sirAE144A-T18 (amp) This study 
pYD133 amyE::Phy-sirAE144A (amp)  This study 
pYD134 amyE::Phy-sirAL69F (amp)  This study 
pYD135 amyE::Phy-sirAA111V (amp)  This study 
pYD136 amyE::Phy-sirAR64P (amp) This study 
pYD137 pminiMAD-sirAE144A (amp)  This study 
pYD138 pminiMAD-sirAS123C (amp)  This study 
pYD139 sirAS123C-T18 (amp) This study 
pYD140 amyE::Phy-sirAS123C (amp)  This study 
pYD141 amyE::Phy-sirAP124L (amp)  This study 
pYD142 amyE::Phy-sirAS106P (amp)  This study 
pYD143 amyE::Phy-sirAL28P (amp)  This study 
pYD146 sirAA111V-T18 (amp) This study 
pYD165 pminiMAD-sirAA111V (amp) This study 
pYD166 pminiMAD-sirAI103V (amp) This study 
pYD167 pminiMAD-sirAT113M (amp) This study 
pYD168 pminiMAD-sirAV118M (amp) This study 
pYD169 pminiMAD-sirAK121N (amp) This study 
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Table 2.2.  Continued. 
 
Plasmid Description Reference 
pYD170 amyE::Phy-sirAF115Y (amp) This study 
pYD171 amyE::Phy-sirAF14A (amp) This study 
pYD172 amyE::Phy-sirAY51A (amp) This study 
pYD173 sirAI103V-T18 (amp) This study 
pYD174 sirAT113M-T18 (amp) This study 
pYD175 sirAV118M-T18 (amp) This study 
pYD176 sirAK121N-T18 (amp) This study 
pYD177 sirAP141T-T18 (amp) This study 
pYD178 dnaAT116N-T25 (kan) This study 
pYD179 dnaAF120S-T25 (kan) This study 
pYD180 dnaAI122T-T25 (kan) This study 
pYD181 dnaAH130D-T25 (kan) This study 
pYD182 dnaAV136A-T25 (kan) This study 
pYD183 dnaAK197N-T25 (kan) This study 
pYD184 dnaAD215V-T25 (kan) This study 
pYD185 dnaAP255L-T25 (kan) This study 
pYD186 dnaAG268R-T25 (kan) This study 
pYD187 sirAF14A-T18 (amp) This study 
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Table 2.3.  Oligonucleotides used in Chapter II. 
Oligo Sequence 5’ to 3’ 
OJH083 ATGACAGAGAAACAGATTCAAGCTATTACACAACCAATCCCG
A 
OYD006 CATTGCATGCGTAACACACAGGAAACAGCTATGGAACGTCAC
TACTATACG 
OYD007 GCATGGATCCGAACCGCTACCGACAAAATTTCTTTCTTTCAC 
OYD011 GCATGGTACCGAACCGCTACCTTTAAGCTGTTCTTTAATTTCTT
T 
OYD035 GCATGGATCCGTAACACACAGGAAACAGCTATGGAAAATATA
TTAGACCTGTG 
OYD043 CAATCACGGCTCCCAATGAATATGCCAGAGACTGGCTGGAGT
CC 
OYD045 TCACGGCTCCCAATGAATTTGTCAGAGACTGGCTGGAGTCCA
G 
OYD046 AAGCTTGCATGCCTGCAGGT 
OYD047 GGTCGGCGGCGTTTGCGTAAC 
OYD059 CAGCCAGTCTCTGGCATATTCATTGGGAGCCGTGATTGTTAAT
G 
OYD061 CTGGACTCCAGCCAGTCTCTGACAAATTCATTGGGAGCCGTGA 
OYD070 GTGTGGAATTGTGAGCGGATAAC 
OYD116 CATTGGACAAGCCTTGAAAAGCAG 
OYD117 GTAATCTCCCGAAGCCACAATTTC 
OYD122 GCATGGATCCCGGCTTTTTTTAGTATCCACAG 
OYD123 GCATGAATTCGTTTGTAAATTTCTCAGAAGACAG 
OYD214 TCGGGATTGGTTGTGTAATAGCTTGAATCTGTTTCTCTGTCAT 
OYD215 GCATGGATCCTCAATGGACCGTTTTGAGAAAC 
OYD216 GCATGAATTCAGGTTTCATTCCCATTTGCATC 
OYD254 GCATGGATCCGGGCAGCGGTGTGGGAAAAATCATAGCAATTA
C 
OYD255 GCATGAATTCTTAGCCATTCGCAGCCACTTCC 
OYD276 AGCAATTACGAACCAAAAAGTCGGGGTCGGCAAAACAACGA 
OYD277 TCGTTGTTTTGCCGACCCCGACTTTTTGGTTCGTAATTGCT 
OYD280 GGTTCTGCTGGTAGATATTGCTCCGCAGGGAAATGCGACAA 
OYD281 TTGTCGCATTTCCCTGCGGAGCAATATCTACCAGCAGAACC 
OYD296 CCATTATGTAATAGATCATAATCC 
OYD297 GACAACTCTGATTAATGCTCC 
OYD302 ATCATAATCTTTACGTATTATTTCG 
OYD305 GGCTTCGGGAGATTACGAGGTAGAAACGATATTCTTTGAAG 
OYD306 CTTCAAAGAATATCGTTTCTACCTCGTAATCTCCCGAAGCC 
OYD310 TATGCTCAATCCAAAATATAATTTTGATACTTTTGTCATCG 
OYD311 CGATGACAAAAGTATCAAAATTATATTTTGGATTGAGCATA 
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Table 2.3.  Continued. 
Oligo Sequence 5’ to 3’ 
OYD312 AAAATATACTTTTGATACTTCTGTCATCGGATCTGGAAACC 
OYD313 GGTTTCCAGATCCGATGACAGAAGTATCAAAAGTATATTTT 
OYD314 TACTTTTGATACTTTTGTCACCGGATCTGGAAACCGATTTG 
OYD315 CAAATCGGTTTCCAGATCCGGTGACAAAAGTATCAAAAGTA 
OYD316 GATCTGGAAACCGATTTGCAGATGCTGCTTCCCTCGCAGTA 
OYD317 TACTGCGAGGGAAGCAGCATCTGCAAATCGGTTTCCAGATC 
OYD326 TGATGTGCTTTTGATAGATGTTATTCAATTTTTAGCGGGGA 
OYD327 TCCCCGCTAAAAATTGAATAACATCTATCAAAAGCACATCA 
OYD328 TGCGCTCACGTTTTGAATGGAGACTTATTACAGATATCACA 
OYD329 TGTGATATCTGTAATAAGTCTCCATTCAAAACGTGAGCGCA 
OYD330 AACTCTATCCGAGATAATAATGCCGTCGACTTCCGCAATCG 
OYD331 CGATTGCGGAAGTCGACGGCATTATTATCTCGGATAGAGTT 
OYD354 CTGTTCAGCGCATTGCGCAC 
OYD362 ATGCAAGCTTACATAAGGAGGAACTACTATGGAACGTCACTAC
TATACG 
OYD363 AGCTGCTAGCTTAGACAAAATTTCTTTCTTTCAC 
OYD364 GCATGCATGCGTAACACACAGGAAA 
OYD365 GCATGGATCCGAACCGCTACCGA 
OYD366 CGTACCTGATCAAAGAGGAAGCTGCCAATCACTATTTCGGCC 
OYD367 GGCCGAAATAGTGATTGGCAGCTTCCTCTTTGATCAGGTACG 
OYD368 GCATGGATCCATGGAACGTCACTACTATACG 
OYD369 GCATGAATTCCTGCAAATTGTCATGGCGAAC 
OYD376 AGCGTTACGGATGGCTAAATACGGTGAAAGAAAGAAATTTT 
OYD377 AAAATTTCTTTCTTTCACCGTATTTAGCCATCCGTAACGCT 
OYD380 GGTTATGTTTGAGCTGTTTCTAGACTATCATTGGACAAGCC 
OYD381 GGCTTGTCCAATGATAGTCTAGAAACAGCTCAAACATAACC 
OYD382 GCTGGATTATATTTATAGAAAAGCTTTGCCGAAAGCAAAAG 
OYD383 CTTTTGCTTTCGGCAAAGCTTTTCTATAAATATAATCCAGC 
OYD384 AGCTGCTAGCTTAGACAAAATTTCTTGCTTTCAC 
OYD387 ATGCGTCGACACATAAGGAGGAACTACTATGGAACGTCACTAC
TATACG 
OYD388 AGCTGCATGCTTAGACAAAATTTCTTTCTTTCAC 
OYD389 ACAAGCCTTGAAAAGCAGCACTATGAAATGACAGAGAAACA 
OYD390 TGTTTCTCTGTCATTTCATAGTGCTGCTTTTCAAGGCTTGT 
OYD391 ATGGCTAAATCCGGTGAAAGCAAGAAATTTTGTCTAAAACC 
OYD392 GGTTTTAGACAAAATTTCTTGCTTTCACCGGATTTAGCCAT 
OYD397 TTACGAGGCAGAAACGATATACTTTGAAGTGTTAAGAAAAG 
OYD398 CTTTTCTTAACACTTCAAAGTATATCGTTTCTGCCTCGTAA 
OYD399 TTGAAGTGTTAAGAAAAGTATGCCCTTGCTTTTTAGCAATG 
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Table 2.3.  Continued. 
 
Oligo Sequence 5’ to 3’ 
OYD400 CATTGCTAAAAAGCAAGGGCATACTTTTCTTAACACTTCAA 
OYD401 AGTGTTAAGAAAAGTAAGCCTTTGCTTTTTAGCAATGGATT 
OYD402 AATCCATTGCTAAAAAGCAAAGGCTTACTTTTCTTAACACT 
OYD403 ACATGATAGAAATTGTGGCTCCGGGAGATTACGAGGCAGAA 
OYD404 TTCTGCCTCGTAATCTCCCGGAGCCACAATTTCTATCATGT 
OYD405 GGAATCGGTTATGTTTGAGCCGTTTCAAGACTATCATTGGA 
OYD406 TCCAATGATAGTCTTGAAACGGCTCAAACATAACCGATTCC 
OYD491 TGAAGGAGCACATGATAGAAGTTGTGGCTTCGGGAGATTAC 
OYD492 GGGAGATTACGAGGCAGAAATGATATTCTTTGAAGTGTTAA 
OYD493 TTAACACTTCAAAGAATATCATTTCTGCCTCGTAATCTCCC 
OYD494 CAGAAACGATATTCTTTGAAATGTTAAGAAAAGTAAGCCCT 
OYD495 AGGGCTTACTTTTCTTAACATTTCAAAGAATATCGTTTCTG 
OYD496 TTCTTTGAAGTGTTAAGAAATGTAAGCCCTTGCTTTTTAGC 
OYD497 GCTAAAAAGCAAGGGCTTACATTTCTTAACACTTCAAAGAA 
OYD498 GTAATCTCCCGAAGCCACAACTTCTATCATGTGCTCCTTCA 
OYD517 CCGGCCGCCAAAGGAAATTCTGACACTTGAAGACAGATTGC 
OYD518 GCAATCTGTCTTCAAGTGTCAGAATTTCCTTTGGCGGCCGG 
OYD526 GCATGGATCCGAACCGCTACCGACAAAATTTCTTGCTTTCAC 
OYD527 ACATGCTGCTTCCCTCGCAGGAGCGGAAGCGCCCGCGAAAG 
OYD528 CTTTCGCGGGCGCTTCCGCTCCTGCGAGGGAAGCAGCATGT 
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2.2.2 Microscopy 
All samples were grown in CH media overnight at room temperature to mid-
exponential, back-diluted to OD600=0.008 in 25 ml CH, and grown at 37°C in a shaking 
waterbath set at 280 rpm for 1.5 hrs. When indicated, 1 mM IPTG was added, and cells 
were grown for an additional 1.5 hrs. All cells were in mid-exponential growth when 
images were captured. To capture images, 1 ml of cells were pelleted at 6,010 x g for 1 
min in a tabletop microfuge at room temperature. The supernatant was removed by 
aspiration and the pellet resuspended in ~10 ul PBS containing FM4-64 membrane stain 
(3 µg/ml)(Life Technologies) and DAPI DNA stain (2 µg/ml)(Molecular Probes). Cells 
were mounted on glass slides with polylysine treated coverslips immediately before 
imaging. Fluorescence microscopy was performed with a Nikon Ti-E microscope 
equipped with a CFI Plan Apo lambda DM 100X objective, and Prior Scientific Lumen 
200 Illumination system, C-FL UV-2E/C DAPI, C-FL GFP HC HISN Zero Shift, C-FL 
YFP HC HISN Zero Shift, and C-FL Cyan GFP, filter cubes, and a CoolSNAP HQ2 
monochrome camera. All images were captured with NIS Elements Advanced Research 
(version 4.10), and processed with NIS Elements and ImageJ64 (240). 
2.2.3 Quantitative forespore chromosome trapping assay  
Assays were carried out as previously described (187). An oriC-proximal 
reporter (-7° yycR::PspoIIQ-yfp) and a right-arm reporter (28° amyE::PspoIIQ-cfp) were used 
to assess chromosome organization. Cells were collected and membranes were stained 
with TMA-DPH (0.02 mM) as described in microscopy. YFP, CFP, and TMA-DPH 
images were captured 2.5 hrs after cells were resuspended and grown in sporulation 
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media (237) at 37°C in a shaking waterbath set at 280 rpm. Images from a minimum of 
four biological replicates were captured for each strain. To quantitate the number of cells 
with the forespore reporters trapped in the forespore, the CFP, YFP, and TMA images 
were pseudocolored and overlaid. Forespores containing detectable signal from YFP, 
CFP, or both from at least four independent fields (n>500 cells per trial) were counted 
manually for each biological replicate, adjusting brightness to ensure that even cells with 
faint signal were counted. Forespores failing to capture either reporter were generally 
<1% and were not included in the counts for -7° reporter excluded. The average 
percentage and standard deviation of forespores with CFP signal only (indicating that the 
-7° oriC-proximal reporter was not captured in the forespore) were plotted using 
Microsoft Excel. The statistical significance between samples (P-value) was determined 
using an unpaired Student’s t-test. 
 
2.2.4 Bacterial two-hybrid assay (B2H), general methods  
 
Bacterial two hybrids were performed essentially as described (241) with the 
following modifications: cloning was carried out in the presence of 0.2% glucose (w/v) 
in addition to antibiotics. E. coli strain DHP1 harboring the relevant pairwise 
interactions were grown to exponential phase in LB with 0.2% glucose (w/v), ampicillin 
(50 μg/ml), and kanamycin (25 μg/ml). Samples were normalized by OD600 and five μl 
of each culture spotted on M9-glucose minimal media plates containing 250 μM 
isopropyl-β-D-thiogalactopyranoside (IPTG), 40 μg/ml 5-bromo-4-chloro-3-indolyl-β-
D-galactopyranoside (X-Gal), ampicillin (50 μg/ml), and kanamycin (25 μg/ml). Plates 
were incubated at room temperature in the dark for 50 to 70 hrs prior to image capture.  
 
 47 
 
2.2.5 Screen for SirA variants that exhibited a loss of interaction with Soj  
 
The loss-of-interaction screen was performed by B2H assay (see above). Soj was 
fused to C-terminus of the cyaA T25 domain (T25-Soj). SirA was fused to N-terminus of 
the cyaA T18 domain (SirA-T18). E. coli strain DHP1 was co-transformed with a 
plasmid encoding wild-type T25-Soj and a ligation reaction between a mutagenized pool 
of sirA PCR products digested with SphI and BamHI and pCH363 cut with SphI and 
BamHI (to generate SirA-T18 fusions). The sirA gene was mutagenized by PCR using 
the Genemorph II random DNA mutagenesis kit (Agilent Technologies). The co-
transformations were plated on LB solid media (1.5% bacto-agar (w/v)) supplemented 
with 0.2% glucose (w/v), ampicillin (50 μg/ml), and kanamycin (25 μg/ml). To screen 
for loss-of-interaction variants, ~2,000 colonies were patched onto M9-glucose minimal 
media plates supplemented with IPTG (250 μM), X-Gal (40 μg/ml), ampicillin (50 
μg/ml), and kanamycin (25 μg/ml). Patches that appeared white were rescreened on M9-
glucose minimal media plates containing IPTG (250 μM), X-Gal (40 μg/ml), ampicillin 
(50 μg/ml), and kanamycin (25 μg/ml) to reduce the number of false negatives. 
Approximately 12% of the clones screened showed a loss of interaction between SirA 
and Soj. PCR with primers OYD70 and OYD354 was used to eliminate loss-of-
interaction candidates that lacked a sirA insert of the appropriate size in the SirA-T18 
plasmid, reducing the number of candidates to 42. These candidates were sequenced to 
eliminate candidates possessing premature stop codons or multiple mutations, reducing 
the number of candidates to 13. To exclude SirA variants that might be misfolded, each 
candidate allele was PCR amplified with OYD362 and OYD363, cloned into the 
HindIII/NheI site of an inducible misexpression vector and growth was assessed as 
described. 
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2.2.6 Screen for SirA variants that exhibit a gain of interaction with DnaAA50V 
The gain-of-interaction screen was performed by first co-transforming E. coli 
strain DHP1 with a plasmid encoding DnaAA50V-T25 and a pool of mutagenized sirA-
T18 ligation products. The sirA gene was mutagenized by PCR using the Genemorph II 
random DNA mutagenesis kit (Agilent Technologies). Co-transformation was selected 
for on LB plates supplemented with 0.2% glucose (w/v), ampicillin (50 μg/ml), and 
kanamycin (25 μg/ml). Gain-of-interaction variants were identified by screening on M9-
glucose minimal media plates supplemented with IPTG (250 μM), X-Gal (40 μg/ml), 
ampicillin (50 μg/ml), and kanamycin (25 μg/ml). Plasmids encoding candidates were 
used as the template to amplify sirA region using OYD70 and OYD354, and each PCR 
product was sequenced by using OYD116 and OYD117 to determine the identity of the 
associated mutations. 
2.2.7 Screen for DnaA variants that exhibit a gain of interaction with SirAY51A  
The gain-of-interaction screen was performed by first co-transforming cells with 
a plasmid encoding SirAY51A-T18 and a pool of mutagenized dnaA-T25 ligation 
products. The co-transformations were plated on LB plates supplemented with 0.2% 
glucose (w/v), ampicillin (50 μg/ml), and kanamycin (25 μg/ml) and gain-of-interaction 
variants were identified by screening patches on M9-glucose minimal media plates 
supplemented with IPTG (250 μM), X-Gal (40 μg/ml), ampicillin (50 μg/ml), and 
kanamycin (25 μg/ml). Plasmids encoding gain-of-interaction candidates were used as 
the template to amplify dnaA using OYD46 and OYD47. Each PCR product was 
sequenced in both directions using OYD296 and OYD297. 
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2.2.8 Allelic replacement of wild-type sirA with sirA mutants   
 
The sirA mutants were generated through allelic replacement. Briefly, each 
mutant gene was generated using overlap extension PCR and cloned into the vector 
pminiMAD, a plasmid harboring a temperature sensitive origin of replication. Each 
plasmid was then transformed into B. subtilis 168 and single-crossover integration was 
selected by plating cells at 37°C in the presence of erythromycin (1 µg/ml) and 
lincomycin (25 µg/ml). Six independent colonies were inoculated into six independent 3 
ml LB cultures and grown overnight at room temperature in a rotary drum set at 60 rpm. 
The next day, the cultures were back-diluted 150X in fresh LB, and grown 8 hrs at room 
temperature. 100 μl of a 10-5 dilution of each culture was plated on 6 independent LB 
plates, and incubated overnight at 37°C. Ten single colonies from each plate were 
patched on LB plate and LB plate supplemented with erythromycin (1 µg/ml) and 
lincomycin (25 µg/ml). After streaking for isolated colonies, genomic DNA was 
collected from several antibiotic sensitive colonies obtained from each independent 
culture. The sirA region was then PCR-amplified (primer pair OYD006 and OYD007) 
and strains carrying the desired mutation were identified by sequencing with primer 
OYD116 and OYD117.  
 
2.2.9 Plate growth assay  
 
B. subtilis strains were streaked on LB plates containing 100 µg/ml 
spectinomycin and 1 mM IPTG when indicated. The plates were incubated at 37°C 
overnight and images were captured on a ScanJet G4050 flatbed scanner (Hewlett 
Packard) set on medium format mode. 
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2.2.10 Western blot analysis   
 
To test the stability of SirA variants by western blot analysis, 2 ml cell pellets 
were collected 2 hrs after resuspension in sporulation media (237) and frozen at -80°C 
until processing. Lysates were generated by resuspending each pellet in 50 μl lysis 
buffer [20 mM Tris pH 7.5, 10 mM EDTA, 1 mg/ml lysozyme, 10 µg/ml DNase I, 100 
µg/ml RNase A, 1mM PMSF] and incubated 15 min at room temperature. Fifty μl of 2X 
sample buffer [0.25 M Tris pH 6.8, 4% SDS, 20% glycerol, 10 mM EDTA] containing 
10% 2-mercaptoethanol was added and samples were boiled for 5 min. Lysate loads 
were normalized by OD600 values obtained at the time of cell harvest (normalized to 
OD600 = 1). Five μl of each cell lysate was loaded, and proteins were separated on a 4-
20% Tris-HCl gradient gels (Lonza). Proteins were transferred to nitrocellulose 
membrane (Pall) for 1 hr at 60 V on an ice bath. Membranes were blocked in PBS [pH 
7.4] containing 0.05% Tween-20 and 5% non-fat milk powder (w/v). Membranes were 
incubated overnight at 4°C with a 1:1,000 dilution of α-SirA peptide antibody 
(CSKRYGWLNPVKERN, Genscript) in PBS [pH 7.4] containing 0.05% Tween-20 and 
5% non-fat milk powder (w/v) and washed. The membranes were then incubated with 
1:10,000 dilutions of horseradish peroxidase-conjugated goat anti-rabbit 
immunoglobulin G secondary antibody (Bio-Rad) in PBS [pH 7.4] containing 0.05% 
Tween-20 and 5% non-fat milk powder (w/v) for 1 hr at room temperature. After 
washing, blots were incubated with SuperSignal West Femto Chemiluminescent 
substrate (Thermo) prior to capture in an Amersham Imager 600 (GE Healthcare). All 
western blots were performed on a minimum of three biological and experimental 
replicates. Densitometric analysis of the levels compared to the wild-type controls were 
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performed with ImageJ (240). Levels of SirA were always within 2-fold of wild-type for 
all of the strains examined. 
 
2.3 Results 
 
2.3.1 A sirA mutant has an oriC segregation defect during sporulation 
 
Soj interacts directly with DnaA Domain III (140, 143) and is required for the 
high fidelity capture of oriC in the forespore compartment (187). SirA also interacts with 
DnaA (7, 79) and a ΔsirA mutant is reported to have a defect in organization of the axial 
filament during sporulation (7). Since Soj and SirA both regulate DnaA activity directly, 
we hypothesized that SirA and Soj might both act through a DnaA-dependent pathway to 
facilitate oriC segregation during sporulation. To test this idea, we determined the 
location of oriC in a ΔsirA mutant using a single cell chromosome organization assay 
that provides a readout of regions of DNA captured or “trapped” in the forespore 
compartment during sporulation (187). We found that 10% of cells in the sirA mutant 
population failed to trap the oriC-proximal reporter (Fig 2.2). Introducing PsirA-sirA back 
into the chromosome at an ectopic locus in the sirA mutant restored oriC trapping to 
levels indistinguishable from wildtype (P>0.5), indicating that the defect could be 
specifically attributed to the loss of sirA (Fig 2.2). In comparison, a Δsoj mutant failed to 
capture an oriC-proximal reporter (integrated at -7°) in 19% of sporulating cells, while 
wildtype failed in less than 1% of cells (Fig. 2.2), similar to prior reports (187). A Δsoj 
ΔsirA double mutant phenocopied the Δsoj mutant, consistent with SirA acting in the 
same pathway as Soj to facilitate oriC capture. The nine percent difference between the 
Δsoj and ΔsirA mutants was reproducible (P<0.001), indicating that Soj also contributes 
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to the capture of oriCs in a SirA-independent manner. The oriC capture defect in the 
Δsoj and Δsoj ΔsirA double mutants was reduced to 10% when the gene for the DNA 
replication checkpoint protein, Sda, was also deleted (Fig 2.2). In contrast, deletion of 
sda in the ΔsirA mutant did not further enhance oriC capture in a statistically significant 
way (P>0.05)(Fig 2.2); at the same time we do not exclude the possibility that the slight 
enhancement of oriC capture seen in the ΔsirA Δsda mutant compared to the ΔsirA 
mutant represents a real biological difference. Synthesis of Sda delays sporulation in 
cells that are actively initiating DNA replication (140). Therefore, these results suggest 
that the fate of the nine percent of oriCs that depend on Soj but not SirA may relate to 
the replication status of this subset of cells, although we did not investigate this 
observation further. 
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Fig. 2.2.  SirA and Soj act in the same pathway to segregate oriC during sporulation. 
Single cell analysis indicating the average percentage of forespores that fail to capture 
the origin reporter (-7°) in the forespore during sporulation. Wildtype (BJH103), Δsoj 
(BYD116), ΔsirA (BJH090), ΔsirA, PsirA-sirA (BJH015), Δsoj ΔsirA (BYD117), Δsoj 
Δsda (BYD470), ΔsirA Δsda (BYD472) and Δsoj ΔsirA Δsda (BYD471). A minimum 
of 500 cells from each of four biological replicates was counted for each strain (total 
n >2000 average). Error bars indicate standard deviation from the average of the four 
trials. The asterisks indicate pairwise comparisons that were statistically 
indistinguishable (P>0.05, students t-test). 
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2.3.2 A wild-type interaction between SirA and Soj is not required for SirA-
dependent oriC capture 
 
Our data indicate that SirA and Soj act in the same pathway to facilitate oriC 
segregation in 10% of cells (Fig 2.2). To assess if SirA might interact directly with Soj 
to facilitate oriC segregation, we performed a bacterial two-hybrid (B2H) assay. A 
positive interaction was observed between SirA-T18 and T25-Soj that was absent in the 
negative controls (Fig 2.3A). To test if the interaction between SirA and Soj was 
important for oriC capture in vivo, we first screened for SirA variants that exhibited a 
loss of interaction with Soj. To obtain such variants, we introduced a mutagenized pool 
of sirA PCR products into a B2H plasmid to generate a SirA-T18 pool, and transformed 
this plasmid pool into E. coli reporter cells harboring the B2H partner plasmid, T25-Soj. 
Next we screened for SirA variants that showed loss of interaction with Soj in the B2H 
assay. sirA alleles that appeared full-length in a PCR test were sequenced, and alleles 
encoding premature stop codons or multiple mutations were eliminated, leaving 13 
candidates (Table 2.4). 
SirA is natively expressed only during sporulation and misexpression (forcing 
expression during vegetative growth by placing under the control of an IPTG-inducible 
promoter on the chromosome) inhibits DnaA activity and prevents colony formation on 
plates (7), a phenotype that is not dependent on Soj (Fig 2.4). Therefore, we screened for 
properly folded proteins using misexpression. Seven of the loss-of-interaction mutants 
did not inhibit DnaA activity, as judged by growth on media containing inducer (Table 
2.4) and were excluded from further analysis since we were unable to assess if they were 
properly folded. The remaining six mutants phenocopied the wild-type sirA vegetative 
misexpression phenotype (Table 2.4), suggesting the proteins were not misfolded. 
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Fig. 2.3.  Identification and characterization of SirA variants that exhibit loss of 
interaction with Soj. (A) B2H between Soj and SirA (CYD286) or Soj and each of the 
following SirA variants: SirAA111V (CYD742), SirAS123C (CYD765), SirAP141T 
(CYD711), SirAE144A (CYD736). Negative controls: empty partner vector with wild-type 
SirA or the indicated SirA variant (column 1) or Soj with the empty partner vector 
(column 2). (B) Growth of strains harboring Phy-sirA (BYD036), Phy-sirAA111V 
(BYD288), Phy-sirAS123C (BYD295), Phy-sirAP141T (BYD283), Phy-sirAE144A (BYD292) or 
Phy-empty (BAM075) following misexpression. (C) Western blot analysis using α-SirA 
antibody on samples taken 2 hrs after sporulation by resuspension. Wildtype (BJH103), 
ΔsirA (BJH090), sirAA111V (BYD306), sirAS123C (BYD310), sirAP141T (BYD299), 
sirAE144A (BYD308). (D) The same misexpression strains listed in B were grown in CH 
liquid media 1.5 hrs after the addition of 1mM IPTG. Cell membranes were stained with 
FM4-64 (pseudocolored pink) and DNA with DAPI (pseudocolored green). White 
arrowheads indicate example anucleate cells. (E) Single cell analysis indicating the 
average percentage of forespores that fail to capture the origin reporter (-7°) in the 
forespore during sporulation using the same strains listed in C. A minimum of 500 cells 
from each of four biological replicates was counted for each strain (total n >2000 
average). Error bars indicate standard deviation from the average of the four trials. The 
wildtype and delta sirA data from Fig 2.2 were re-plotted to aid comparison. Only the 
ΔsirA mutant and sirAP141T differ significantly from wildtype. 
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Fig. 2.3.  Continued 
57 
Table 2.4.  Identification of SirA variants that do not interact with Soj in B2H. Growth 
refers to the resistance (R), or sensitivity (S) of the cells to SirA-mediated growth 
inhibition following misexpression from an IPTG inducible promoter (Phy). Each of the 
misexpression constructs was integrated in single copy at the amyE locus. 
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Fig. 2.4.  Soj is not required for SirA to prevent colony formation on the plate. Cells 
harboring one copy of Phy-sirA (BYD036) or the Phy promoter without an insert 
(BAM075) in a wild-type background or a Δsoj background (BYD574 and BYD575, 
respectively) were streaked on an LB plate supplemented with 100 µg/ml spectinomycin 
and 1 mM IPTG. Cells were grown at 37°C overnight before image capture.   
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Next we performed the chromosome organization assay on strains harboring 
SirAA111V, SirAS123C, SirAP141T, or SirAE144A. These variants were initially chosen because 
they showed loss-of-interaction with Soj (Fig 2.3A), prevented growth on plates when 
misexpressed (Fig 2.3B), clustered in residues distal to the described DnaA-SirA 
interaction interface implicated in regulation of DnaA (Fig 2.5), and exhibited 
comparable levels of SirA protein compared to wildtype when expressed from the native 
locus (Fig 2.3C). When we investigated the membrane and nucleoid phenotypes 
associated with vegetative misexpression, SirAA111V, SirAP141T, and SirAE144A appeared 
indistinguishable from the control strain misexpressing wild-type SirA, including the 
generation of anucleate cells (Fig 2.3D). However, SirAS123C displayed no obvious signs 
of inhibited DNA replication, and instead exhibited slightly curved cells or cell poles 
(Fig 2.3D). After 150 min induction, cells expressing SirAS123C exhibited hooked poles, 
bent filaments, and signs of lysis (Fig 2.6). The nucleoids in these cells showed no 
obvious indications of replication inhibition, suggesting the mechanism leading to cell 
killing in this strain is distinct from the other three loss-of-interaction variants. 
Cells expressing SirAA111V, SirAS123C, and SirAE144A in place of wild-type SirA 
captured the oriC reporter at levels statistically indistinguishable from wildtype (Fig 
2.3E). In contrast, the SirAP141T variant phenocopied the sirA mutant, failing to capture 
oriC in 10% of sporulating cells (Fig 2.3E). From these data we conclude that a wild-
type interaction between SirA and Soj is not required for SirA-dependent oriC capture 
and that SirAP141T appears to be critical for wild-type SirA activity. Moreover, since 
SirAP141T can still inhibit DNA replication (Table 2.4, Fig 2.3B and 2.3D), these results 
suggest that the oriC capture function of SirA comprises a genetically separable and 
distinct activity. 
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Fig. 2.5.  SirA-DnaA Domain I crystal structure. Structure from PDB: 4TPS (79). B. 
subtilis DnaA Domain I (pink) and B. subtilis SirA (light green). The location of 
SirAP141T which exhibits gain of interaction with DnaAA50V and loss of interaction with 
Soj (red). Location of other SirA variants that exhibit loss-of-interaction with Soj 
(orange). Location of SirA variants (except SirAP141T) that exhibit gain of interaction 
with DnaAA50V (cyan). The location of the SirAE144A substitution is not shown because it 
is absent in the structure. Location of substitutions exhibiting loss of interaction with 
wild-type DnaA (bright green). Location of DnaA substitutions that exhibit loss of 
interaction with wild-type SirA (purple). 
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Fig. 2.6.  Misexpression of SirAS123C in liquid culture. Cells harboring one copy of Phy-
sirAS123C (BYD295) strains grown in CH liquid media for 1.5 hrs (top) and 2.5 hrs 
(bottom) after the addition of 1mM IPTG. Cell membranes were stained with FM4-64 
(pseudocolored pink) and DNA with DAPI (pseudocolored green). 
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2.3.3 SirA facilitates oriC capture independent of its ability to inhibit DNA 
replication 
 
To further test the hypothesis that SirA’s ability to inhibit DnaA activity was 
independent from SirA’s observed role in oriC segregation, we generated two sirA 
variants, SirAF14A and SirAY51A, which are defective in their ability to inhibit DnaA. 
SirAF14A has an amino acid substitution at the described interaction interface between 
SirA and DnaA and was previously shown to be defective in the ability to inhibit DnaA 
activity in vivo (79). Since SirAY51 is also located at the SirA-DnaA interaction interface 
(79), we predicted a substitution in Y51 would also result in a loss-of-function 
phenotype. Compared to wild-type SirA, both SirAF14A and SirAY51A showed reduced 
interaction with full-length DnaA in a B2H assay (Fig 2.7A). In addition, cells 
misexpressing SirAF14A or SirAY51A during vegetative growth grew well on plates (Fig 
2.7B) and did not generate anucleates in liquid culture (Fig 2.7C). These results indicate 
that SirAF14A and SirAY51A are perturbed in their ability to inhibit DNA replication.   
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Fig. 2.7.  SirAF14A and SirAY51A exhibit reduced capacities to inhibit DNA replication. 
(A) B2H assay between DnaA and SirA (CYD050), DnaA and SirAF14A (CYD823), and 
DnaA and SirAY51A (CYD051). Negative controls: empty partner vector with wild-type 
SirA or the indicated SirA variant (column 1) or DnaA with the empty partner vector 
(column 2). (B) Growth of strains harboring Phy-sirA (BYD036), Phy-sirAF14A (BYD462), 
Phy-sirAY51A (BYD463) or Phy-empty (BAM075) following misexpression. (C) The same 
misexpression strains grown in CH liquid media 1.5 hrs after the addition of 1mM IPTG.  
Cell membranes were stained with FM4-64 (pseudocolored pink) and DNA with DAPI 
(pseudocolored green). White arrowheads indicate example anucleate cells. (D) Western 
blot analysis using α-SirA antibody on samples taken 2 hrs after sporulation by 
resuspension. Wildtype (BJH103), ΔsirA (BJH090), sirAF14A (BYD302), sirAY51A 
(BYD067). 
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Based on the observation that the DNA replication and oriC capture phenotypes 
were uncoupled in cells expressing SirAP141T, we hypothesized that SirAF14A and 
SirAY51A would still be able to facilitate oriC capture. To test this hypothesis, we 
replaced native sirA with alleles encoding either SirAF14A or SirAY51A at the native locus. 
Western blot analysis indicated that variants were stable and expressed at levels 
indistinguishable from those in wildtype (Fig 2.7D). Next, we tested the ability of the 
variants to facilitate oriC capture in the single cell trapping assay (187). The SirAY51A 
variant supported oriC capture at levels statistically indistinguishable from wildtype 
(P>0.05)(Fig 2.8). The SirAF14A variant produced a more intermediate phenotype, 
although it supported capture of the oriC-proximal reporter at levels more similar to 
wildtype than the ΔsirA mutant (4% vs. 10%)(Fig 2.8). These results further suggest that 
SirA’s role in oriC capture can be uncoupled from its ability to inhibit DNA replication 
initiation. 
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Fig. 2.8.  SirA facilitates oriC capture independent of its ability to inhibit DNA 
replication. Single cell analysis indicating the average percentage of forespores that fail 
to capture the origin reporter (-7°) in the forespore during sporulation. Wildtype 
(BJH103), ΔsirA (BJH090), sirAF14A (BYD302), sirAY51A (BYD067), dnaAF49Y 
(BYD073), dnaAA50V (BYD303). A minimum of 500 cells from each of four biological 
replicates was counted for each strain (total n >2000 average). Error bars indicate 
standard deviation from the average of the four trials. The data for wild-type and ΔsirA 
are identical to those in Fig 2.2. The asterisks indicate pairwise comparisons that were 
statistically indistinguishable (P>0.05, students t-test). 
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Although cells misexpressing SirAY51A and SirAF14A during vegetative growth 
exhibited phenotypes consistent with a reduced ability to inhibit DnaA-dependent 
replication initiation (Fig 2.7B and 2.7C), it is possible the variants retained sufficient 
activity to inhibit DNA replication initiation during sporulation. Therefore, we extended 
our analysis to test oriC capture in cells harboring variants of DnaA (DnaAF49Y and 
DnaAA50V) previously shown to be insensitive to SirA misexpression (81). We replaced 
wild-type dnaA with alleles encoding DnaAF49Y and DnaAA50V (markerless replacement 
of the wild-type gene at the native locus) and tested the ability of cells to resist the 
effects of SirA misexpression. Cells possessing either DnaAF49Y or DnaAA50V grew 
indistinguishably from wildtype during vegetative growth (Fig 2.9A) and possessed 
wild-type nucleoid morphology before SirA induction (Fig 2.9B), indicating that the 
variants were functional with respect to supporting DNA replication initiation in vivo. 
Both DnaA variants were also resistant to misexpression of SirA as judged by both 
growth on plates (Fig 2.9A) and nucleoid morphology (Fig 2.9B). These results confirm 
prior findings that cells utilizing DnaAF49Y or DnaAA50V are indeed resistant to SirA’s 
ability to inhibit DNA replication initiation (81). Moreover, the variants did not 
detectably interact with wild-type SirA in a B2H assay (Fig 2.9C), consistent with the 
loss-of-interaction observed in a yeast two-hybrid assay (81). 
 67 
 
 
 
 
Fig. 2.9.  DnaAF49Y and DnaAA50V are insensitive to SirA. (A) Growth of strains 
harboring Phy-sirA in backgrounds encoding wild-type dnaA (BYD036), dnaAF49Y 
(BYD464) or dnaAA50V (BYD465) following misexpression. (B) The same 
misexpression strains grown in CH liquid media 1.5 hrs after the addition of 1mM IPTG. 
Cell membranes were stained with FM4-64 (pseudocolored pink) and DNA with DAPI 
(pseudocolored green). White arrowheads indicate example anucleate cells. (C) B2H 
assay between SirA and DnaA (CYD050), SirA and DnaAF49Y (CYD053), and SirA and 
DnaAA50V (CYD055). Negative controls: empty partner vector with wild-type DnaA or 
the indicated DnaA variant (column 1) or SirA with the empty partner vector (column 2). 
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To test if cells utilizing DnaAF49Y or DnaAA50V were compromised in oriC 
segregation, we performed the chromosome organization assay in strain backgrounds 
harboring alleles encoding either DnaAF49Y or DnaAA50V in place of wild-type dnaA at 
the native locus. Both DnaAF49Y and DnaAA50V supported capture of the oriC-proximal 
reporter at levels statistically indistinguishable from wild-type DnaA (P>0.05)(Fig 2.8). 
These results further support the conclusion that SirA’s role in oriC capture is not 
dependent on its ability to inhibit DNA replication through its interactions with DnaA 
Domain I. At the same time, we do not exclude the possibility that SirA promotes oriC 
segregation through another DnaA-dependent mechanism. 
 
2.3.4 Residues near the C-terminus of SirA and in DnaA Domain III promote 
interaction between the two proteins 
 
Our data suggest that the DnaA Domain I interaction is not required for oriC 
segregation, and we identified one variant, SirAP141T, that supported DNA replication but 
not oriC segregation. Since this substitution occurred in the extreme C-terminus of SirA 
in a region distal to the described SirA-DnaA interaction interface (Fig 2.5), we 
hypothesized that this second region of SirA might interact with a distinct region of 
DnaA to promote oriC segregation. We were unable to assess the possibility of a second 
interaction interface using known data, as the SirA-DnaA co-crystal structure could only 
be obtained using only DnaA Domain I (79). Moreover, the suppressor selection utilized 
to identify DnaA residues important for interaction relied upon the ability of SirA to 
inhibit DNA replication (81), which our data indicate is a genetically separable activity. 
Therefore, we designed two genetic screens to identify SirA and DnaA residues that 
contribute to interaction between the two full-length proteins. 
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To identify residues of DnaA important for interaction with SirA, we performed 
a gain-of-interaction screen based on the observation that SirAY51A and wild-type DnaA 
do not detectably interact in the B2H assay (Fig 2.7A). We mutagenized dnaA and 
screened for DnaA variants that showed restored interaction with SirAY51A (Table 2.5 
and Fig 2.10). Unexpectedly, each of the nine variants we identified, DnaAT116N, 
DnaAF120S, DnaAI122T, DnaAH130D, DnaAV136A, DnaAK197N, DnaAD215V, DnaAP255L, and 
DnaAG268R possessed substitutions in DnaA Domain III (Table 2.5 and Fig 2.11), a 
region outside of the known SirA-DnaA interaction interface (79). Of note, DnaAF120, 
DnaAI122, and DnaAH130 cluster to a region of DnaA Domain III previously implicated in 
the toxicity bypass associated with induced expression of SojG12V, a constitutive 
monomer of Soj that also shows gain of interaction with wild-type DnaA (143). These 
results could suggest SirA and Soj are capable of targeting the same region of DnaA, 
although we do not exclude other possibilities. 
In a complementary approach, we took advantage of the fact that wild-type SirA 
and DnaAA50V do not interact in the B2H assay (Fig 2.9C) to identify regions of SirA 
important for SirA-DnaA interaction. We mutagenized sirA and screened for SirA 
variants that restored interaction with DnaAA50V (Table 2.5 and Fig 2.10). Surprisingly, 
all of the gain-of-interaction variants we identified (SirAI103V, SirAT113M, SirAV118M, 
SirAK121N, and SirAP141T) mapped to a region of SirA distal to the characterized SirA-
DnaA Domain I binding interface (Table 2.5 and Fig 2.5). Taken together, the location 
of the variants identified in the two gain-of-interaction screens are consistent with the 
idea that residues in SirA’s C-terminus interact directly with DnaA Domain III. 
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Table 2.5.  Residues outside the characterized SirA-DnaA interface promote 
interaction. Identification of DnaA and SirA variants that result in gain of interaction 
with SirAY51A and DnaAA50V, respectively, in a B2H assay. 
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Fig. 2.10.  Residues outside the characterized SirA-DnaA interface promote interaction 
between the two proteins. B2H assay between SirAY51A and wild-type DnaA (CYD051), 
or SirAY51A and each of the following DnaA variants: DnaAT116N (CYD602), DnaAF120S 
(CYD605), DnaAI122T (CYD608), DnaAH130D (CYD611), DnaAV136A (CYD626), 
DnaAK197N (CYD629), DnaAD215V (CYD632), DnaAP255L (CYD635), DnaAG268R 
(CYD638). (B) B2H assay between DnaAA50V and wild-type SirA (CYD055), and 
DnaAA50V and each of the following SirA variants: SirAI103V (CYD168), SirAT113M 
(CYD169), SirAV118M (CYD172), SirAK121N (CYD173), SirAP141T (CYD175). 
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Fig. 2.11.  DnaA Domain III crystal structure. Structure from PDB: 2Z4S (242). T. 
maritima DnaA Domain III (pink). The location of DnaA substitutions that exhibit gain 
of interaction with SirAY51A are shown in cyan on the structure and indicated on the 
sequence alignment by red asterisks. The location of residue changes that confer 
resistance to SojG12V misexpression are indicated with filled black triangles on the 
sequence alignment. The location of residue changes that confer resistance to YabA 
misexpression are indicated with filled blue circles. The location of residues implicated 
in DnaD interaction are indicated with filled black circles. 
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Of note, SirAP141T was also identified in the SirA-Soj loss-of-interaction screen 
(Table 2.4 and Fig. 2.3), and each of the SirA-DnaAA50V gain-of-interaction variants 
identified also exhibited a loss of interaction with Soj in a B2H assay (Fig 2.12A). 
Moreover, with the exception of SirAP141T (Fig 2.3E) and SirAT113M (which were 
statistically different from wildtype, P<0.05), each of the variants fully supported wild-
type capture of oriC (Fig 2.12B). None of the variants prevented colony formation on 
plates when misexpressed, suggesting they did not inhibit DNA replication (Fig 2.12C). 
These data further support the conclusion that SirA’s roles in DNA replication and oriC 
segregation are functionally distinct. 
In bacteria, DNA replication generally takes place at a single oriC and is 
followed by rapid segregation of the newly replicated origin toward the cell pole (or 
future cell pole)(Fig 2.1). The ParABS system, found in a wide-range of both Gram 
positive and Gram negative bacteria (136), has been implicated in the segregation of 
chromosomes following replication (243). However, in B. subtilis, cells without Soj 
(ParA) have no detectable defect in chromosome segregation during vegetative growth 
(139) and a majority (>98%) of cells lacking Spo0J (ParB) still effectively partition 
chromosomes between daughter cells (202). Spo0J becomes critical when chromosome 
condensation is severely impacted by the absence of a functional SMC complex (168), 
yet the SMC complex is itself only essential during conditions of fast growth (168, 206), 
and even an smc spo0J double mutant is still viable under slow growth conditions (168). 
Thus, although Spo0J and SMC are clearly important for fidelity, additional mechanisms 
likely exist to facilitate chromosome segregation. 
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Fig. 2.12.  Variants with mutations in residues outside the characterized SirA-DnaA 
interface can still segregate oriC but cannot inhibit DNA replication. (A) B2H assay 
between Soj and SirA (CYD286), and Soj and each of the following SirA variants: 
SirAI103V (CYD1050), SirAT113M (CYD715), SirAV118M (CYD716), SirAK121N (CYD717). 
Negative controls: empty partner vector with wild-type SirA or the indicated SirA 
variant (top row) or wild-type Soj with the empty partner vector (bottom row). (B) 
Single cell analysis indicating the average percentage of forespores that fail to capture 
the origin reporter (-7°) in the forespore during sporulation. Wildtype (BJH103), ΔsirA 
(BJH090), sirAI103V (BYD533), sirAT113M (BYD498), sirAV118M (BYD499), sirAK121N 
(BYD500). A minimum of 2,000 cells from four biological replicates were counted for 
each strain. The asterisks indicate pairwise comparisons that were statistically 
indistinguishable (P>0.05, students t-test). The difference between wildtype and 
sirAT113M was significant (P=0.04). Error bars indicate standard deviation from the 
average of the four trials. The data for wildtype, ΔsirA, and sirAP141T are the same as 
Figure 2.3. (C) Growth of strains harboring Phy-sirA (BYD036), Phy-sirAI103V (BYD549), 
Phy-sirAT113M (BYD550), Phy-sirAV118M (BYD551), Phy-sirAK121N (BYD552) or Phy-empty 
(BAM075) following misexpression. 
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2.4 Discussion 
 
Recent evidence indicates that in B. subtilis, Soj’s major function is to regulate 
DNA replication initiation by interacting directly with DnaA (140, 143). More 
specifically, a Soj monomer interacts directly with DnaA Domain III to inhibit DnaA 
oligomerization until the appropriate cell cycle cue is received for initiation (143). Spo0J 
participates in this regulation by stimulating Soj’s ATPase activity, thus converting Soj 
from a dimer to a monomer (Fig 2.1, vegetative)(142). During sporulation, Soj is also 
important for ensuring that the replication origins of ~20% of sporulating cells are 
captured in the forespore compartment (187). It is not known if Soj’s oriC capture 
function depends on its ability to regulate DnaA activity, however we observed that 
about half of the forespores that fail to capture oriC in a Δsoj mutant can be rescued by 
deleting sda (the percentage of oriCs out of forespore decreases from ~20% to 
~10%)(Fig 2.2). Since Sda executes the sporulation block imposed on actively initiating 
cells (96), this result hints that the oriC capture defect may relate to the association of 
DnaA with oriC. 
There is some precedence for DnaA affecting oriC positioning. In Caulobacter 
crescentus, which requires a functioning ParABS system for oriC segregation (199, 
244), DnaA has been shown to promote oriC segregation independent of its role in 
initiating DNA replication (228). This finding raises the interesting possibility that other 
bacteria might also utilize initiator proteins to facilitate chromosome segregation. How 
might this occur? One possibility, which is supported by a growing body of data, is that 
regulators of DNA replication are spatially coupled to proteins that mark the boundaries 
of cell poles (and future cell poles) such as DivIVA (245, 246) and MinD (247). 
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Consistent with this hypothesis, Soj is capable of localizing at/near septa in a manner 
that depends on MinD (140, 248). 
Restricting replication initiation to the boundaries of poles and future poles 
would be an efficient way to facilitate oriC segregation during vegetative growth (Fig 
2.1), but it would also pose a new problem for sporulating B. subtilis; during sporulation, 
the cell quarters become the sites where polar division occurs, so positioning of oriC at 
these sites could drastically decrease the probability of oriC being captured on the 
forespore side of the septum. RacA presumably decreases this probability by anchoring 
the centromere-like element generated by Spo0J bound at parS sites at the extreme cell 
pole in a DivIVA-dependent manner (20, 138, 233). Additionally, MinD was recently 
shown to act upstream of Soj in oriC capture (144). Interestingly, GFP-MinD shows a 
significant redistribution from the cell quarter toward a subpolar position during 
sporulation, and the authors of this study propose that MinD is part of a larger polar 
segregation complex (which includes Soj), that facilitates redistribution of oriC from the 
cell quarter toward the extreme cell pole (Fig 2.1)(144). 
In the present study, our goal was to further investigate the relationship between 
oriC segregation and the activity of the DnaA inhibitor SirA (7, 79, 81). We found that 
in addition to inhibiting DNA replication, SirA is also important for chromosome 
segregation during sporulation. More specifically, we found that 10% of sporulating 
cells require SirA to capture oriC in the forespore (Fig 2.2). Epistasis experiments 
indicate that SirA acts in the same pathway as Soj to facilitate oriC segregation (Fig 2.2). 
Intriguingly, Soj and SirA interact in a B2H assay (Fig 2.3A and 2.12A); however, since 
most of the SirA-Soj loss-of-interaction variants remain functional with respect to 
facilitating oriC capture (Fig 2.3E and 2.12B), the physiological relevance of this 
interaction is currently unclear. The G12V substitution in Soj that exhibits gain of 
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interaction with DnaA (140) occurs at the interface of a Soj dimer and prevents dimer 
formation (142). Therefore, one speculation is that if SirA and Soj target the same 
surface on DnaA Domain III (this remains to be determined, see below), Soj and SirA 
may be capable of forming a heterodimer. 
One of the most significant findings in this study is the observation that SirA’s 
ability to inhibit DNA replication through contacts with DnaA Domain I appears to be 
completely distinct from SirA’s role in oriC segregation. DnaA variants insensitive to 
SirA’s replication inhibiting activity (DnaAF49Y or DnaAA50V) and several SirA variants 
perturbed in their ability to inhibit DNA replication (SirAY51A, SirAI103V, SirAV118M, and 
SirAK121N), each exhibit wild-type oriC capture phenotypes (Fig 2.8 and Fig 2.12B). 
Reciprocally, we identified one SirA variant (SirAP141T) that inhibits DNA replication, 
yet is unable to support oriC capture. Functional analyses of several SirA-DnaA gain-of-
interaction variants further suggest that the oriC capture function of SirA is mediated 
through a previously uncharacterized interaction between SirA and DnaA Domain III. 
Interestingly, we did not identify even a single compensatory substitution that restored 
interaction at the known interface between in SirA and DnaA Domain I in either of the 
gain of interaction screens, suggesting the requisite substitutions are rare or may require 
more than one amino acid change. In addition, although we think it is unlikely since 
SirA does not interact with wild-type E. coli DnaA (81), we also cannot exclude the 
possibility that the gain of interactions we observe are mediated through one or more E. 
coli proteins acquiring the capacity to bridge the interaction between SirA and DnaA in 
the B2H. 
In the absence of structural data, we are unable to confidently assess if SirA 
might have the capability to interact with DnaA Domain I and Domain III 
simultaneously, or if such an interaction would be mutually exclusive (either DnaA 
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Domain I or Domain III). We favor the second model, as all but one of the SirA-DnaA 
gain-of-interaction variants we identified support oriC capture (Fig 2.12B), but no longer 
prevent growth following misexpression (Fig 2.12C). We hypothesize that these SirA 
variants do not kill because they have an increased propensity to interact with Domain 
III over Domain I. 
Several of the substitutions in DnaA Domain III that show gain of interaction 
with SirA (specifically DnaAF120S, DnaAI122T, and DnaAH130D) map to a surface 
previously shown to suppress the toxicity associated with overexpression of SojG12V, a 
monomeric variant of Soj (Fig 2.11)(143). Interestingly, SojG12V also shows gain of 
interaction with DnaA (140). Substitutions obtained in residues in this region of DnaA 
(A132 and A131) also exhibited overreplication phenotypes that could act as general 
suppressors of replication inhibition, thus this region of DnaA was not considered a 
likely location for direct interaction with Soj (143). Residues in this region of DnaA 
have also been implicated as possible sites of interaction with YabA and DnaD (Fig 
2.9)(127, 249), two other DnaA regulators that can also inhibit DnaA oligomerization 
(127, 250). It is feasible that if Soj targets this surface of DnaA, then substitutions that 
change the Soj-DnaA interaction might also affect DnaD and YabA binding, leading to 
overreplication.   
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Fig. 2.13.  Models for SirA activity. SirA inhibits DNA replication through interactions 
with DnaA Domain I; this activity is not required for oriC capture. SirA targets DnaA 
Domain III to maintain oriC in a state favorable for repositioning. In Model I, Soj acts 
upstream of SirA, generating a conformation of DnaA favorable for SirA association. 
The association of SirA with DnaA Domain III then permits oriC repositioning. In 
Model II, Soj acts downstream of SirA to facilitate oriC capture. Model I does not 
exclude the possibility that Soj may also be required to facilitate oriC capture through an 
independent, downstream mechanism (open arrow). 
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If SirA targets the same surface of DnaA Domain III as Soj, then why would 
both SirA and Soj be required to reposition oriC toward the extreme cell pole during 
sporulation (Fig 2.13)? Current data does not reveal if SirA acts upstream, downstream, 
or in parallel with Soj in oriC capture. We hypothesize that at some point prior to polar 
division, Soj is no longer able to perform its function in inhibiting new rounds of DNA 
replication, perhaps because it is repositioned toward the distal pole via interactions with 
MinD (144) or because Spo0J is no longer available to stimulate formation of the Soj 
monomer. In this capacity, SirA could functionally replace Soj (Fig 2.13), interacting 
with DnaA Domain III and thereby inhibiting oligomerization at oriC (Fig 2.13). SirA 
could also prevent DnaA from associating with the membrane-associated initiation 
proteins DnaD/B, thus keeping oriC free to segregate. The additional requirement of Soj 
for oriC capture could also suggest that Soj is required to create a conformation of DnaA 
favorable for SirA to bind DnaA Domain III (Fig 2.13, Model I), and/or that Soj acts 
downstream of SirA to facilitate oriC repositioning through an independent mechanism 
(Fig 2.13, Model I and II). Regardless of the mechanism, we propose that in this 
capacity, SirA’s function is to ensure that the 10% of cells that would otherwise fail to 
capture oriC are able to do so. This 10% decrease may seem small, however since oriC 
capture is critical for successful sporulation (22), having such failsafe mechanisms in 
place would result in a significant fitness advantage in the face of selective pressures like 
desiccation. 
It is intriguing that Soj and SirA, two different proteins involved in oriC 
positioning, also directly regulate aspects of initiator function. Jacob and Brenner, in 
their discussion of the replicon model for DNA replication in bacteria, alluded to the 
possibility of such a connection more than 50 years ago. “In bacteria, a simple and 
precise system insuring both the regulation of chromosome duplication and the 
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distribution of the two formed chromosomes to the two daughter cells could result from 
a connection between the chromosome and the bacterial surface; the initiator, for 
instance, being attached to some specific structure of the cell surface” (251). Although 
some details of their model turned out to be wrong (for example, elongation between 
anchored origins does not account for the rapid segregation of chromosomes following 
initiation), the core idea that interactions among the initiator, the chromosome, and the 
membrane could help partition chromosomes still remains a valid model. Such a model 
explains not only the robustness of chromosome segregation observed in model systems, 
but also hints at how chromosome partitioning may have evolved in early forms of life 
proliferating through vesiculation and blebbing of membranes (252). 
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CHAPTER III 
SirA INHIBITS DNA REPLICATION INITIATION BY INTERACTING WITH 
DnaA DOMAIN I DURING Bacillus subtilis SPORULATION 
 
3.1 Introduction 
 
In bacteria, the initiator protein DnaA is precisely regulated to tightly control 
DNA replication initiation and consequently, genome inheritance (46, 97, 253). DnaA is 
essential, highly conserved, and possesses four functional domains (74). Domain I, 
which is close to the N-terminus, has been to shown to be important for DnaA self-
dimerization (76) and helicase loading (75), as well as interaction with several regulators 
of DNA replication, including DiaA in Escherichia coli (78, 80) and HobA in 
Helicobactor pylori (126). Domain II is a non-essential flexible linker and is poorly 
conserved (84), although some data suggest it may stimulate helicase loading in E. coli 
(254). Domain III is the largest domain and possesses an AAA+ ATPase region (74), 
that is critical for ATP binding and hydrolysis as well as DnaA oligomerization (85, 86). 
Domain IV, which is located at the C-terminus, possesses the helix-turn-helix motif that 
mediates DNA binding (65). 
During replication initiation, DnaA binds to and oligomerizes at the origin region 
and unwinds it, allowing other replisome components, such as helicase and DNA 
polymerase, to be loaded (63, 65). In E. coli, the replicative helicase DnaB is loaded to 
the unwound origin region with the help of the helicase loader DnaC (68-70); in B. 
subtilis, which follows different naming conventions for some of the replication proteins, 
three additional proteins, DnaD, DnaB and DnaI, are also needed in order to load the 
replicative helicase DnaC (72, 73). After DnaA-dependent oriC unwinding, DnaD is 
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recruited to DnaA, followed by the membrane-associated protein DnaB (72). The 
addition of DnaB to the complex leads to recruitment of the helicase loader DnaI, which 
then facilitates loading of the replicative helicase DnaC and DNA polymerase III (Fig 
1.3)(73).  
During rapid growth, B. subtilis can initiate a new round of DNA replication 
before completing the prior rounds of synthesis, resulting in cells with 2, 4, or even 8 
copies of oriC (16). However, during sporulation, only two copies of the genome are 
required, and mechanisms exist to shut down new rounds of DNA replication (24). Three 
independent mechanisms have been shown to contribute to the regulation of DNA 
replication during sporulation. First, new rounds of replication are prevented in response 
to an entry into stationary phase (32). Second, the global sporulation response regulator, 
Spo0A, has been shown to repress the expression of dnaA, dnaN and dnaG, genes that 
encode replisome components (36). Finally, a sporulation specific protein, SirA 
(Sporulation inhibitor of replication A) is synthesized, maintaining sporulating cells in a 
diploid state by interacting directly with the initiation protein DnaA (7, 79, 81). A ΔsirA 
mutant shows an over-replication phenotype during sporulation, sometimes resulting in 
production of so-called “twins” in which a single mother cell generates two spores (7). 
The twin spores are defective in germination, indicating that over-replication is 
detrimental for the sporulating cell (92, 255). 
SirA, which is the main focus of this dissertation, has been shown to inhibit DNA 
replication initiation by interacting with DnaA (7, 81). At the time this study was 
initiated, very little was known about how SirA inhibited DnaA function. To better 
characterize SirA’s mechanism of action, conditions to overexpress a soluble form of 
SirA were screened. Although no conditions were found to solubilize SirA, co-
expression of SirA with DnaA, but not DnaD or DnaB resulted in an altered degradation 
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pattern during expression testing. Bacterial two-hybrid (B2H) interaction screening 
indicated that if SirA interacts with DnaD or DnaB, then such interactions are below the 
threshold of detection for the assay.   
To identify possible functional targets associated with SirA misexpression during 
vegetative growth, suppressors resistant to SirA-mediated inhibition of DNA replication 
were isolated. All of the isolated suppressors identified, both spontaneous and following 
NTG-mediated mutagenesis, generated one of four substitutions in DnaA Domain I: 
DnaAN47D, DnaAF49Y, DnaAA50T and DnaAA50V. These results suggested that DnaA is 
likely the only target required for SirA-mediated inhibition of DNA replication, and 
implicated DnaA Domain I as the possible interaction interface for SirA. In 2011, Rahn-
Lee et al. published a study showing that DnaA Domain I is sufficient for SirA 
interaction in yeast two-hybrid (Y2H)(81). These authors also showed that a positive 
interaction between SirA and E. coli DnaAV47A (but not wild-type E. coli DnaA) was 
detected by Y2H (81). To test if SirA would target DnaA activity in a heterologous 
system, an E. coli-based plasmid maintenance assay was developed. The results suggest 
that SirA can target E. coli DnaAV47A activity, even though E. coli lacks DnaD and 
DnaB, consistent with the idea that SirA acts to inhibit DNA replication primarily 
through targeting of DnaA. In 2014, Jameson et al. solved a structure of SirA in complex 
with DnaA Domain I (79). The results of this study corroborated the genetic results 
obtained by both Rahn-Lee et al and our group indicating that SirA interacts directly 
with DnaA Domain I. 
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3.2 Materials and methods 
3.2.1 General methods 
All B. subtilis strains were derived from B. subtilis 168. E. coli and B. subtilis 
strains utilized in this study are listed in Table 3.1. Plasmids are listed in Table 3.2. 
Oligonucleotide primers are listed in Table 3.3.  
All cloning was carried out in E. coli DH5α. E. coli strain DHP1 was used for 
assaying interaction in the B2H. For transformation of E. coli, antibiotics were included 
at the following concentrations when indicated: 100 µg/ml ampicillin, and 25 µg/ml 
kanamycin. For transformation and selection of B. subtilis, antibiotics, when required, 
were included at the following concentrations: 100 µg/ml spectinomycin, 0.8 µg/ml 
phleomycin, and 1 µg/ml erythromycin with 25 µg/ml lincomycin (MLS). 
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Table 3.1.  Strains used in Chapter III. 
 
Strain Description Reference 
Parental   
B. subtilis 168 Bacillus subtilis laboratory strain 168 trpC2  BGSC (1A866) 
B. megaterium 
WH320 
Host strain for B. megaterium protein 
expression system 
MoBiTec 
E. coli DH5α F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 
deoR nupG Φ80dlacZΔM15 Δ(lacZYA-
argF)U169, hsdR17(rK
- mK
+), λ–  
 
E. coli DHP1 F-, cya-99, araD139, galE15, galK16, rpsL1 
(Strr), hsdR2, mcrA1,mcrB1; 
Tom Bernhardt 
E. coli  
BL21 (DE3) 
F– ompT gal dcm lon hsdSB(rB
–mB
–) [malB+]K-
12(λS) 
λ(DE3 [lacI lacUV5-T7p07 ind1 sam7 nin5])  
 
E. coli  
BL21 (DE3) 
pLysS 
F– ompT gal dcm lon hsdSB(rB
–mB
–) [malB+]K-
12(λS) 
λ(DE3 [lacI lacUV5-T7p07 ind1 sam7 nin5]) 
pLysS[T7p20 orip15A](Cm
R) 
 
E. coli 
MG1655 
K-12 F– λ– ilvG– rfb-50 rph-1  
E. coli MS3898 asnB32 relA1 spoT1 thi-1 ilv-192 zia::pKN500 
(pKN500=mini-R1) 
dnaA mad-2 (F-) recA1 (imm434)  
Jon M. Kaguni 
B. subtilis 168   
BYD027 amyE::Phy-sirA (spec), yhdG::Phy-sirA (phleo), 
sacA::Phy-lacZ (erm) 
This study 
DHP1   
CYD050 dnaA-T25 (kan), sirA-T18 (amp) This study 
CYD052 dnaAN47D-T25 (kan), sirA-T18 (amp) This study 
CYD053 dnaAF49Y-T25 (kan), sirA-T18 (amp) This study 
CYD054 dnaAA50T-T25 (kan), sirA-T18 (amp) This study 
CYD055 dnaAA50V-T25 (kan), sirA-T18 (amp) This study 
CYD060 dnaA-T25 (kan), empty-T18 (amp) This study 
CYD061 empty-T25 (kan), sirA-T18 (amp) This study 
CYD063 dnaAN47D-T25 (kan), empty-T18 (amp) This study 
CYD065 dnaAA50T-T25 (kan), empty-T18 (amp) This study 
CYD066 dnaAA50V-T25 (kan), empty-T18 (amp) This study 
CYD092 dnaAS23A-T25 (kan), sirA-T18 (amp) This study 
CYD093 dnaAE25A-T25 (kan), sirA-T18 (amp) This study 
CYD094 dnaAW27A-T25 (kan), sirA-T18 (amp) This study 
CYD095 dnaAW53A-T25 (kan), sirA-T18 (amp) This study 
CYD098 dnaAS23A-T25 (kan), empty-T18 (amp) This study 
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Table 3.1.  Continued. 
 
Strain Description Reference 
CYD099 dnaAE25A-T25 (kan), empty-T18 (amp) This study 
CYD100 dnaAW27A-T25 (kan), empty-T18 (amp) This study 
CYD101 dnaAW53A-T25 (kan), empty-T18 (amp) This study 
CYD123 dnaAF24A-T25 (kan), sirA-T18 (amp) This study 
CYD124 dnaAT26S-T25 (kan), sirA-T18 (amp) This study 
CYD125 dnaAE48R-T25 (kan), sirA-T18 (amp) This study 
CYD126 dnaAR51L-T25 (kan), sirA-T18 (amp) This study 
CYD127 dnaAD52N-T25 (kan), sirA-T18 (amp) This study 
CYD131 sirA-T25 (kan), empty-T18 (amp) This study 
CYD137 dnaAF24A-T25 (kan), empty-T18 (amp) This study 
CYD138 dnaAT26S-T25 (kan), empty-T18 (amp) This study 
CYD139 dnaAE48R-T25 (kan), empty-T18 (amp) This study 
CYD140 dnaAR51L-T25 (kan), empty-T18 (amp) This study 
CYD141 dnaAD52N-T25 (kan), empty-T18 (amp) This study 
CYD492 sirA-T25 (kan), T18-dnaD (amp) This study 
CYD499 sirA-T25 (kan), dnaB-T18 (amp) This study 
CYD537 empty-T25 (kan), dnaB-T18 (amp) This study 
CYD595 empty-T25 (kan), T18-dnaD (amp) This study 
CYD686 sirA-T25 (kan), T18-empty (amp) This study 
MG1655   
CJW089 sirA-pBAD24 (amp) David Z. Rudner 
MS3898   
CYD227 pBR322 in MS3898  This study 
CYD228 pRB100 in MS3898  This study 
CYD229 pYD192 in MS3898  This study 
CYD237 pYD193 in MS3898  This study 
CYD238 pYD194 in MS3898  This study 
CYD239 pYD195 in MS3898  This study 
CYD267 pYD196 in MS3898  This study 
CYD268 pYD197 in MS3898  This study 
CYD269 pYD198 in MS3898  This study 
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Table 3.2.  Plasmids used in Chapter III. 
 
Plasmid Description Reference 
pACYC184 non-oriC plasmid (cat) Jon M. Kaguni 
pBR322 non-dnaA plasmid (amp) Jon M. Kaguni 
pCM959-
CmR 
E. coli oriC-pACYC184 (cat) Jon M. Kaguni 
pJW029 sirA-pBAD24 (amp) David Z. Rudner 
pKM328 dnaA-His6-sirA-pET DUET (amp) David Z. Rudner 
pLM022 sirA-His6-pET24b+ (kan) David Z. Rudner 
pLM023 His6-sirA-pRsetA (kan) David Z. Rudner 
pRB100 E. coli dnaA-pBR322 (amp) Jon M. Kaguni 
pYD025 dnaB-His6-sirA-pET DUET (amp) This study 
pYD026 dnaD-His6-sirA-pET DUET (amp) This study 
pYD030 sirA-His6-pMM1522 (amp) This study 
pYD052 His6-SUMO-sirA-pTB146 (amp)  
(sirA from B. megaterium) 
This study 
pYD053 His6-SUMO-sirA-pTB146 (amp) 
(sirA from B. licheniformis) 
This study 
pYD054 His6-SUMO-sirA-pTB146 (amp) 
(sirA from B. amyloliquefaciens) 
This study 
pYD192 E. coli dnaAV47A-pBR322 (amp) This study 
pYD193 sirA-pBR322 (amp) This study 
pYD194 E. coli dnaA-sirA-pBR322 (amp) This study 
pYD195 E. coli dnaAV47A-sirA-pBR322 (amp) This study 
pYD196 sirAY51A-pBR322 (amp) This study 
pYD197 E. coli dnaA-sirAY51A-pBR322 (amp) This study 
pYD198 E. coli dnaAV47A-sirAY51A-pBR322 (amp) This study 
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Table 3.3.  Oligonucleotides used in Chapter III. 
 
Oligo Sequence 5’ to 3’ 
OJH083 ATGACAGAGAAACAGATTCAAGCTATTACACAACCAATCCCG
A 
OJH165 TATACATATGGCTGACTATTGGAAAGAT 
OJH166 TCGAGGGTACCGACTTAATAGGCAGAGTATTTTTTCA 
OJH167 TATACATATGAAAAAACAGCAATTTATTGATA 
OJH168 TCGAGGGTACCGACTTATTGTTCAAGCCAATTGTAAAA 
OJH169 GATCCGAATTCGATGGAACGTCACTACTATACG 
OJH170 AGCTTGTCGACCTGTTAGACAAAATTTCTTTCTTTCAC 
OYD054 GGGAAATGTACAATGGAACGTCACTACTATACG 
OYD055 GCCGGCATGCGGGACAAAATTTCTTTCTTTCAC 
OYD075 AAAAAGCTCTTCCGGTGTGAGAACGTATGAAGTATATTT 
OYD076 TTTTTCTCGAGTTACACAAATTTTCTTGTTTTCACAG 
OYD077 AAAAAGCTCTTCCGGTATGGAACGCCATTATTATACGTATT 
OYD078 TTTTTCTCGAGTTATACAAAATTTCTTTCTTTCACAGG 
OYD079 AAAAAGCTCTTCCGGTATGGAACGTCATTACTATACACAC 
OYD080 TTTTTCTCGAGTTAGACAAAATTTCTTTCTCTGACC 
OYD159 CTTGTCCCGTACCCAATCGAGGGCAAAACGGTTTGGCGCGTA
C 
OYD160 GTACGCGCCAAACCGTTTTGCCCTCGATTGGGTACGGGACAA
G 
OYD193 CATTGCTGCAGGCATCGTGG 
OYD194 AGGTTTACGATGACAATGTTCTG 
OYD195 CACCGCATGCAGCAGGTGAG 
OYD214 TCGGGATTGGTTGTGTAATAGCTTGAATCTGTTTCTCTGTCAT 
OYD238 GATCCATATGGGATTTGTCCTACTCAGGAG 
OYD251 GATCGCTCTTCCAGCTGACGTCTAAGAAACCATTATTAT 
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3.2.2 Protein overexpression in E. coli   
 
10 ng of plasmid was transformed into 100 µl E. coli BL21 (DE3) chemical 
competent cells (treated by RbCl, see details below) and plated on an LB-Lennox agar 
plate with proper antibiotics. Fresh colonies were used to inoculate 25 ml of Cinnabar 
media (Teknova) in a 250 ml baffled flask with appropriate antibiotic, and culture was 
placed in shaking waterbath set at 280 rpm and 30°C. Cells were grown to an OD600 of 
5, at which time 100 µl of uninduced cell pellet was collected by centrifugation at 6,010 
x g for 1 min at room temperature. The supernatant was removed by aspiration and the 
pellet placed at -80°C until processing. Protein expression was induced for 5 hrs 
following the addition of 1 mM IPTG. To test for induction, 100 µl of cells were 
collected as described above. To analyze induction, pellets were resuspended in 50 µl 
SDS sample buffer and samples were boiled for 10 min prior to loading on a 4-20% 
Tris-Glycine protein gel (BioRad). Samples were normalized to each other by OD600 
values. For solubility test, cultures were pelleted in a 50 ml falcon tube at 2,576 x g for 
10 min at room temperature. Pellets were resuspended in 5 ml lysis buffer [50 mM Tris-
HCl pH 8.0, 300 mM NaCl, 10 mM imidazole, 200 µg/ml lysozyme, 10 µg/ml DNase, 
10 µl protease inhibitor cocktail P8465 (sigma)] and the cells were lysed by using a 
French press. Cell debris as well as insoluble proteins were separated from the soluble 
proteins by spinning down at 13,000 x g for 30 min at 4°C. The supernatant (containing 
soluble proteins) were transferred to a new 50 ml falcon tube and the pellets were 
resuspended in 10 ml SDS sample buffer. 50 µl of the supernatant was mixed with 50 µl 
2X SDS sample buffer and boiled for 10 min. 100 µl of the resuspended pellet was also 
boiled for 10 min. Samples were normalized to each other by OD600 values. Protein gels 
were ran at 80 V for 30 min at room temperature, followed by 200 V for 30 min at room 
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temperature. Gels were stained with coomassie blue for 2 hrs at room temperature and 
destained with 10% acetic acid, 50% methanol and 40% dH2O at room temperature 
overnight.  
 
3.2.3 Protein purification by Nickel column affinity chromatography  
 
Protein expression and cell lysis are almost the same as above except for the 
modifications below: plasmids were transformed into E. coli BL21 (DE3) pLysS cells; 
the cells were grown with proper antibiotics and 0.1% glucose; cell pellets were 
resuspended in 30 ml lysis buffer [50 mM Tris-HCl pH 8.0, 300 mM KCl, 10% glycerol, 
20 mM imidazole, 10 µg/ml DNase, 10 µl protease inhibitor cocktail P8465 (sigma)].  
The soluble part (supernatant) is then purified by Nickel column affinity 
chromatography. 1 ml Ni-NTA Agarose beads (0.5 ml bed volume) were equilibrated by 
lysis buffer and then the supernatant was loaded on the column. Flow-through was 
stored in a 50 ml falcon tube for later use. Column was then washed with 10 ml wash 
buffer (the same as lysis buffer) and then eluted eight times with 250 µl elution buffer 
[50 mM Tris-HCl pH 8.0, 300 mM KCl, 10% glycerol, 250 mM imidazole]. All the 
samples were normalized by OD600 prior to loading on the gel.   
 
3.2.4 In vitro protein synthesis   
 
Reactions were carried out according to manufacturer instructions using 1µg 
PCR product as template. The PCR product template for the expression of N-terminal 
6X His tagged SirA was amplified by using pLM023 as the template and 
OJH140/OJH142 as the primers. The PCR product template for the expression of C-
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terminal 6X His tagged SirA was amplified by using pLM022 as the template and 
OJH140/OJH141 as the primers. For the Qiagen EasyXpress Protein Synthesis Kit, 1 µg 
template, 17.5 µl E. coli extract and 20 µl EasyXpress Reaction Buffer were mixed, 
adding RNase-free water to the total volume of 50 µl. The reaction was incubated at 
37°C for 1 hr and then centrifuged at 21,130 x g for 5 min at room temperature. The 
supernatant was transferred to another tube, adding 50 µl of 2X SDS sample buffer and 
boiled for 10 min prior to loading on the gel. The pellet was resuspended in 100 µl 1X 
SDS sample buffer and boiled for 10 min prior to loading. For the NEB PURExpress® 
In Vitro Protein Synthesis Kit, 1 µg template, 10 µl solution A and 7.5 µl solution B 
were mixed, adding nuclease-free water to the total volume of 25 µl. The mixture was 
incubated at 37°C for 2 hrs and centrifuged at 21,130 x g for 5 min at room temperature. 
The supernatant was transferred to another tube and 25 µl of 2X SDS sample buffer was 
added. The sample was boiled for 10 min prior to loading on the gel; the pellet was 
resuspended in 50 µl 1X SDS sample buffer and boiled for 10 min prior to loading. 
 
3.2.5 Protoplasting Bacillus megaterium   
 
One freshly streaked single colony was inoculated in 5 ml LB-Lennox medium 
and grown at 37°C to mid-exponential phase. Cells were pelleted at 2,576 x g for 10 min 
at room temperature and washed twice with 1X SMM buffer [500mM sucrose, 20mM 
maleic acid, 20mM magnesium chloride, pH 6.5]. Pellets were resuspended in 500 µl 1X 
SMM buffer containing 500 µg/ml lysozyme, gently shaked for 30 min at room 
temperature until 90% of the cells have protoplasted. Cells were then spun down at 
2,576 x g for 10 min at room temperature, aliquoted in 500 µl and stored at -80°C until 
use. 
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3.2.6 Transformation of B. megaterium protoplasts 
 
500 µl of protoplast suspension (see above) was thawed on ice and 5 µg plasmid 
was added. 1.5 ml of 1X SMM buffer containing 40% (w/v) PEG6000 was then added 
and the protoplasts were incubated for 2 min at room temperature. 5 ml 1X SMM buffer 
was added and the protoplasts were gently mixed. Protoplasts were harvested by 
centrifugation at 1,300 x g for 10 min at room temperature. The supernatant was 
discarded and the pellets were resuspended in 500 µl 1X SMM buffer, and gently 
agitated at 37°C for 1.5 hrs. 200 µl cells were then added into 2.5 ml CR5-top agar 
[300mM sucrose, 30mM 3-morpholinopropane-1-sulfonic acid (MOPS), 16.5mM NaOH 
pH 7.3; 15mM potassium sulfate, 50mM magnesium chloride, 20mM calcium chloride, 
0.4mM monopotassium phosphate, 50mM proline, 1% glucose; 0.2 mg/ml casamino 
acids, 10 mg/ml yeast extract, 0.4% agar], gently mixed and poured onto a prewarmed 
LB-Lennox agar plate supplemented with 10 µg/ml tetracycline. Plates were incubated at 
37°C overnight and colonies that arose were re-streaked on a fresh LB-Lennox agar 
plate supplemented with 10 µg/ml tetracycline. 
 
3.2.7 Protein overexpression in B. megaterium  
 
One freshly streaked single colony was inoculated in 5 ml LB-Lennox medium 
supplemented with 10 µg/ml tetracycline, and grown at 37°C to mid-exponential phase. 
The culture was back-diluted to OD600 = 0.02 in 25 ml LB-Lennox medium 
supplemented with 10 µg/ml tetracycline in a 250 ml baffled flask, and grown at 37°C in 
a shaking waterbath set at 280 rpm to OD600 = 0.3. 1 ml uninduced sample was collected 
by centrifugation at 6,010 x g for 1 min at room temperature. Xylose was added to the 
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culture to a final concentration of 0.5% (w/v) to induce protein expression. Cultures 
were grown at 37°C until OD600 = 1.5. 1 ml sample was pelleted at the same way as 
described above. Pellets for both uninduced and induced samples were resuspended in 
50 µl lysis buffer [20 mM Tris pH 7.5, 1 mg/ml lysozyme, 10 µg/ml DNase I, 100 µg/ml 
RNase A, 1 mM phenylmethylsulfonyl fluoride (PMSF)] and incubated for 15 min at 
room temperature. 50 µl 2X SDS sample buffer was added, boiled for 10 min prior to 
loading. Lysate loads were normalized by OD600 values obtained at the time of cell 
harvest. 
 
3.2.8 Western blot analysis   
 
Protein samples were prepared as described in the above paragraphs. Western 
blots were performed essentially the same as described in Materials and Methods in 
Chapter II. 5 μl of each sample was loaded on a 4-20% Tris-HCl gradient gels (BioRad). 
Proteins were transferred to nitrocellulose membrane (Pall) for 1 hr at 60 V on an ice 
bath. Membranes were blocked in PBS [pH 7.4] containing 0.05% Tween-20 and 5% 
non-fat milk powder (w/v). Membranes were incubated overnight at 4°C with a 1:1,000 
dilution of α-SirA peptide antibody (CSKRYGWLNPVKERN, Genscript) in PBS [pH 
7.4] containing 0.05% Tween-20 and 5% non-fat milk powder (w/v) and washed. The 
membranes were then incubated with a 1:10,000 dilution of horseradish peroxidase-
conjugated goat anti-rabbit immunoglobulin G secondary antibody (Bio-Rad) in PBS 
[pH 7.4] containing 0.05% Tween-20 and 5% non-fat milk powder (w/v) for 1 hr at 
room temperature. After washing, blots were incubated with SuperSignal West Femto 
Chemiluminescent substrate (Thermo) prior to capture in an Amersham Imager 600 (GE 
Healthcare).   
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3.2.9 Spontaneous suppressor selection   
 
Six independent single colonies of BYD027 (2X Phy-sirA, Phy-lacZ) were used to 
inoculate six independent 5 ml LB-Lennox cultures. The cultures were grown for 6 hrs at 
37°C and 0.3 µl of each culture was diluted in 100 µl LB and plated on an LB-Lennox 
agar plate containing 100 µg/ml spectinomycin and 1 mM IPTG. After overnight growth 
at 37°C, suppressor colonies that arose were patched on LB-Lennox agar plates 
supplemented with 100 µg/ml spectinomycin as well as LB-Lennox agar plates 
supplemented with 100 µg/ml spectinomycin, 1mM IPTG, and 40 µg/ml 5-bromo-4-
chloro-3-indolyl-β-D-galactopyranoside (X-Gal). The patches were then grown at 37°C 
overnight. Only patches that appeared blue on the X-Gal plate were selected for further 
analysis; this screen eliminated mutants unable to derepress Phy in the presence of IPTG, 
specifically LacI dominant mutants (256). In addition, each Phy-sirA construct (there 
were two copies in the genome of the strain used for suppressor selection, see above) 
was transformed into a wild-type background to ensure that the original expression 
construct remained fully functional with respect to preventing cell growth on LB-Lennox 
agar plates supplemented with the relevant antibiotic and 1mM IPTG. The dnaA region 
of each suppressor strain was amplified from genomic DNA using OYD122 and 
OYD13. The PCR product was sequenced in the forward and reverse direction using 
OYD296 and OYD297. 
 
3.2.10 Suppressor selection by NTG mutagenesis   
 
A single colony of BYD027 (2X Phy-sirA, Phy-lacZ) was inoculated in 5 ml LB-
Lennox medium at 37°C to mid-exponential phase, back-diluted to OD600 = 0.01 in 25 
 96 
 
ml LB-Lennox medium in 250 ml baffled flasks, and grown at 37°C in a shaking 
waterbath set at 280 rpm to OD600 = 1. Cells were pelleted at 2,576 x g for 5 min at room 
temperature and washed one time with SC buffer [150mM NaCl, 10mM NaCitrate]. 
Pellets were resuspended with 10 ml SC buffer containing one of the following 
concentrations of N-Methyl-N-nitro-N-nitrosoguanidine (NTG): 1 µg/ml, 5 µg/ml or 10 
µg/ml. The cell suspensions were then incubated at 37°C for 10 min. After incubation, 
the cells were pelleted at 2,576 x g for 5 min at room temperature and washed twice with 
LB-Lennox medium. Pellets were then resuspended with 25 ml LB-Lennox medium 
containing 15% glycerol, aliquoted and stored at -80°C. To obtain suppressors resistant 
to SirA misexpression during vegetative growth, 1 µl of the NTG treated cells were 
plated on LB-Lennox agar plate supplemented with 100 µg/ml spectinomycin and 1mM 
IPTG. Further analysis proceeded as described under the section on spontaneous 
suppressor selection. 
 
3.2.11 Bacterial two-hybrid assay (B2H), general methods  
 
Bacterial two hybrids were performed essentially as described (241) with the 
following modifications: cloning was carried out in the presence of 0.2% glucose (w/v) 
in addition to the appropriate antibiotics. E. coli strain DHP1 harboring the relevant 
pairwise interactions were grown to exponential phase in LB-Lennox media 
supplemented with 0.2% glucose (w/v), ampicillin (50 μg/ml), and kanamycin (25 
μg/ml). Samples were normalized by OD600 and five μl of each culture spotted on M9-
glucose minimal media plates containing 250μM IPTG, 40 μg/ml X-Gal, ampicillin (50 
μg/ml), and kanamycin (25 μg/ml). Plates were incubated at room temperature in the 
dark for 50 to 70 hrs prior to image capture. 
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3.2.12 Plasmid maintenance assay   
 
1 ng of pBR322 (or pRB100, or pYD192, see Table 3.1, Table 3.2 and the legend 
of Table 3.4) was transformed into RbCl competent E. coli strain CYD199 (see 
below)(76) and plated on LB-Lennox agar plates supplemented with 100 μg/ml 
ampicillin. The plate was incubated overnight at 37°C. Single colonies from each plate 
were isolated, generating CYD227 and other relevant strains. Each of these strains was 
made RbCl competent (see below), aliquoted, and frozen at -80°C for future 
transformations. To test for maintenance of the oriC-containing plasmid, 100 ng of 
pCM959-CmR (oriC plasmid) was then transformed into the RbCl competent CYD227 
and other relevant strains, followed by plating on LB-Lennox agar plates supplemented 
with ampicillin (100 μg/ml) and chloramphenicol (30 μg/ml). Plates were incubated at 
37°C for 48 hrs, and the number of colonies on each plate was enumerated. In order to 
be able to directly compare them, 1 ng of pACYC184 (non-oriC plasmid) was 
transformed into the same competent cells as mentioned above, to know the relative 
competence for each strain. 
 
3.2.13 Making RbCl E. coli competent cells   
 
One freshly streaked single colony was inoculated in 5 ml LB-Lennox medium 
supplemented with proper antibiotics, grown at 37°C to mid-exponential phase. This 
culture was diluted an OD600 = 0.01 in 50 ml LB-Lennox medium supplemented with 
proper antibiotics in a 250 ml baffled flasks, and grown at 37°C in a shaking waterbath 
set at 280 rpm to OD600 = 0.5. The culture was collected in a 50 ml falcon tube and 
placed on ice for 15 min. Cells were pelleted by centrifugation at at 2,576 x g for 10 min 
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at 4°C, and the supernatant was discarded. Pellets were resuspended in 5 ml of cold TFB 
I [30mM potassium acetate, 100 mM rubidium chloride, 10 mM CaCl2, 50 mM MnCl2, 
15% glycerol, pH 5.8] and placed on ice for 15 min. Cells were pelleted again at 2,576 x 
g for 10 min at 4°C. The supernatant was discarded whereas the pellet was resuspended 
in 1 ml of cold TFB II [10mM 3-morpholinopropane-1-sulfonic acid (MOPS), 10 mM 
rubidium chloride, 75 mM CaCl2, 15% glycerol, pH 6.5] and placed on ice for 30 min. 
Cells were aliquoted and stored at -80°C until use. 
 
3.2.14 Microscopy   
 
1 ng of pJW029 (sirA-pBAD24) was transformed into E. coli MG1655 cells and 
plated on LB-Lennox agar (1.5% w/v) plates containing 100 µg/ml ampicillin to make 
CJW089. For microscopy experiments, a single colony of CJW089 was inoculated in 25 
ml LB-Lennox medium with 100 µg/ml ampicillin in a 250 ml baffled flasks and placed 
in a shaking waterbath set at.37°C and 280 rpm. At low OD600 (~0.04), 0.2% arabinose 
was added to the induced cultures. Images were captured 2 hrs post-induction. 1 ml 
culture was pelleted by centrifugation at 6,010 x g for 1 min at room temperature, then 
pellets were resuspended in ~5 µl DAPI (2 µg/ml) before mounting on glass slides with 
polylysine-treated coverslips.  
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3.3 Results 
 
3.3.1 SirA is insoluble when overexpressed in E. coli 
 
In an effort to obtain purified SirA for biochemical assays and structural studies, 
we attempted to define conditions to obtain a soluble form of SirA protein. sirA was 
cloned into pET overexpression vectors containing either N or C-terminal 6X His tags as 
well as an N-terminal His-SUMO tag. For each expression construct, two different rich 
media (LB-Lennox and Cinnabar) were tried at three different growth temperatures 
(37°C, 30°C and 22°C), and samples were fractionated into a soluble (S) and pellet (P) 
fraction as described above. Under all of the conditions tested, SirA was expressed, but 
found exclusively in the insoluble, pellet fraction under our standard lysis conditions 
(see materials and methods). The 30°C induction in Cinnabar media is shown as a 
representative result in Fig 3.1. SirA was also found exclusively in the insoluble fraction 
when expressed using two-different commercial in vitro transcription and translation 
systems (Fig 3.2). In some cases, homologs of a protein can be expressed in a soluble 
state. Therefore, we also attempted to express SirA homologs from several other 
Bacillus species fused to an N-terminal His-SUMO tag. Each of the homologs was also 
found in the insoluble fraction following the cell lysis step (Fig 3.3). 
E. coli is not always an optimal system to overexpress soluble proteins. Several 
Gram positive protein overexpression systems exist, including one for B. megaterium, a 
species closely related to B. subtilis (257). Using the B. megaterium overexpression 
system developed by MoBiTec, we attempted to overexpress a C-terminal 6X His-
tagged version of SirA (see Materials and Methods for details). Using this system, SirA 
was expressed, but was once again found in the insoluble fraction (Fig 3.4). 
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Fig. 3.1.  SirA overexpressed in E. coli in Cinnabar media. The expected molecular 
weight of His-tagged SirA is ~18 kDa. pLM023 (His-SirA) or pLM022 (SirA-His) was 
transformed into E. coli BL21 (DE3) competent cells and grown in Cinnabar media as 
described in materials and methods. After fractionation, the supernatant (S) and pellet 
(P) fractions were analyzed by SDS-PAGE. 
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Fig. 3.2.  SirA expressed in cell-free transcription and translation system. PCR product 
amplified using pLM023 (His-SirA) or pLM022 (SirA-His) as template was used as 
template to synthesize protein. After synthesis, samples were centrifuged to separate the 
supernatant (S) and the pellet (P) fractions. (A) Expression performed using the 
EasyXpress Protein Synthesis Kit” (Qiagen). Plasmid encoding E. coli EF-Tu was used 
as the positive control. (B) Expression performed using PURExpress® In Vitro Protein 
Synthesis Kit (New England BioLabs). Plasmid encoding E. coli DHFR was used as the 
positive control. 
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Fig. 3.3.  SirA from other Bacillus species overexpressed in E. coli. Expected size of the 
His-Sumo-SirA proteins is ~30 kDa. pYD052 (His-SUMO-SirA from B. megaterium), 
pYD053 (His-SUMO-SirA from B. licheniformis) or pYD054 (His-SUMO-SirA from B. 
amyloliquefaciens) were transformed into E. coli BL21 (DE3) competent cells and 
grown in the Cinnabar media to an OD600 of ~5. Induction was for 5 hrs with 1 mM 
IPTG. Samples were then collected, lysed and fractionated. After centrifugation, 
supernatant (S) and pellet (P) fractions were each loaded on the gel.  
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Fig. 3.4.  SirA overexpression in B. megaterium. Expected size of the SirA-His proteins 
is as indicated. pYD030 (SirA-His plasmid used in B. megaterium overexpression 
system) was transformed into B. megaterium protoplasts and grew in LB-Lennox media. 
When indicated, 1mM IPTG was used to induce protein expression. Samples were then 
collected and lysed. After centrifugation, supernatant and pellet were each loaded on the 
gel. “S” stands for “supernatant” and “P” stands for “pellet”. 
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Since conditions to obtain soluble protein following overexpression were not 
successful, we attempted to refold the protein obtained from the pellet fractions using 
sequential 1.0 M dialysis step-downs. SirA in the pellet fraction was solubilized by the 
addition of 8.0 M urea. SirA remained in solution until the step-down from 6.0 M to 5.0 
M urea, at which point the protein rapidly precipitated from solution. 
Sometimes proteins that are normally found in complexes are stabilized or 
solubilized when they are co-expressed or co-purified in the presence of native binding 
partners. Since SirA was previously shown to interact directly with DnaA (7, 81), we co-
expressed SirA with DnaA. In addition, co-expression of SirA with either DnaD or 
DnaB (two other proteins required for initiation in B. subtilis) was also tested. As shown 
in Fig 3.5, SirA was found in the pellet fraction in each of the conditions tested (Fig 3.5). 
Interestingly, when SirA was co-expressed with untagged DnaA, two bands were present 
in the expected 17 kDa range (Fig 3.5A), while only one band was present when SirA 
was co-expressed with either untagged DnaB (Fig 3.5B) or untagged DnaD (Fig 3.5C). 
To test if the lower band was truncated SirA, we performed western blot analysis using 
both an anti-SirA C-terminal specific peptide antibody (CSKRYGWLNPVKERN, 
Genscript) and anti-His primary antibody (Sigma). Both the upper and lower bands 
cross-reacted with SirA using the anti-His antibody (Fig 3.6A), indicating that both 
bands contained the N-terminus of His-SirA. However, the the top band but not the 
bottom band was not with a peptide antibody that detects only the extreme C-terminus of 
SirA (Fig 3.6B), suggesting the higher mobility protein had been proteolytically cleaved 
near the C-terminus. These results suggested that DnaA-interaction made SirA more 
susceptible to proteolytic cleavage, possibly due to conformational changes induced by 
DnaA binding. 
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Fig. 3.5.  B. subtilis SirA co-expressed with other replication initiation proteins. 
pKM328 (His-SirA, together with B. subtilis DnaA, on pDUET vector) (A), pYD025 
(His-SirA, together with B. subtilis DnaB, on pDUET vector) (B) or pYD026 (His-SirA, 
together with B. subtilis DnaD, on pDUET vector) (C) was transformed into E. coli 
BL21 (DE3) competent cells and grew in the Cinnabar media. Samples were then 
collected, lysed, and fractionated. Normalized loads of the supernatant (S) and pellet (P) 
fractions were run on a 4-20% gradient gel (BioRad).  
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Fig. 3.6.  C-terminal SirA is cleaved when co-expressed with B. subtilis DnaA. (A) The 
same samples shown in Fig 3.5A were used to perform western blot with the N-terminal 
recognizing anti-His antibody (Sigma). Supernatant (S) and pellet (P) fractions are 
shown. (B) The same samples shown in Fig 3.5A were used to perform western blot 
with the C-terminus recognizing anti-SirA peptide antibody. The lane labeled “B” is the 
pellet from cells co-expressing SirA with DnaB, shown for comparison.  
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Fig. 3.7.  A soluble form of C-terminal cleaved SirA can be enriched following Nickel 
affinity chromatography of the soluble overexpression fraction. pLM023 (His-SirA) (A) 
or pLM022 (SirA-His) (B) was transformed into E. coli BL21 (DE3) competent cells 
and grown in Cinnabar media. Samples were collected and fractionated as described in 
materials and methods. On this gel, lysates from uninduced sample (U) and induced 
sample (I) are shown, followed by the supernatant (S) and the pellet (P) after lysis and 
centrifugation. The flow-through (FL), washing sample (W) and multiple elution 
samples (E1 to E7) during purification were loaded next.  
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Interestingly, even though overexpressed His-SirA appears to fractionate 
exclusively to the insoluble fraction based on coomassie staining (Fig 3.1), if the soluble 
fraction is collected and subjected to Nickel affinity chromatography, a cleaved, but 
soluble form of His-SirA can be enriched for and eluted (Fig 3.7A). The cleavage must 
occur near the C-terminus, as the His-tag in this construct is N-terminal. In addition, the 
C-terminal His-tagged construct did not have this cleaved product (Fig 3.7B). These 
results suggest that the aggregation of full-length SirA may be mediated through self-
interactions occurring near SirA’s C-terminus. 
 
3.3.2 SirA does not interact with DnaD or DnaB in bacterial two-hybrid assay 
 
In B. subtilis, binding of DnaA at oriC is followed by recruitment of DnaD, and 
the subsequent association of a pre-initiation complex with the membrane through 
interactions with the membrane-associated protein DnaB (72). Assembly of this complex 
precedes loading of the helicase (DnaC) and DNA polymerase III (71). Inactivation of 
either DnaD or DnaB phenocopies inactivation of DnaA, with cells failing to initiate 
DNA replication (258). During sporulation, SirA inhibits the initiation of DNA 
replication (7), at least partially by targeting DnaA Domain I (Chapter II)(this study)(79, 
81); we also showed that SirA has a second, distinct function in promoting the 
segregation of oriC from the cell quarter to the distal cell pole during sporulation (See 
Chapter II)(77). Based on this data, we hypothesized that one way SirA might function 
in oriC segregation is to disrupt or prevent interactions between the DnaA-oriC complex 
and the membrane, for example by preventing an interaction between DnaA and DnaD, 
or DnaD and DnaB. In this way, SirA could function to keep oriC free for segregation 
toward the distal pole (see Fig 2.2 and Fig 2.13)(77). SirA could disrupt/prevent 
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interactions with the membrane by binding to DnaA and preventing its association with 
DnaD. Alternatively, SirA could interact with DnaD and/or DnaB directly. To test if 
SirA interacts directly with either DnaD or DnaB, bacterial two-hybrid assays were 
performed. As shown in Fig 3.8, no interaction greater than that observed in the negative 
controls was not detected between with SirA and either DnaD or DnaB. Since DnaB is a 
membrane-associated protein and membrane associated proteins often give high 
background in B2H assays, the assay was repeated with DnaB truncations lacking a 
transmembrane domain; however, the interaction remained negative (data not shown). 
Based on this data, it was concluded that DnaD and DnaB either do not interact directly 
with SirA, or that the interaction is below the threshold of detection for the assay. 
 
3.3.3 DnaA Domain I is important for SirA function in vivo 
 
SirA was previously shown to interact with DnaA directly (7). Based on this 
observation, Rahn-Lee et al. directly mutagenized dnaA and identified four DnaA 
variants, DnaAN47D, DnaAF49Y, DnaAA50T and DnaAA50V, which supported cell viability, 
but were insensitive to SirA-mediated killing following misexpression (81). These 
variants were also determined to result in loss of interaction with wild-type SirA in a 
yeast two-hybrid assay (81). In a concurrent study, we sought to identify spontaneous 
suppressor mutations that resulted in resistance to SirA-mediated killing. Cells harboring 
two copies of the IPTG-inducible SirA misexpression construct were plated on media 
containing IPTG, and resulting suppressors were screened to ensure that the 
misexpression constructs remained functional (see Materials and Methods for details). 
Thirty different SirA-resistant mutants were identified in this screen. Sequencing of the 
dnaA region in each mutant revealed one of four substitutions: DnaAN47D, DnaAF49Y, 
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DnaAA50T and DnaAA50V, invariant to those identified in the study utilizing random 
mutagenesis of dnaA. Each of these substitutions was sufficient to confer resistance to 
SirA in a clean genetic background. These results suggested that SirA likely inhibits 
DNA replication through direct interactions with DnaA Domain I. Increasing the 
mutation rate by exposing cells to the mutagen NTG did not result in the identification of 
additional variants, strongly suggesting that the results of both initial screens were 
saturating. 
 
3.3.4 DnaA Domain I is important for SirA interaction in B2H 
 
In two independent studies, one utilizing random mutagenesis of dnaA and one 
looking for spontaneous mutants, B. subtilis DnaA N47, F49 and A50 were implicated in 
resistance to SirA’s killing phenotype. Rahn–lee et al showed that DnaAN47D, DnaAF49Y, 
DnaAA50T and DnaAA50V resulted in loss of interaction with wild-type SirA in a yeast 
two-hybrid assay (81). We independently determined that DnaAN47D, DnaAF49Y, 
DnaAA50T and DnaAA50V resulted in loss of interaction with wild-type SirA in a B2H 
assay (Fig 3.9). 
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Fig. 3.8.  SirA does not interact with DnaD and DnaB in a B2H assay. B2H between 
SirA and DnaD (CYD492), or DnaB (CYD499) are shown on the left. Negative controls 
are on the right: empty partner vector with wild-type DnaD (CYD595) or DnaB 
(CYD537) (middle column) or SirA with the empty partner vector (CYD686 or 
CYD131) (right column). 
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Fig. 3.9.  SirA does not interact with DnaA variants containing point mutations in 
domain I. B2H between SirA and wild-type DnaA (CYD050), DnaAN47D (CYD052), 
DnaAF49Y (CYD053), DnaAA50T (CYD054) or DnaAA50V (CYD055) are shown on the 
left. Negative controls are on the right: empty partner vector with wild-type DnaA 
(CYD060), DnaAN47D (CYD063), DnaAF49Y (CYD064), DnaAA50T (CYD065) or 
DnaAA50V (CYD066) (middle column) or SirA with the empty partner vector (CYD061) 
(right column). 
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Interestingly, B. subtilis DnaA F49, which is the equivalent of E. coli DnaA F46 
was previously shown to be important for interaction between DnaA and DiaA, a 
positive regulator of DnaA in E. coli (122). Based on this observation, we hypothesized 
that E. coli DiaA and SirA might interact in a similar way with DnaA, but with opposite 
activities (positive and negative regulation, respectively). The crystal structures of E. 
coli DiaA and DnaA domain I have been solved (PDB ID: 2YVA and 2E0G, 
respectively)(75, 80). Using NMR to further study the DiaA-DnaA interaction (122), 
Keyamura et al. found that DiaA likely makes contacts with E. coli DnaA E21, W25 and 
W50 (S23, W27 and W53 in B. subtilis, respectively)(Fig 3.10, Fig 3.11)(122). 
Additional residues in this region of DnaA were also hypothesized to be important for 
the E. coli DnaA-DiaA interaction. We hypothesized that if SirA interacts with DnaA 
similar to DiaA, then substitutions in equivalent residues in B. subtilis DnaA might 
result in a change in interaction between SirA and DnaA. To test this hypothesis, each of 
the above-mentioned residues (S23, W27 and W53) as well as the ones around the 
potential interaction interface was replaced with Alanine. All but one of the variants 
showed loss-of-interaction with SirA by B2H. These results further suggest that SirA 
interacts directly with DnaA Domain I, and suggest that SirA and DiaA may interface 
with DnaA in similar ways (Fig 3.9, Fig 3.12). 
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Fig. 3.10.  E. coli DnaA Domain I structure. E. coli DnaA Domain I structure (PDB ID: 
2E0G)(75), showing only residues 1-80. Residues labeled in red have been shown to be 
important for E. coli DnaA-DiaA interaction (122). Residues labeled in orange are 
hypothesized to be important for DiaA interaction. Relevant residues shown as sticks (A) 
or through surface modeling (B) for comparison. 
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Fig. 3.11.  Alignment between E. coli DnaA and B. sub DnaA. Red asterisks indicate 
residues that have been shown to be important for E. coli DnaA-DiaA interaction (122); 
orange arrows point to the residues that are hypothesized to be important for DiaA 
interaction. 
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Fig. 3.12.  DnaA Domain I is important for SirA interaction. B2H between SirA and 
wild-type B. subtilis DnaA (CYD050), DnaAS23A (CYD092), DnaAF24A (CYD123), 
DnaAE25A (CYD093), DnaAT26S (CYD124), DnaAW27A (CYD094), DnaAE48R 
(CYD125), DnaAR51L (CYD126), DnaAD52N (CYD127) and DnaAW53A (CYD095).  
Negative controls: empty partner vector with wild-type DnaA (CYD060), DnaAS23A 
(CYD098), DnaAF24A (CYD137), DnaAE25A (CYD099), DnaAT26S (CYD138), 
DnaAW27A (CYD100), DnaAE48R (CYD139), DnaAR51L (CYD140), DnaAD52N (CYD141) 
and DnaAW53A (CYD101)(left column) or SirA with the empty partner vector (right 
column) 
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Attempts to replace wild-type dnaA with dnaA mutants encoding any of the 
Alanine substitutions were unsuccessful, suggesting that the proteins do not support 
viability in vivo. This result is consistent with the fact that none of the variants were 
obtained in the SirA-resistant suppressor selections. Since the substitutions did not 
support viability in vivo, we were unable to determine if the proteins were folded stably 
expressed and folded correctly. However, B. subtilis DnaAS23A showed gain-of-
interaction with SirA in a B2H assay, suggesting it is at least folded. Interestingly, in E. 
coli, the equivalent substitution (DnaAE21A) results in a loss of interaction with DiaA 
(122). These contrasting behaviors following substitution at this region of DnaA may 
provide insight regarding how DiaA and SirA are able to respectively function as 
positive and negative regulators of DnaA activity. 
 
3.3.5 SirA can affect E. coli DnaAV47A function in vivo 
 
When expressed in E. coli from a high or medium copy number plasmid, SirA 
has no detectable effect on E. coli DNA replication as judged by DAPI staining of the 
nucleoid (Fig 3.13). Rahn-Lee et al. showed that wild-type SirA does not interact with 
wild-type E. coli DnaA in a yeast two-hybrid assay (81). Interestingly, E. coli DnaA V47 
is A50 in B. subtilis. I and others have found that in B. subtilis, a DnaAA50V variant is 
resistant to SirA (see the text above and Fig 2.9A, B)(77, 81) and B. subtilis DnaAA50V 
does not interact with SirA in a B2H assay (Fig 2.9C, Fig 3.9)(77). These results suggest 
that having an Adenine at this position might be important for interaction. Consistent 
with this idea, the E. coli DnaAV47A variant shows interaction with SirA in a yeast two-
hybrid assay (81). Based on these data, we hypothesized that E. coli expressing 
DnaAV47A might render E. coli sensitive to SirA expression. To test this hypothesis, I 
attempted to replace wild-type dnaA with dnaAV47A on the E. coli chromosome. 
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Repeated attempts to generate the mutant were unsuccessful, possibly due to inviability 
of the resultant strain. 
To circumscribe this problem, we adapted an established plasmid maintenance 
assay. This assay tests the ability of a plasmid-encoded copy of dnaA to support 
replication of a separate DnaA-dependent plasmid (76). The assay utilizes an E. coli 
strain that does not require DnaA for chromosomal replication, thus uncoupling the host 
strain viability from DnaA activity (76). In the assay, E. coli dnaA or the dnaA mutant 
being tested is present on a DnaA-independent replicating plasmid encoding ampicillin 
resistance (ampR). A second DnaA-dependent plasmid (oriC plasmid) encoding 
chloramphenicol resistance (catR) is used to assess if the DnaA being made is functional. 
If the dnaA on the ampR plasmid is functional, then the oriC plasmid will be replicated, 
resulting in chloramphenicol-resistant transformants. The results are shown in Table 3.4. 
Although all the strains were made competent in the same time by using the same 
batch of media and buffer, it is still possible that different strain background may have 
difference in competence. In order to be able to directly compare the results shown in 
Table 3.4 and draw conclusions, we used another plasmid which replication is 
independent of DnaA as the control. The plasmid was transformed into each strain (the 
same as the ones in Table 3.4) and the number of colonies were counted and reported in 
Table 3.5.  
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Fig. 3.13.  SirA overexpression does not obviously inhibit wild-type E. coli DNA 
replication, based on nucleoid morphology. MG1655 harboring PBAD-sirA (CJW089) 
was grown in LB-Lennox media supplemented with 100 µg/ml ampicillin at 37°C to 
mid-exponential and back-diluted in the same media to an OD600 of ~0.04. When 
indicated, 0.2% arabinose was added to induce protein expression. Cells were grown for 
2 hrs at 37°C before image capture. DNA was stained with DAPI (2 µg/ml). All images 
were scaled identically. 
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Table 3.4.  E. coli-based plasmid maintenance assay. In this assay, the E. coli strain 
utilized replicates DNA independent of DnaA. The DnaA variant being tested is encoded 
on an ampR plasmid that also replicates independent of DnaA. The catR plasmid utilizes 
DnaA for its replication. Recovery of transformants indicates that the catR plasmid was 
replicated. 100 ng of pCM959-CmR (oriC plasmid) was transformed into CYD227 
(empty + empty), CYD228 (empty + DnaAwt), CYD229 (empty + DnaAV47A), CYD237 
(SirAwt + empty), CYD238 (SirAwt + DnaAwt), CYD239 (SirAwt + DnaAV47A), CYD267 
(SirAY51A + empty), CYD268 (SirAY51A + DnaAwt) or CYD269 (SirAY51A + DnaAV47A), 
and cells were selected on LB-Lennox agar plates containing both ampicillin and 
chloramphenicol. The values indicate the average number of colonies obtained in three 
independent transformations followed by the standard deviation. 
 
 Empty vector SirAwt SirAY51A 
Empty vector (ampR) 0 0 0 
DnaAwt (amp
R) 92±3 46±4 47±4 
DnaAV47A (amp
R) 91±4 0 23±3 
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Table 3.5.  Control for the plasmid maintenance assay. The catR plasmid does not 
require DnaA for its replication, thus is used as a control to test the competence 
difference between each strain. Transformants indicates that the catR plasmid was 
replicated. 1 ng of pACYC184 (DnaA-independent plasmid) was transformed into the 
same strains as shown in Table 3.4, and cells were selected on LB-Lennox agar plates 
containing both ampicillin and chloramphenicol. The values indicate the average number 
of colonies obtained in three independent transformations followed by the standard 
deviation. 
 
 Empty vector SirAwt SirAY51A 
Empty vector (ampR) 226±19 227±7 211±11 
DnaAwt (amp
R) 521±14 530±22 525±18 
DnaAV47A (amp
R) 560±15 509±14 512±11 
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Using this assay, we determined that both wild-type DnaA and DnaAV47A 
supported DNA replication, as evidenced by the recovery of similar numbers of catR 
transformants (Table 3.4). Constitutively expressed sirA or the sirA mutant was then 
cloned onto the DnaA dependent plasmid, and once again catR transformants were 
selected for. As shown in Table 3.4, transformants were readily obtained for cells 
expressing wild-type DnaA, but not the DnaAV47A variant. Notably, there were 
reproducibly approximately 2-fold fewer colonies for even wild-type DnaA compared to 
the control lacking SirA (actually it is 4-fold fewer considering the competence 
difference between each strain, see above and Table 3.5), suggesting that SirA may have 
some limited capacity to inhibit even wild-type E. coli DnaA activity. These results also 
suggest that SirA is capable of more strongly inhibiting DnaAV47A activity. Next we 
hypothesized that SirAY51A, a variant with reduced ability to inhibit DNA replication 
(Fig 2.7)(77), would also show reduced ability to inhibit E. coli DnaA-dependent 
replication in plasmid maintenance assay. Consistent with idea, introduction of SirAY51A 
did result in the recovery of catR transformants (about 2X reduced compared to the 
control strain lacking SirA)(Table 3.4). In total, these results suggest that the mechanism 
by which SirA inhibits DnaA-dependent DNA replication does not absolutely require 
any Bacillus specific factors, further implicating DnaA as the primary target of SirA 
function. 
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3.4 Discussion 
 
3.4.1 SirA is insoluble when overexpressed in E. coli 
 
To our knowledge, the only overexpression condition known to produce soluble 
SirA is co-expression of SirA with B. subtilis DnaA Domain I (79). While this form was 
useful in obtaining structural information, it was not useful in biochemical assays since 
the complex could not be reversed (79). The reasons underlying SirA’s poor solubility 
are unclear from the structure itself. The protein is globular and relatively small (~18 
kDa), with no sequences suggestive of membrane association. It is striking that a C-
terminally cleaved form of SirA appears to be soluble (Fig 3.7).  
One interpretation of this result is that SirA is capable of self-association through 
interactions requiring the extreme C-terminus. In the crystal structure, amino acid 
assignments could only be made up until residue P141. The remaining seven amino 
acids, VKERNFV were disordered (79). The self-association we observed following 
SirA expression could be disordered aggregation, or it could be assembly of some sort of 
higher-order oligomer. These ideas could be tested using a number of in vitro methods. 
For example, overexpression of SirA variants with C-terminal truncations would be 
expected to increase SirA’s solubility. Such a result could have a number of implications 
for our current model explaining how SirA functions both to inhibit DnaA activity and to 
promote oriC segregation. The DnaA gain of interaction substitutions identified in 
Chapter II (Table 2.5)(77) occur exclusively in the C-terminus of SirA. If these variants 
are less able to self-associate, then it could shift the population of SirA toward a more 
monomeric form that is better able to interact with DnaA Domain I. If it is true, this 
could have also resulted in the gain of interaction read-out in the B2H assay. This 
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hypothesis could be tested by assaying the SirA gain of interaction variants for increased 
solubility following protein overexpression. Similarly, the DnaA Domain III variants 
identified in in the gain of interaction screen could have resulted from DnaA being less 
able to oligomerize, thus favoring its interaction with SirA (Chapter II, Table 2.5)(77) 
could also be variants shifted toward a more monomeric version of DnaA. Future 
experiments will be aimed at characterizing the variants using biochemical methods. 
 
3.4.2 DnaA Domain I is important for SirA interaction and killing activity 
 
We performed suppressor selections following SirA expression both by using the 
mutagen NTG and selecting for spontaneous mutations. We obtained the same four 
variants (DnaAN47D, DnaAF49Y, DnaAA50T and DnaAA50V) obtained by others who 
directly mutagenized dnaA and introduced the alleles into the B. subtilis chromosome 
(81). These results suggest that DnaA Domain I may be the only target for SirA to 
inhibit DNA replication initiation. We also identified additional loss-of-interaction 
variants possessed substitutions on DnaA Domain I (Fig 3.12), further supporting the 
conclusion that DnaA Domain I is the primary, if not sole target required by SirA to 
perform its function in DNA replication inhibition. However, it is also possible that 
mutations in other SirA targets (either in other dnaA or in other gene products) might 
result in cellular lethality, thus precluding their identification through suppressor 
selection. 
 
 
 
 
 125 
 
3.4.3 SirA can inhibit DnaA function without any B. subtilis specific factors 
 
SirA inhibits DNA replication by interacting with DnaA Domain I, and the N47, 
F49 and A50 residues in B. subtilis DnaA are important for SirA-DnaA interaction (This 
study)(81). Moreover, we showed that SirA can affect E. coli DnaAV47A function, further 
suggesting that the Alanine at position 47 (position 50 in B. subtilis) is important for 
SirA to efficiently target DnaA activity. Importantly, this result also indicates that SirA 
does not require any Bacillus specific factors to inhibit DnaA’s activity in vivo. 
Consistent with this observation, no interaction was detected between SirA and the 
initiation factors DnaD and DnaB by B2H analysis (Fig 3.8). At the same time, these 
negative results do not exclude the possibility that in vivo, SirA could affect its role in 
oriC segregation by preventing association of a DnaA-oriC complex with the membrane, 
perhaps by preventing association of DnaA with DnaD and/or DnaB.   
It has been shown that in E. coli, DnaA Domain I is important for DnaA self-
dimerization, which is essential for its cooperative oligomerization on DNA (76, 83). 
Although DnaA Domain I is not required for B. subtilis DnaA self-oligomerization in 
vitro (143), it is still possible that DnaA Domain I function contributes to DnaA 
oligomerization and/or DNA binding in vivo. Since we’ve shown that SirA targets DnaA 
Domain I to inhibit DNA replication initiation, it is possible that this inhibition is due to 
the disruption of DnaA self-dimerization. To test this idea, the ability of DnaA to form a 
homodimer through Domain I could be tested in vivo using a modified λcI repression 
assay (259). If it did, the effect of SirA on formation of this complex could be assessed. 
This hypothesis could also be tested in vitro if soluble SirA can be obtained. 
 DnaA Domain I has also been shown to be important for helicase loading in E. 
coli (260, 261). In B. subtilis, DnaD and DnaB are also required (71). However, these 
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results do not exclude the possibility that DnaA Domain I is separately important for 
helicase loading in B. subtilis. In addition, E. coli DnaAE21 (which is DnaAS23 in B. 
subtilis) has been shown to be important for E. coli helicase loading, possibly by directly 
interacting with the helicase (75). We observed that B. subtilis DnaAS23 is also important 
for SirA interaction (Fig 3.12). Therefore, it is also possible that SirA may inhibit DNA 
replication by disrupting helicase loading. We think SirA is unlikely to regulate ATP 
binding/hydrolysis of DnaA, due to the high nucleotide exchange rate in B. subtilis 
(127). Future experiments aimed at purifying a soluble version of SirA will allow further 
testing of this and other hypotheses.   
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CHAPTER IV 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
In bacteria, chromosome replication and segregation are tightly regulated to 
ensure that each future daughter cell will inherit at least one copy of the genome (16). 
Despite the significance of genome inheritance, very little is known about how bacterial 
cells coordinate DNA replication and segregation with cell growth and division. The 
work presented in this dissertation provides significant insight into two fundamental 
questions: how is DNA replication regulated, and how are the replicated chromosomes 
segregated? 
Previous results have shown that a sporulation specific protein SirA (Sporulation 
inhibitor of replication A) inhibits DNA replication initiation during Bacillus subtilis 
sporulation by directly interacting with the initiator protein DnaA (7, 81). In bacteria, 
DNA replication initiation and origin segregation are closely coordinated (182, 183). 
Results in Chapter II suggest that in addition to inhibiting DNA replication, SirA also 
plays an important role in ensuring proper oriC segregation during sporulation. The data 
suggest that SirA facilitates oriC capture by acting in the same pathway as another DnaA 
regulator critical for oriC partitioning, Soj (140, 143, 187). One of the most important 
conclusions in Chapter II is that SirA’s ability to inhibit DNA replication initiation is 
distinct from its role in origin segregation. Results in Chapter II suggest that oriC 
segregation may be intimately linked to interactions between DnaA and oriC. The 
intimate relationship between DNA replication initiation and chromosome segregation is 
highlighted by the identification of yet another factor (SirA) that not only regulates 
DnaA activity, but also plays a role in oriC segregation. In Chapter III, additional 
experiments were performed to better understand how SirA inhibits DNA replication at 
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the molecular level. Results in Chapter III show that DnaA Domain I is important for 
SirA interaction, and that this interaction is required for SirA to inhibit DNA replication 
initiation. Furthermore, by performing genetic screens, the interaction interface between 
SirA and DnaA are determined, further supporting the information provided by the co-
crystal structure between SirA and B. subtilis DnaA Domain I (79). Finally, results in 
Chapter III indicate that SirA can inhibit replication in a manner that does not require 
any B. subtilis specific factors. These results suggest that SirA does not require other 
proteins, such as DnaD or DnaB to direct replication inhibition.  
 
4.1 SirA acts in the same pathway as Soj to facilitate oriC capture during B. subtilis 
sporulation 
 
Soj has been shown to be important for oriC segregation during B. subtilis 
sporulation, as a soj mutant fails to capture oriC in ~20% of sporulating cells (187). 
Results in Chapter II are consistent with this published result, with the further 
observation that the segregation defect could be reduced to ~10% if the gene for the 
replication checkpoint protein Sda was also deleted (Fig 2.2). Since Soj has been shown 
to be able to inhibit DNA replication (140, 143) and Sda executes the sporulation block 
imposed on actively initiating cells (96), these results hint that half of the oriC capture 
defect in observed in the Δsoj mutant may relate to Soj’s ability to inhibit DNA 
replication. Interestingly, results in Chapter II also show that a similar number of origins 
in the ΔsirA mutant (~10%) do not capture oriC in the forespore (Fig 2.2). Since Soj and 
SirA appear to act in the same pathway to facilitate oriC capture, I propose that this 
remaining 10% of origins requires the activity of both Soj and SirA. Currently there is 
no evidence to indicate whether SirA acts upstream, downstream, or in parallel with Soj 
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to support oriC partitioning. One possibility is that SirA interacts with DnaA to release 
oriC from a membrane-associated pre-replication complex, and that Soj acts downstream 
of SirA to segregate the free oriC toward the distal cell pole (Fig 2.13). One possible 
mechanism to explain how Soj might perform this function is proposed by Kloosterman 
et al. (144). In this paper, the authors showed that the MinD/MinJ/ComN protein 
complex is relocalized from the cell quarter position to the distal cell cell pole through 
interactions with DivIVA. Soj (which interacts with MinD) may promote oriC 
segregation through its interactions with Spo0J (which binds near oriC) and MinD. 
Further experiments will be required to provide more information regarding the 
mechanism.  
Another interesting question is why only 10% of cells fail to capture oriC in the 
ΔsirA mutant? One speculation, which is outlined in Fig 4.1, is that in a mixed 
population of fast growing cells, only a subset are preparing to initiate replication. In B. 
subtilis, initiation occurs at the membrane and requires the formation of a complex 
which I generically call a pre-replication complex (71), similar to terminology proposed 
for E. coli (66). Replication only initiates when the proper cell cycle cue is received. At 
some point early in sporulation, the signal to initiate replication is shut down, and oriC 
needs to be segregated to the distal cell pole. In my model, oriCs not attached to the 
membrane (90%) are able to segregate; however, origins associated with the membrane 
that have not had the chance to initiate become stuck. In this model, one of SirA’s 
primary functions is not to inhibit new rounds of replication, as has been proposed (7), 
but rather to disrupt interactions between DnaA and oriC so that oriC is free to be 
segregated by Soj. Cells lacking sirA are unable to segregate those oriCs stuck on the 
membrane, thus resulting in the ~10% oriC capture defect observed in Chapter II (Fig 
2.2, Fig 4.1). Alternatively, if expressed early enough with respect to when the pre-
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replication complex would be formed, SirA could prevent DnaA from ever engaging 
oriC. Further biochemical assays could be done to test some of these ideas (see below). 
 
4.2 SirA’s replication inhibition mechanism might be conserved in other bacterial 
species 
 
Both the prior results and the results presented in Chapter III indicate that SirA 
inhibits DNA replication initiation by directly interacting with DnaA Domain I (7, 79, 
81). In addition, results in Chapter III suggest that SirA can inhibit DnaA activity 
without needing any B. subtilis specific factors (such as B. subtilis DnaD and/or DnaB) 
(Table 3.4). Since DnaA Domain I is important for DnaA self-dimerization and helicase 
loading (76, 83), it is possible that SirA inhibits replication by disrupting one or both of 
these processes. In E. coli, DnaA self-dimerization through Domain I is required for 
cooperative DnaA oligomerization (82, 83). To test if SirA is able to disrupt DnaA self-
dimerization, λcI repression assay (259) could be performed to detect DnaA 
dimerization status in the absence and presence of SirA. Another possibility is that SirA 
affects helicase loading and results in replication inhibition. In E. coli, DnaAE21 
(DnaAS23 in B. subtilis) is important for helicase loading (75). Interestingly, results in 
Chapter III shows that this residue is also important for SirA interaction in B. subtilis. 
The ability to obtain soluble SirA (see discussion below) would be useful to test some of 
these hypotheses. 
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Fig. 4.1.  Model for SirA’s role in oriC segregation during B. subtilis sporulation. In a 
mixed population of fast growing cells, only a subset of cells (~10%) have formed pre-
replication complexes at the cell membrane. During B. subtilis sporulation, those oriCs 
not attached to the membrane are freely segregated to the cell pole (left panel). Those 
cells that have engaged the oriC in pre-replication complexes become stuck at the 
membrane as the signal for new rounds of initiation has been shut down. In wild-type 
cells, SirA interacts with DnaA and releases oriC from pre-replication complex, 
allowing it to be segregated to the cell pole (middle panel). In cells lacking sirA, stuck 
oriCs cannot be segregated to the cell pole, thus contributing to the ~10% oriC defect 
observed in the single cell chromosome organization assay (right panel). 
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So far, the only condition for producing soluble SirA in E. coli protein 
overexpression system is to co-express SirA with B. subtilis DnaA Domain I (79). In 
Chapter III, preliminary evidence is presented that SirA may be capable of self-
association through interactions mediated by its C-terminus. More specifically, it has 
been observed that if the extreme C-terminus of SirA is cleaved, the protein becomes 
soluble (Fig 3.6, Fig 3.7). To further test this idea, engineered C-terminal truncations of 
SirA could be overexpressed and tested for solubility. 
 
4.3 SirA’s role in oriC capture can be uncoupled from its ability to inhibit DNA 
replication initiation 
 
Results in Chapter II have shown that two DnaA variants which are insensitive to 
SirA’s killing activity (DnaAF49Y, DnaAA50V), and several SirA variants that are 
defective in their ability to inhibit DNA replication (SirAY51A, SirAI103V, SirAV118M, and 
SirAK121N), all captured oriC at levels similar to wildtype (Fig 2.8, Fig 2.12). These 
observations lead to one of the most significant conclusions in Chapter II: SirA’s 
functions in DNA replication and oriC segregation represent distinct functions of the 
protein. Similar to SirA, Soj also functions both as an inhibitor of DnaA (140, 143), and 
to promote oriC capture during sporulation (Fig 2.2)(187). In Caulobacter crescentus, 
the conserved initiation protein DnaA has been shown to be important for chromosome 
segregation independent of its role in DNA replication (228). Since replication initiation 
and oriC segregation are closely coordinated in bacteria (182, 183), it could be 
reasonably speculated that bacteria utilize replication initiation proteins to facilitate 
chromosome segregation. This idea is supported by a growing number of results that the 
replication regulators are spatially coupled to proteins that marked the boundaries of the 
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cell poles where the oriC is positioned (245-247). A similar idea was proposed more 
than fifty years ago when it was proposed that the precise regulation of chromosome 
replication and segregation could result from a connection between the chromosome and 
the cell surface (262). Results in Chapter II have provided further supports to this idea. 
Linking the oriC to the membrane (possibly through interactions with initators) could 
help explain the robustness of chromosome partitioning observed in current model 
systems, even those lacking all known partitioning systems (2, 3, 16, 190). Furthermore, 
if the sites of attachment were somehow coordinated with cell growth, this model could 
explain how early forms of life, proliferating through vesiculation (252) may have 
segregated their genetic material.  
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APPENDIX I 
YodL AND YisK POSSESS SHAPE-MODIFYING ACTIVITIES THAT ARE 
SUPPRESSED BY MUTATIONS IN Bacillus subtilis MreB AND Mbl* 
 
Introduction 
 
Bacterial cell growth requires that the machineries directing enlargement and 
division of the bacterial cell envelope be coordinated in both time and space (263). The 
cell envelope is comprised of membranes and a macromolecular mesh of peptidoglycan 
(PG) that possesses both rigid and elastic properties (264, 265). PG is highly cross-
linked, allowing bacteria to maintain shapes and avoid lysis, even in the presence of 
several atmospheres of internal turgor pressure. PG rearrangements are required during 
the inward redirection of growth that occurs at the time of cell division, but are also 
necessary when cells insert new PG and dynamically modify their morphologies in 
response to developmental or environmental signals (266, 267). To avoid lysis during 
PG rearrangements, bacteria must carefully regulate the making and breaking of glycan 
strands and peptide crosslinks (265). In rod-shaped bacteria, PG enlargement during 
steady-state growth is constrained in one dimension along the cell’s long-axis and can 
either occur through polar growth, as is the case in Agrobacterium tumefaciens and 
Streptomyces coelicolor, or through incorporation of new cell wall material along the 
length of the cell cylinder, as observed in Escherichia coli, Bacillus subtilis, and 
Caulobacter crescentus (268). 
To control cell diameter and create osmotically stable PG, bacteria that exhibit
 170 
 
non-polar growth require the activity of the highly conserved actin-like protein MreB. 
Biochemical, genetic, and cell biological data suggest that MreB likely directs PG 
synthesis during cell elongation and in some bacteria, MreB may also function during 
cell division (269-271). MreB possesses ATPase activity, and polymerizes at sites along 
the cytoplasmic side of the inner membrane (272). ATP binding and hydrolysis is 
required for MreB polymerization and activity (273) and two S-benzylisothiourea 
derivatives, A22 and MP265, target the ATPase domain of MreB in Gram negative 
organisms, possibly preventing nucleotide hydrolysis and/or release (274-277). 
Depletion or inactivation of MreB is lethal except in some conditional backgrounds 
(278), so organisms sensitive to A22 and/or MP265 lose shape and eventually lyse (274-
277). 
MreB has been found to interact with several other proteins involved in PG 
synthesis, including the bitopic membrane protein RodZ (270, 279-282). RodZ interacts 
directly with MreB through a cytoplasmic helix-turn-helix motif located at its N-
terminus (279). A co-crystal structure of RodZ and MreB shows the N-terminus of RodZ 
extending into a conserved hydrophobic pocket located in subdomain IIA of MreB 
(279). Depletion of RodZ also leads to loss of cell shape and cell death (283-285). 
However, in various mutant backgrounds, rodZ can be deleted without loss of rod shape 
or viability, indicating that RodZ is not absolutely required for MreB’s function in 
maintaining shape (286-288). Based on these observations and others, it has been 
proposed that MreB-RodZ interactions may regulate some aspect of MreB activity (272, 
288).  
Gram-positives often encode multiple paralogs (289). B. subtilis possesses three 
mreB family genes: mreB, mbl, and mreBH. mreB is distinguished from mbl and mreBH 
by its location within the highly conserved mreBCD operon. Although mreB, mbl, and 
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mreBH are essential, it has been reported that each can be deleted under conditions in 
which cells are provided sufficient magnesium (290-292), or in strain backgrounds 
lacking ponA, the gene encoding penicillin binding protein 1 (PBP1)(282). In addition, 
all three genes can be deleted in a single background with only minor effects on cell 
shape if any one of the paralogs is artificially overexpressed in trans from an inducible 
promoter (293). The ability of any one of the paralogs to compensate for the loss of the 
others, at least under some growth conditions, strongly suggests that MreB, Mbl, and 
MreBH share significant functional redundancy (293, 294).   
At the same time, several lines of evidence suggest that the paralogs possess non-
overlapping functions. The genes themselves exhibit different patterns of transcriptional 
regulation, suggesting that each likely possesses specialized activities that are important 
in different growth contexts. For example, mreB and mbl are maximally expressed at the 
end of exponential growth, but expression falls off sharply during stationary phase (295), 
whereas mreBH is part of the SigI heat-shock regulon (296). There is also evidence 
suggesting that each protein may possess specialized activities. For example, MreBH 
interacts with the lytic transglycosylase LytE, and is required for LytE localization 
(297), whereas the lytic transglycosylase CwlO, depends on Mbl for wild-type function 
(297). More recently MreB (but not Mbl or MreBH) was shown to aid in escape from the 
competent cell state (295).    
Aside from RodZ (272, 288), only a handful of proteins targeting MreB activity 
in vivo have been identified. In E. coli, the YeeU-YeeV prophage toxin-antitoxin system 
is comprised of a negative regulator of MreB polymerization, CbtA (298), and a positive 
regulator of MreB bundling, CbeA (299). Another E. coli prophage toxin, CptA, is also 
reported to inhibit MreB polymerization (300). The MbiA protein of C. crescentus 
appears to regulate MreB in vivo, however, its physiological role is unknown (301). 
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Given the importance of PG synthesis to cell viability and in cell shape control, it is 
likely that many undiscovered factors exist that modulate the activity of MreB and its 
paralogs. 
In the present work we describe the identification of YodL and YisK, modulators 
of MreB and Mbl activity that are expressed during early stages of B. subtilis 
sporulation. Misexpression of either yodL or yisK during vegetative growth results in 
loss of cell width control and cell death. Genetic evidence indicates that YodL targets 
and inhibits MreB activity, whereas YisK targets and inhibits Mbl. Our data also show 
that YisK activity affects cell length control through an Mbl and MreBH-independent 
pathway. 
 
Materials and Methods 
 
General methods.   
 
All B. subtilis strains were derived from B. subtilis 168. E. coli and B. subtilis 
strains utilized in this study are listed in Table A1.1. Plasmids are listed in Table A1.2. 
Oligonucleotide primers are listed in Table A1.3.  
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Table A1.1.  Strains used in Appendix I. 
 
Strain Description Reference 
Parental   
B. subtilis 
168 
Bacillus subtilis laboratory strain 168 trpC2  BGSC (1A866) 
B. subtilis 
3610 
spo0H::cat (sigH::cat) (303) 
B. subtilis 
PY79 
Bacillus subtilis laboratory strain (238) 
E. coli DH5α F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 
deoR nupG Φ80dlacZΔM15 Δ(lacZYA-
argF)U169, hsdR17(rK
- mK
+), λ–  
 
B. subtilis 
168 
  
BAS040 amyE::Phy-yodL (spec)   This study 
BAS041 amyE::Phy-yisK (spec)   This study 
BAS146 ponA::erm, kanΩΔmreB This study 
BAS147 ponA::erm, kanΩΔmbl This study 
BAS170 amyE::PyodL-lacZ (spec)   This study 
BAS171 amyE::PyodL-gfp (spec)   This study 
BAS191 amyE::Phy-yodL (spec), yhdG::Phy-yodL (phleo)   This study 
BAS192 amyE::PyisK-lacZ (spec)   This study 
BAS193 amyE::PyisK-gfp (spec)   This study 
BAS205 amyE::Pempty-gfp (spec)   This study 
BAS248 ponA::erm, kanΩΔmbl, catΩΔmreBH, 
amyE::Phy-yisK (spec), yhdG::Phy-yisK (phleo)   
This study 
BAS249 ponA::erm, kanΩΔmbl, catΩΔmreBH, 
amyE::Phy-yodL (spec), yhdG::Phy-yodL (phleo)   
This study 
BAS265 spo0A::erm This study 
BAS266 amyE::PyodL-gfp (spec), spo0A::erm   This study 
BAS267 amyE::PyisK-gfp (spec), spo0A::erm This study 
BAS282 sigH::cat This study 
BAS301 amyE::PyodL-lacZ (spec), spo0A::erm   This study 
BAS302 amyE::PyisK-lacZ (spec), spo0A::erm     This study 
BAS303 amyE::PyodL-lacZ (spec), sigH::cat This study 
BAS304 amyE::PyisK-lacZ (spec), sigH::cat     This study 
BAS305 amyE::PyodL-lacZ (spec), spo0A::erm,  
sigH::cat   
This study 
BAS306 amyE::PyisK-lacZ (spec), spo0A::erm,  
sigH::cat     
This study 
BDR992 amyE::Phy-lacZ (spec) David Z. Rudner 
BKE10750 yisK::erm BGSC 
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Table A1.1.  Continued. 
 
Strain Description Reference 
BKE19640 yodL::erm BGSC 
BKE22320 ponA::erm BGSC 
BYD048 amyE::Phy-yodL (spec), ycgO::Phy-yodL (tet), 
yhdG::Phy-yodL (phleo), sacA::Phy-lacZ (erm) 
This study 
BYD074 amyE::Phy-yisK (spec), yhdG::Phy-yisK (phleo)   This study 
BYD076 amyE::Phy-yisK (spec), yhdG::Phy-yisK (phleo), 
yycR::Phy-yisK (cat), sacA::Phy-lacZ (erm) 
This study 
BYD175 ponA::erm, amyE:: Phy-yisK (spec), yhdG::Phy-
yisK (phleo)   
This study 
BYD176 ponA::erm, amyE:: Phy-yodL (spec), yhdG::Phy-
yodL (phleo)   
This study 
BYD177 kanΩmreBG323E, amyE::Phy-yisK (spec), 
yhdG::Phy-yisK (phleo), yycR::Phy-yisK (cat) 
This study 
BYD178 kanΩmreBP147R, amyE::Phy-yisK (spec), 
yhdG::Phy-yisK (phleo), yycR::Phy-yisK (cat) 
This study 
BYD179 kanΩmreBR282S, amyE::Phy-yisK (spec), 
yhdG::Phy-yisK (phleo), yycR::Phy-yisK (cat) 
This study 
BYD180 kanΩmreBG143A, amyE::Phy-yisK (spec), 
yhdG::Phy-yisK (phleo), yycR::Phy-yisK (cat) 
This study 
BYD184 kanΩmreBR117G, amyE::Phy-yisK (spec), 
yhdG::Phy-yisK (phleo), yycR::Phy-yisK (cat) 
This study 
BYD258 ponA::erm, kanΩΔmbl, amyE::Phy-yisK (spec), 
yhdG::Phy-yisK (phleo)   
This study 
BYD259 ponA::erm, kanΩΔmbl, amyE::Phy-yodL (spec), 
yhdG::Phy-yodL (phleo)   
This study 
BYD262 ponA::erm, kanΩΔmreB, amyE::Phy-yisK 
(spec), yhdG::Phy-yisK (phleo)   
This study 
BYD263 ponA::erm, kanΩΔmreB, amyE::Phy-yodL 
(spec), yhdG::Phy-yodL (phleo)   
This study 
BYD276 ΔyodL This study 
BYD278 ΔyisK This study 
BYD279 ΔyodL, ΔyisK This study 
BYD281 amyE::Phy-yisK (spec), ycgO::Phy-yisK (tet), 
yhdG::Phy-yodL (phleo), yycR::Phy-yodL (cat)   
This study 
BYD327 kanΩmreBG323E, amyE::Phy-yodL (spec), 
yhdG::Phy-yodL (phleo), yycR::Phy-yodL (cat) 
This study 
BYD328 kanΩmreBR117G, amyE::Phy-yodL (spec), 
yhdG::Phy-yodL (phleo), yycR::Phy-yodL (cat) 
This study 
BYD329 kanΩmreBN145D, amyE::Phy-yodL (spec), 
yhdG::Phy-yodL (phleo), yycR::Phy-yodL (cat) 
This study 
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Table A1.1.  Continued. 
 
Strain Description Reference 
BYD330 kanΩmreBP147R, amyE::Phy-yodL (spec), 
yhdG::Phy-yodL (phleo), yycR::Phy-yodL (cat) 
This study 
BYD332 kanΩmreBS154R,R230C, amyE::Phy-yodL (spec), 
yhdG::Phy-yodL (phleo), yycR::Phy-yodL (cat) 
This study 
BYD333 kanΩmreBG143A, amyE::Phy-yodL (spec), 
yhdG::Phy-yodL (phleo), yycR::Phy-yodL (cat) 
This study 
BYD334 kanΩmblE250K, amyE::Phy-yisK (spec), 
yhdG::Phy-yisK (phleo), yycR::Phy-yisK (cat) 
This study 
BYD335 kanΩmblT317I, amyE::Phy-yodL (spec), 
yhdG::Phy-yodL (phleo), yycR::Phy-yodL (cat) 
This study 
BYD336 kanΩmblT158M, amyE::Phy-yodL (spec), 
yhdG::Phy-yodL (phleo), yycR::Phy-yodL (cat) 
This study 
BYD337 kanΩmblΔS251, amyE::Phy-yisK (spec), 
yhdG::Phy-yisK (phleo), yycR::Phy-yisK (cat) 
This study 
BYD338 kanΩmblP309L, amyE::Phy-yisK (spec), 
yhdG::Phy-yisK (phleo), yycR::Phy-yisK (cat) 
This study 
BYD339 kanΩmblG156D, amyE::Phy-yisK (spec), 
yhdG::Phy-yisK (phleo), yycR::Phy-yisK (cat) 
This study 
BYD340 kanΩmblT158A, amyE::Phy-yisK (spec), 
yhdG::Phy-yisK (phleo), yycR::Phy-yisK (cat) 
This study 
BYD341 kanΩmblD153N, amyE::Phy-yisK (spec), 
yhdG::Phy-yisK (phleo), yycR::Phy-yisK (cat) 
This study 
BYD342 kanΩmblR63C, amyE::Phy-yisK (spec), 
yhdG::Phy-yisK (phleo), yycR::Phy-yisK (cat) 
This study 
BYD343 kanΩmblM51I, amyE::Phy-yisK (spec), 
yhdG::Phy-yisK (phleo), yycR::Phy-yisK (cat) 
This study 
BYD344 kanΩmblA314T, amyE::Phy-yisK (spec), 
yhdG::Phy-yisK (phleo), yycR::Phy-yisK (cat) 
This study 
BYD345 kanΩmblE204G, amyE::Phy-yisK (spec), 
yhdG::Phy-yisK (phleo), yycR::Phy-yisK (cat) 
This study 
BYD346 kanΩmblE250K, amyE::Phy-yodL (spec), 
yhdG::Phy-yodL (phleo), yycR::Phy-yodL (cat) 
This study 
BYD348 kanΩmblT158A, amyE::Phy-yodL (spec), 
yhdG::Phy-yodL (phleo), yycR::Phy-yodL (cat) 
This study 
BYD349 kanΩmblG156D, amyE::Phy-yodL (spec), 
yhdG::Phy-yodL (phleo), yycR::Phy-yodL (cat) 
This study 
BYD351 kanΩmblD153N, amyE::Phy-yodL (spec), 
yhdG::Phy-yodL (phleo), yycR::Phy-yodL (cat) 
This study 
BYD352 kanΩmblM51I, amyE::Phy-yodL (spec), 
yhdG::Phy-yodL (phleo), yycR::Phy-yodL (cat) 
This study 
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Table A1.1.  Continued. 
 
Strain Description Reference 
BYD353 kanΩmblA314T, amyE::Phy-yodL (spec), 
yhdG::Phy-yodL (phleo), yycR::Phy-yodL (cat) 
This study 
BYD354 kanΩmblE204G, amyE::Phy-yodL (spec), 
yhdG::Phy-yodL (phleo), yycR::Phy-yodL (cat) 
This study 
BYD361 amyE::Phy-yisK (spec), yhdG::Phy-yodL (phleo)   This study 
BYD363 kanΩmreBS154R,R230C, amyE::Phy-yisK (spec), 
yhdG::Phy-yisK (phleo), yycR::Phy-yisK (cat) 
This study 
BYD365 kanΩmreBR282S, amyE::Phy-yodL (spec), 
yhdG::Phy-yodL (phleo), yycR::Phy-yodL (cat) 
This study 
BYD404 kanΩmreBN145D, amyE::Phy-yisK (spec), 
yhdG::Phy-yisK (phleo), yycR::Phy-yisK (cat) 
This study 
BYD405 kanΩmblR63C, amyE::Phy-yodL (spec), 
yhdG::Phy-yodL (phleo), yycR::Phy-yodL (cat) 
This study 
BYD406 kanΩmblΔS251, amyE::Phy-yodL (spec), 
yhdG::Phy-yodL (phleo), yycR::Phy-yodL (cat) 
This study 
BYD407 kanΩmblP309L, amyE::Phy-yodL (spec), 
yhdG::Phy-yodL (phleo), yycR::Phy-yodL (cat) 
This study 
BYD510 ΔyodL, ΔyisK, amyE::PyisK-yisK (spec)   This study 
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Table A1.2.  Plasmids used in Appendix I. 
 
Plasmid Description Reference 
pAS015 yhdG::Phy-yisK (amp) This study 
pAS040 amyE::PyodL-lacZ (amp) This study 
pAS041 amyE::PyodL-gfp (amp) This study 
pAS044 amyE::PyisK-lacZ (amp) This study 
pAS045 amyE::PyisK-gfp (amp) This study 
pAS047 amyE::gfp (amp) This study 
pAS067 amyE::PyisK-yisK (amp) This study 
pDR111 amyE::Phy (amp)   David Z. Rudner 
pDR244 
Temperature sensitive Cre recombinase 
plasmid (amp)(spec) 
David Z. Rudner 
pJH036 sacA::Phy-lacZ (amp) This study 
pJW004 yhdG::Phy (amp)   This study 
pJW006 amyE::Phy-sirA-gfp (amp)  (7) 
pJW033 ycgO::Phy (amp)   This study 
pJW034 yycR::Phy (amp)(cat)   This study 
pKM062 sacA::erm (amp) David Z. Rudner 
pWX114 yrvN::Phy (amp)(kan)  David Z. Rudner 
pYD073 yhdG::Phy-yodL (amp)   This study 
pYD155 yycR::Phy-yodL (amp)   This study 
pYD156 ycgO::Phy-yisK (amp)   This study 
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Table A1.3.  Oligonucleotides used in Appendix I. 
 
Oligo Sequence 5’ to 3’ 
OAM001 AGAAGCGTTAGCGGCAGCAAGTGAT 
OAM002 CCATGTCTGCCCGTATTTCGCGTAAGGAAATCCATTATGTACT
ATTTCGATCAGACCAG 
OAM009 GAAAACAATAAACCCTTGCATAGGGGGATCGGGCAAGGCTAG
ACGGGACTTACC 
OAM010 ATGGACACAACAACAGCAAAACAGGC 
OAM011 TAATGGATTTCCTTACGCGAAATA 
OAM013 AGTAGTTCCTCCTTATGTAAGC 
OAS064 TCCTCCTTTTCAAAAGAAAAAAAC 
OAS067 TGTTACATATTGCTGCTTTTTGGT 
OAS078 GGATCCCAGCGAACCATTTGA 
OAS079 GTCGACAAATTCCTCGTAGGC 
OAS080 CCTATCACCTCAAATGGTTCGCTGGGATCCAAAGCAAAAATA
CCCTAAAGGGAA 
OAS081 GTCCCGAGCGCCTACGAGGAATTTGTCGACACACTTTTTTTTT
CGTCGAATTAAG 
OAS086 CGAATACATACGATCCTACAGC 
OAS087 CCTATCACCTCAAATGGTTCGCTGGGATCCAAAAAGTTGGAA
GCACAATAAGTT 
OAS088 GTCCCGAGCGCCTACGAGGAATTTGTCGACATCACCTGGCATT
GCCTTCTT 
OAS089 ATTAATGGTGATATTCTTCATTGA 
OAS091 AGATGGATGTGCTCCAGTGCTCCAAGATCTATACCAAGGTCT 
OAS092 AGACCTTGGTATAGATCTTGGAGCACTGGAGCACATCCATCT 
OAS095 GGAAGCTTGTCCATATTATCAAGATTTGCAGTACCGAGGTCAA
TA 
OAS096 TATTGACCTCGGTACTGCAAATCTTGATAATATGGACAAGCTT
CC 
OAS114 TCTAAGGAATTCCTGTTTTAGTCGGCATAAGCAG 
OAS116 GTAATCTTACGTCAGTAACTTCCACCAAGATCCCCTCCCTTTT
ATTT 
OAS117 AAGAAATAAAAGGGAGGGGATCTTGGTGGAAGTTACTGACGT
AAGAT 
OAS118 ACTTAGGGATCCTTATTTTTGACACCAGACCAACT 
OAS119 TGAAAAGTTCTTCTCCTTTACTCATCAAGATCCCCTCCCTTTTA
TTT 
OAS120 AAGAAATAAAAGGGAGGGGATCTTGATGAGTAAAGGAGAAG
AACTTTTC 
OAS121 ACTTAGGGATCCTTATTTGTATAGTTCATCCATGCCAT 
OAS134 TCTAAGGAATTCTCCTTTTCAGCTGCTCCCGAT 
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Table A1.3.  Continued. 
 
Oligo Sequence 5’ to 3’ 
OAS135 GTAATCTTACGTCAGTAACTTCCACGTTATTCCTCCATCATCTT
TTAAA 
OAS136 ATTTAAAAGATGATGGAGGAATAACGTGGAAGTTACTGACGT
AAGAT 
OAS137 TGAAAAGTTCTTCTCCTTTACTCATGTTATTCCTCCATCATCTT
TTAAA 
OAS138 ATTTAAAAGATGATGGAGGAATAACATGAGTAAAGGAGAAG
AACTTTTC 
OAS148 TCTAAGGAATTCATGAGTAAAGGAGAAGAACTTTTC 
OAS149 ACTTAGGGATCCTTATTTGTATAGTTCATCCATGCC 
OAS274 TCTAAGGAATTCTCCTTTTCAGCTGCTCCCGA 
OAS275 ACTTAGGGATCCTCAGCCAATTTGGTTTGACAG 
OEA035 GGATAACAATTAAGCTTACATAAGGAGGAACTACTATGAAAT
TTGCGACAGGGGAACTT 
OEA036 TTCCACCGAATTAGCTTGCATGCGGCTAGCCCAGTTTTATTCA
GCCAATTTGGT 
OEA275 GGATAACAATTAAGCTTACATAAGGAGGAACTACTATGATGT
TATCCGTGTTTAAAAAG 
OEA276 TTCCACCGAATTAGCTTGCATGCGGCTAGCTTTCTTTTCATTAT
GTCGTTTGTA 
OJH159 CTGCAGGAATTCGACTCTCTA 
OJH160 TAGCTTGCATGCGGCTAGC 
OJH185 CAGGAATTCGACTCTCTAGC 
OJH186 CTCAGCTAGCTAACTCACATTAATTGCGTTGC 
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Escherichia coli DH5α was used for cloning. All E. coli strains were grown in 
LB-Lennox medium supplemented with 100 µg/ml ampicillin. The following 
concentrations of antibiotics were used for generating B. subtilis strains: 100 µg/ml 
spectinomycin, 7.5 µg/ml chloramphenicol, 0.8 mg/ml phleomycin, 10 µg/ml 
tetracycline, 10 µg/ml kanamycin. To select for erythromycin resistance, plates were 
supplemented with 1 µg/ml erythromycin (erm) and 25 µg/ml lincomycin. B. subtilis 
transformations were carried out as described previously (302). When indicated, the LB 
in the B. subtilis microscopy experiments was LB-Lennox broth. Sporulation by 
resuspension was carried out at 37°C according to the Sterlini-Mandelstam method 
(237). Penassay broth (PAB) is composed of 5 g peptone, 1.5 g beef extract, 1.5 g yeast 
extract, 1.0 g D-glucose (dextrose), 3.5 g NaCl, 3.68 g dipotassium phosphate, and 1.32 
g monopotassium phosphate per liter of distilled water. To make solid media, the 
relevant media was supplemented with 1.5% (w/v) bacto-agar. 
 
Microscopy   
 
For microscopy experiments, all strains were grown in the indicated medium in 
volumes of 25 ml in 250 ml baffled flasks, and placed in a shaking waterbath set at 37°C 
and 280 rpm. Unless stated otherwise, misexpression was performed by inducing 
samples with 1.0 mM isopropyl-beta-D-thiogalactopyranoside (IPTG) and imaging 
samples 90 min post-induction. Fluorescence microscopy was performed with a Nikon 
Ti-E microscope equipped with a CFI Plan Apo lambda DM 100X objective, Prior 
Scientific Lumen 200 Illumination system, C-FL UV-2E/C DAPI and C-FL GFP HC 
HISN Zero Shift filter cubes, and a CoolSNAP HQ2 monochrome camera. Membranes 
were stained with TMA-DPH [1-(4-trimethylammoniumphenyl)-6-phenyl-1,3,5-
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hexatriene p -toluenesulfonate] (0.02 mM) and imaged with exposure times of 1 sec with 
a neutral density filter in place to reduce cytoplasmic background. All GFP images were 
captured with a 1 sec exposure time. All images were captured with NIS Elements 
Advanced Research (version 4.10), and processed with NIS Elements Advanced 
Research (version 4.10) and ImageJ64 (240). Cells were mounted on glass slides with 
1% agarose pads or polylysine-treated coverslips prior to imaging. To quantitate cell 
lengths for Fig A1.11, the cell lengths for 500 cells were determined for each population. 
The statistical significance of cell length differences between populations was 
determined using an unpaired student’s t-test. 
 
Plate growth assay   
 
B. subtilis strains were streaked on LB-Lennox plates containing 100 µg/ml 
spectinomycin and 1 mM IPTG. The plates were supplemented with the indicated 
concentrations of MgCl2 when indicated. Plates were incubated at 37°C overnight and 
images were captured on a ScanJet G4050 flatbed scanner (Hewlett Packard). 
 
Heat kill   
 
Spore formation was quantified by growing cells in Difco sporulation medium 
(DSM)(304). A freshly grown single colony of each strain was inoculated into 2 mL of 
DSM media and placed in a roller drum at 37°C, 60 rpm for 36 hrs. To determine colony 
forming units/ml, an aliquot of each culture was serially diluted and plated on DSM agar 
plates. To enumerate heat resistant spores/ml, the serial diluted cultures were subjected 
to a 20 min heat treatment at 80°C and plated on DSM agar plates. The plates were 
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incubated at 37°C overnight and the next day colony counts were determined. The 
relative sporulation frequency compared to wildtype was determined by calculating the 
spores/CFU of each experimental and dividing it by the spores/CFU of wildtype. The 
reported statistical significance was determined using an unpaired student’s t-test. 
 
Transcription fusions   
 
Transcriptional fusions were constructed by fusing a ~200 bp region up to the 
start codon of either yodL or yisK to gfp or lacZ and integrating the fusions into the B. 
subtilis chromosome at the amyE locus (for more details, see strain construction in the 
supplemental text). Microscopy was conducted on each strain over a timecourse in 
sporulation by resuspension media (see general methods) or in a nutrient exhaustion 
timecourse in CH (237). Beta-galactosidase assays were performed as described (305), 
except all samples were frozen at -80°C before processing. All experiments were 
performed on at least three independent biological replicates. 
 
Suppressor selections   
 
Single colonies of BYD048 (3X Phy-yodL, Phy-lacZ) or BYD076 (3X Phy-yisK, 
Phy-lacZ) were used to inoculate independent 5 ml LB-Lennox cultures. Six independent 
cultures were grown for each strain. The cultures were grown for 6 hrs at 37°C and 0.3 
µl of each culture was diluted in 100 µl LB and plated on an LB-Lennox agar plate 
containing 100 µg/ml spectinomycin and 1 mM IPTG. After overnight growth, 
suppressors that arose were patched on both LB-Lennox agar plates supplemented with 
100 µg/ml spectinomycin and LB-Lennox agar plates supplemented with 100 µg/ml 
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spectinomycin, 1.0 mM IPTG, and 40 µg/ml X-Gal and grown at 37°C overnight. Only 
blue colonies were selected for further analysis; this screen eliminated mutants unable to 
derepress Phy in the presence of IPTG. In addition, each Phy-yodL or Phy-yisK construct 
was transformed into a wildtype background to ensure that the construct remained fully 
functional with respect to preventing cell growth on LB-Lennox agar plates 
supplemented with the relevant antibiotic and 1 mM IPTG. 
 
Whole-genome sequencing and analysis   
 
Genomic DNA was isolated from six YodL-resistant suppressors obtained from 
independent cultures as well as the parent strain (BYD048) by inoculating a single 
colony in 6 ml LB-Lennox media and growing at 37°C for 4 hr in a roller drum. Cells 
were collected by spinning at 21,130 x g for 2 min at room temperature, resuspending 
the pellets in lysis buffer [20 mM Tris-HCl pH 7.5, 50 mM EDTA pH 8, 100 mM NaCl, 
and 2 mg/ml lysozyme] and incubating at 37°C for 30 min. Sarkosyl was added to a final 
concentration of 1% (w/v). Protein was removed by extracting with 600 μl phenol, 
centrifuging at 21,130 x g for 5 min at room temperature, and transferring the top 
(aqueous layer) to a new microcentrifuge tube. This was followed by an extraction with 
600 μl phenol-saturated chloroform and centrifugation at 21,130 x g for 5 min at room 
temperature. After transferring the aqueous layer to a new microcentrifuge tube, a final 
extraction was performed with 100% chloroform, followed by centrifugation at 21,130 x 
g for 5 min at room temperature. The aqueous layer was transferred to a new 
microcentrifuge tube, being careful to avoid the interphase material. To precipitate the 
genomic DNA, a 1/10th volume of 3.0 M Na-acetate and 1 ml of 100% ethanol was 
added, and the tube was inverted multiple times. The sample was centrifuged at 21,130 x 
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g for 1 min at room temperature in a microcentrifuge. The pellet was washed with 150 μl 
70% ethanol and resuspended in 500 μl TE [10 mM Tris pH 7.5, 1 mM EDTA, pH 8.0]. 
To eliminate potential RNA contamination, RNase was added to a final concentration of 
200 μg/ml and the sample was incubated at 55°C for 1 hr. To remove the RNase, the 
genomic DNA was re-purified by phenol-chloroform extraction and ethanol precipitation 
as described above. The final pellet was resuspended in 100 μl TE. Bar-coded libraries 
were prepared from each genomic DNA sample using a TruSeq DNA kit according to 
manufacture specifications (Illumina), and the samples were subjected to Illumina-based 
whole-genome sequencing using a MiSeq 250 paired-end run (Illumina). CLC Genomics 
Workbench (Qiagen) was used to map the sequence reads against the Bs168 reference 
genome and to identify single nucleotide polymorphisms, insertions, and deletions. 
Mutations associated with the Phy integration contructs and those in which less than 40% 
of the reads differed from the reference genome were excluded as candidate changes 
responsible for suppression in our initial analysis (Table A1.5). The remaining 
suppressors mutations were identified by PCR amplifying mreB (using primer set 
OAS044 and OAS045) and mbl (using primer set OAS046 and OAS047), and 
sequencing with the same primers. To determine if the candidate suppressors alleles 
identified were sufficient to confer resistance to the original selective pressure, each was 
linked to a kanamycin resistance cassette and moved by transformation into a clean 
genetic background. 
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Results 
 
YodL and YisK affect cell width 
 
To identify novel factors involved in cellular morphogenesis, we created an 
ordered gene misexpression library comprising over 800 previously uncharacterized 
genes from B. subtilis. Each gene was placed under the control of an IPTG-inducible 
promoter (Phy) and integrated in single copy (1X) at amyE, a non-essential locus in the B. 
subtilis chromosome. The library (called the BEIGEL for Bacillus Ectopic Inducible 
Gene Expression Library), was screened for misexpression phenotypes that perturbed 
growth on solid media, and also resulted in obvious defects in nucleoid morphology, 
changes in cell division frequency, and/or perturbations in overall cell shape in liquid 
cultures. Two strains, one harboring Phy-yodL and one harboring Phy-yisK, were unable to 
form colonies on plates containing inducer (Fig A1.1A) and also produced wide, 
irregular cells with slightly tapered poles following misexpression in LB liquid media 
(Fig A1.1B). Cell lysis and aberrant cell divisions were also observed. Introducing a 
second copy (2X) of each Phy misexpression construct into the chromosome did not 
appreciably enhance cell widening at the 90 min post-induction timepoint, although cell 
lysis was more readily observed (Fig A1.1B). Phy-yisK (2X) misexpression also led to a 
drop in optical density over time (Fig A1.2A), consistent with the cell lysis observed 
microscopically. We conclude that the activities of yodL and yisK target one or more 
processes integral to width control during cell elongation. 
 186 
 
 
 
 
Fig. A1.1.  Misexpression of YodL and YisK prevents cell growth on solid media and 
causes loss of cell shape in liquid media. (A) Cells harboring one (1X) or two (2X) 
copies of Phy-yodL (BAS040 and BAS191) or Phy-yisK (BAS041 and BYD074) were 
streaked on an LB plate supplemented with 100 µg/ml spectinomycin and, when 
indicated, 1 mM IPTG or 1 mM IPTG and the denoted concentration of MgCl2. Plates 
were incubated for ~16 hrs at 37°C before image capture (top). (B) The strains 
described above were grown in LB-Lennox media at 37°C to mid-exponential and back-
diluted to an OD600 of ~0.02. When indicated, 1 mM IPTG or 1 mM IPTG and the 
denoted concentration of MgCl2 was added. Cells were grown for 1.5 hrs at 37°C before 
image capture. Membranes were stained with TMA-DPH. All images were scaled 
identically. 
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Fig. A1.2.  Growth curves in LB following misexpression of YodL and/or YisK. 2X 
Phy-yodL (BAS191), 2X Phy-yisK (BYD074) and 2X Phy-yodL, 2X Phy-yisK (BYD281) 
were grown in LB media at 37°C to mid-exponential diluted to an OD600 of <0.02. At 
time 0, 1 mM IPTG or 1 mM IPTG and the indicated concentration of MgCl2 was added. 
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The yodL and yisK misexpression phenotypes are similar to those observed when 
proteins involved in cell elongation are perturbed in B. subtilis (282, 293, 306). Since the 
addition of magnesium was previously reported to suppress the lethality and/or 
morphological phenotypes associated with depletion or deletion of some proteins 
important for cell elongation in B. subtilis (280, 282, 291, 293, 307), we assessed if the 
Phy-yodL and Phy-yisK misexpression phenotypes could be rescued by growing cells with 
media supplemented with two different concentrations of MgCl2. The YodL-producing 
cells failed to grow on any LB media containing inducer, regardless of MgCl2 
concentration (Fig A1.1A). In contrast, LB supplemented with 25 mM MgCl2 restored 
viability to the strain producing YisK (Fig A1.1A). Interestingly, even 25 mM MgCl2 
was not sufficient to suppress the cell-widening effect associated with YodL and YisK 
misexpression (Fig A1.1B), although these cells did not lyse (Fig A1.2C). Since PAB 
medium was often used in the prior studies showing MgCl2 supplementation rescued cell 
shape (280, 282, 291, 293, 307), we also assayed for growth on PAB following YodL 
and YisK expression. PAB supplemented with 25 mM MgCl2 rescued growth on plates 
(Fig A1.3A), but still did not rescue morphology in liquid culture (Fig A1.3B). 
 
 
 
 189 
 
 
 
 
Fig. A1.3.  Misexpression of YodL and YisK on PAB media. (A) Cells were streaked 
on PAB solid media supplemented with 100 µg/ml spectinomycin and, when indicated, 1 
mM IPTG and the denoted concentration of MgCl2. Plates were incubated for ~16 hr at 
37°C before image capture. (B) Cells were grown in PAB liquid media at 37°C to mid-
exponential and back-diluted to an OD600 of <0.02. When indicated, 1 mM IPTG and the 
denoted concentration of MgCl2 was added. Cells were then grown for 1.5 hrs at 37°C 
before image capture. Membranes are stained with TMA-DPH (white). All images are 
shown at the same magnification. 
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yodL and yisK expression 
 
To better understand the possible physiological functions of the yodL and yisK 
gene products, we analyzed the genes and their genetic contexts bioinformatically. yodL 
is predicted to encode a 12.5 kDa hypothetical protein which, based on amino acid 
similarity, is conserved in the Bacillus genus. In data from a global microarray study 
analyzing conditional gene expression in B. subtilis, yodL is expressed as a 
monocistronic mRNA, exhibiting peak expression ~2 hrs after entry into sporulation 
(14). yodL expression is most strongly correlated with expression of racA and refZ 
(yttP)(14), genes directly regulated by Spo0A (36). yodL was not previously identified as 
a member of the Spo0A regulon controlling early sporulation gene expression (32, 36), 
however a more recent study found that yodL expression during sporulation is reduced in 
a Δspo0A mutant (308). Consistent with this observation, we identified a putative Spo0A 
box approximately ~75 bp upstream of the annotated yodL start codon (Fig A1.4A). yisK 
is predicted to encode a 33 kDa protein and is annotated as a putative catabolic enzyme 
based on its similarity to proteins involved in the degradation of aromatic amino acids 
(309). yisK was previously identified as a member of the SigH regulon, and possesses a 
SigH -35/-10 motif (Fig A1.4B)(32). Expression of yisK peaks ~2 hrs after entry into 
sporulation (301) and is most strongly correlated with expression of kinA (14), a gene 
regulated by both SigH (the stationary phase sigma factor)(32, 37, 310, 311) and Spo0A 
(36, 311). As with yodL, we identified a putative Spo0A box in the regulatory region 
upstream of the yisK start codon (Fig A1.4B).   
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Fig. A1.4.  DNA sequence upstream of yodL and yisK. (A) Putative Spo0A box 
(underlined) upstream of the yodL start codon. (B) SigH binding motifs (double 
underline) and putative Spo0A box (underlined) upstream of yisK start codon. 
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To independently test if yodL and yisK expression are consistent with Spo0A-
dependent regulation, we fused the putative regulatory regions upstream of each gene to 
a gfp reporter gene, and integrated the fusions into the amyE locus. We then followed 
expression from the promoter fusions over a timecourse in CH liquid broth, a rich 
medium in which the cells first grow exponentially, transition to stationary phase, and 
finally gradually enter sporulation (Fig A1.5A-C). In this timecourse, GFP signal from 
PyisK-gfp increased dramatically from time 0 (OD600 ~0.6) to time 1 hr (OD600 ~1.6) (Fig 
A1.5C), consistent with yisK’s prior characterization as a SigH-regulated gene (32). In 
contrast, GFP fluorescence from PyodL-gfp became evident at a later timepoint (120 min) 
and was more heterogeneous (Fig A1.5C), consistent with expression patterns previously 
observed for other Spo0A-P regulated genes (312, 313).   
To quantitate expression from the promoters, we generated PyodL-lacZ and PyisK-
lacZ reporter strains and collected samples over a CH timecourse beginning with early 
exponential (OD600 = 0.2). Expression from PyodL-lacZ rose steadily beginning about 2 
hrs after exit from exponential growth, and continued to rise at least until the final 
timepoint taken (Fig A1.5D). In contrast, expression from PyisK-lacZ rose as cells 
transitioned from early to late exponential growth, reached peak levels shortly after exit 
from exponential growth, and remained steady for the remainder of the timepoints (Fig 
A1.5E). Wild-type expression from both PyodL-lacZ and PyisK-lacZ required both SigH 
and Spo0A, and was largely eliminated in the absence of both regulators (Fig A1.5D and 
Ap1.5E). We did not attempt to draw further conclusions from this data, since Spo0A 
and SigH each require the other for wildtype levels of expression (see discussion).   
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Fig. A1.5.  Expression from yodL and yisK promoters during a CH timecourse. 
Expression from the putative yodL and yisK promoter regions was monitored in CH 
medium at 37°C over a timecourse. The OD600 (A and B) and production of either GFP 
(C) or beta-galactosidase (D and E) was monitored at 30 min intervals. Membranes 
were stained with TMA-DPH. All GFP channel images were captured with 1 sec 
exposures and scaled identically to allow for direct comparison. In this media, time 0 
represents the last exponential timepoint, not the initiation of sporulation. 
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Fig. A1.6.  Expression from yodL and yisK promoters following sporulation by 
resuspension. Expression from the putative yodL and yisK promoter regions was 
monitored in resuspension medium. The production of either GFP (A) or beta-
galactosidase (B and C) was monitored at 20 min intervals. Membranes were stained 
with TMA-DPH. All GFP channel images were captured with 1 sec exposures and 
scaled identically to allow for direct comparison. 
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Fig. A1.7.  A strain harboring a GFP reporter without a promoter during a sporulation 
timecourse. BAS205 (Pempty-gfp) was induced to sporulate via resuspension, and 
membranes are stained with TMA (white). Signal from GFP was scaled identically for 
all images and pseudocolored green. All images are shown at the same magnification. 
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We then followed expression from the promoter fusions over a time-course 
following the sporulation by resuspension method, which generates a more synchronous 
entry into sporulation (314). At time 0, neither the strain harboring PyodL-gfp, nor the 
strain harboring PyisK-gfp showed appreciable levels of fluorescence (Fig A1.6A), 
appearing similar to a negative control harboring gfp without a promoter (Fig A1.7). 
Between 0 and 40 min, both strains showed detectable increases in fluorescence. At 60 
min, when the first polar division characteristic of sporulation begins to manifest, both 
strains were more strongly fluorescent (Fig A1.6A). GFP fluorescence from PyodL was 
qualitatively more intense than fluorescence produced from PyisK (all images were 
captured and scaled with identical parameters to allow for direct comparison). Moreover, 
the GFP signal continued to accumulate in the strain harboring PyodL-gfp for at least two 
hrs (Fig A1.6A) and was heterogenous, consistent with activation by Spo0A. In contrast, 
the fluorescence signal produced from PyisK-gfp was similar across the population and 
appeared similar at the 60 and 120 min timepoints (Fig A1.6A), consistent with SigH 
regulation. 
To quantitate expression from the promoters during a sporulation by 
resuspension timecourse, we collected timepoints from strains harboring either the PyodL-
lacZ or PyisK-lacZ reporter constructs and performed beta-galactosidase assays. 
Expression from PyodL-lacZ rose rapidly between the 40 min and 100 min timepoints, and 
steadily declined thereafter (Fig A1.6B). The decline in signal was not observed for the 
GFP reporter, likely because the GFP is stable once synthesized (315). In contrast, 
expression from PyisK-lacZ was highest at the time of resuspension (T0) and declined up 
until the final timepoint (Fig A1.6C).  
Collectively, the patterns expression we observe for yodL are consistent with 
those observed for genes activated by high-threshold levels of Spo0A during sporulation, 
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including racA, spoIIG, and spoIIA (316). In contrast, yisK’s expression pattern is 
similar to that observed for kinA (14, 34, 310), with expression increasing in late 
exponential and stationary phase and early sporulation in a SigH-dependent manner (Fig 
A1.5), but decreasing during a sporulation by resuspension timecourse (Fig A1.6). We 
do not exclude the possibility that YodL and YisK might also function in other growth 
contexts. 
 
A ΔyodL ΔyisK mutant is defective in sporulation 
 
Since yodL and yisK expression correlates with other early sporulation genes, we 
next investigated if the gene products influenced the production of heat-resistant spores. 
To determine the number of heat-resistant spores in a sporulation culture, we quantified 
the number of colony forming units (CFU) present in cultures before (total CFU) and 
after (heat-resistant CFU) a heat treatment that kills vegetative cells. These values were 
normalized to display the sporulation efficiency of the mutants relative to wildtype. 
Single mutants in which either yodL or yisK were deleted displayed only mild (97% and 
94%, respectively) reductions in relative sporulation efficiency (Table A1.4). Although 
the single mutants always sporulated less efficiently than wildtype in each experimental 
replicate, the differences were not statistically significant with only six experimental 
replicates. In contrast, the ΔyodL ΔyisK double mutant produced ~20% less heat-
resistant spores than wildtype (P<0.0006)(Table A1.4). No decrease in total CFU was 
observed for any of the mutants compared to wildtype, indicating that the reduction in 
heat-resistant spores in the ΔyodL ΔyisK mutant was not due to reduced cell viability 
before heat treatment (Table A1.4). The gene downstream of yisK, yisL, is transcribed in 
the same direction as yisK. To determine if the reduction in sporulation we observed 
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might be partially attributable to polar effects of the yisK deletion on yisL expression, we 
introduced PyisK-yisK at an ectopic locus (amyE) in the ΔyodL ΔyisK mutant and repeated 
the heat-kill assay. The ectopic copy of PyisK-yisK restored sporulation in the ΔyodL 
ΔyisK to levels statistically indistinguishable from the ΔyodL single mutant (Table 
A1.4). These results lend support to the idea that YodL and YisK function during early 
sporulation and possess activities that, directly or indirectly, affect the production of 
viable spores. We do not exclude the possibility that YodL and YisK might also function 
outside the context of sporulation. 
Given that yisK and yodL expression during vegetative growth leads to cell 
widening, we hypothesized that yisK and yodL mutants might produce thinner cells or 
spores during sporulation. However, no qualitative differences in cell or spore width 
were observed for the ΔyodL, ΔyisK, or ΔyodL ΔyisK mutant populations compared to 
wildtype during a sporulation timecourse (Fig A1.8). We also observed no qualitative 
differences in the shapes of germinating cells (data not shown). Thus, although YodL 
and YisK contribute to the production of heat-resistant spores, they do not appear to be 
required to generate any of the major morphological changes required for spore 
production.  
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Table A1.4.  Sporulation efficiency of yodL and yisK mutants. Sporulation efficiency is 
the number of spores/ml divided by the total cfu/ml × 100%.  Relative sporulation 
efficiency is sporulation efficiency normalized to wildtype × 100%. The data shown is 
the average of three independent biological replicates. The difference in sporulation 
efficiency between wildtype and the ΔyodL ΔyisK double mutant is statistically significant 
(P<0.0006). 
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Fig. A1.8.  Strains lacking yodL and/or yisK appear morphologically similar to 
wildtype during a sporulation timecourse. B. subtilis 168 (wt), BYD276 (ΔyodL), 
BYD278 (ΔyisK) and BYD279 (ΔyodL ΔyisK) were grown induced to sporulate via 
resuspension, and cells were grown for the indicated amount of time at 37°C before 
image capture. Membranes are stained with TMA-DPH (white). All images are shown at 
the same magnification. 
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MreB and Mbl are genetic targets of YodL and YisK activity 
 
To identify genetic targets associated with YodL and YisK activity, we took 
advantage of the fact that misexpression of the proteins during vegetative growth 
prevents colony formation on plates and performed suppressor selection analysis. Strains 
harboring three copies of each misexpression cassette were utilized to reduce the 
chances of obtaining trivial suppressors in the misexpression cassette itself. In addition, 
Phy-lacZ was used as a reporter to eliminate suppressors unable to release LacI 
repression following addition of inducer. In total, we obtained 14 suppressors resistant to 
YodL expression and 13 suppressors resistant to YisK expression. Six of the suppressors 
resistant to YodL were subjected to whole-genome sequencing. The results of the 
sequencing are shown in Table A1.5. All of the suppressors possessed mutations in 
either mreB or mbl, genes previously shown to be important in regulating cell width 
(Table A1.5). Using targeted sequencing, we determined that the remaining suppressor 
strains resistant to YodL also harbored mutations in mreB or mbl. Since the phenotypes 
of YodL and YisK expression were similar, we also performed targeted sequencing of 
the mreB and mbl chromosomal regions in the YisK-resistant suppressors. All but one of 
the YisK-resistant suppressors possessed mutations in mbl; the remaining suppressor 
harbored a mutation in mreB.   
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Table A1.5.  Whole-genome sequencing analysis of genomic DNA from six YodL-
resistant suppressors. BYD048 (three copies of Phy-yodL) was used for suppressor 
selection. Candidates were analyzed by whole-genome sequencing as described in the 
materials and methods. 
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To determine if the point mutations we identified were sufficient to confer 
resistance to YodL or YisK misexpression, we generated the mutant alleles in clean 
genetic backgrounds and assayed for resistance to three copies (3X) of each 
misexpression construct (Table A1.6). In all cases but one, the engineered strains were 
resistant to the same selective pressure applied in the original selections (either 3X yodL 
or 3X yisK)(Table A1.6), indicating that the mreB or mbl mutations identified through 
sequencing were sufficient to confer resistance. When we attempted to engineer a strain 
harboring only MreBS154R, all but one of the strains also possessed a second substitution, 
MreBR230C. Although the remaining strain possessed only the MreBS154R substitution in 
MreB, unlike the original suppressor identified by whole genome sequencing (Table 
A1.5), the MreBS154R harboring strain was also sensitive to YodL expression. Based on 
these data, we suspect that the strain harboring MreBS154R might be unstable, and 
possibly predisposed to the accumulation of second-site mutations. 
The YodL-resistant strains generally possessed mutations resulting in amino acid 
substitutions with charge changes (Table A1.6). When mapped to the T. maritima MreB 
structure, 5/7 of the unique suppressor strains possessed amino acid substitutions in a 
region important for mediating the interaction between MreB and the bitopic membrane 
protein RodZ (MreBG143A, MreBN145D, MreBP147R, MreBS154R, and MreBR282S)(Table 
A1.6 and Fig A1.9)(279, 320); three of these substitutions occur in residues that make up 
the RodZ-MreB binding surface (MreBN140, MreBP142, and MreBR279 in T. 
maritima)(279).   
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Table A1.6.  Analysis of suppressor strains resistant to YodL and/or YisK. The 
suppressor selections are described in detail in materials and methods. Candidate 
mutations were introduced into clean genetic backgrounds harboring three copies of Phy-
yodL or three copies of Phy-yisK, and the resultant strains were assessed for resistance 
(R) or sensitivity (S) to either yodL or yisK expression as judged by ability to grow on 
LB plates supplemented with 1 mM IPTG and 100 μg/ml spectinomycin. 1Originally 
identified using whole-genome sequencing (Table S1). 2Residues previously implicated 
in the RodZ-MreB interaction (279). 3Residues previously implicated in resistance to 
A22 (317-319). The (*) indicates that two suppressors possessing the same nucleotide 
change were obtained in original selection. The underlined residues displayed specificity 
in resistance to YodL over YisK (top) or YisK over YodL (bottom). 
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Fig. A1.9.  Location of MreB residues conferring resistance to YodL. The co-crystal 
structure of RodZ-MreB (2WUS)(279) was extracted from the Protein Data Bank. MreB 
is labeled in brown and RodZ is labeled in grey. The identity and locations of the amino 
acid substitutions obtained from the YodL spontaneous suppressor selections are 
indicated on the structure, marked by a black asterisk above the relevant amino acid on 
the sequence alignment. Substitutions that confer resistance to YodL over YisK are 
shown in bold. Residues previously implicated in the MreB-RodZ interaction interface 
(279) are indicated by red asterisks. The filled circles indicate the location of the 
substitutions in Mbl conferring resistance to YodL misexpression. MreBR117G 
(underlined) was identified in a suppressor selections conferring resistance to YodL as 
well as in suppressor selections conferring resistance to YisK. 
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A majority of the YisK-resistant Mbl variants clustered in regions of Mbl that are 
predicted to make up the ATP-binding pocket (Table A1.6 and Fig A1.10). Moreover, 
seven of the substitutions occurred in amino acids previously associated with resistance 
to the MreB inhibitor A22 in C. crescentus and Vibrio cholerae (Fig A1.10)(274, 317, 
319).  
MreBR117G and MblE250K were independently isolated in both the YodL and YisK 
suppressor selections, raising the possibility that at least some of the other MreB and 
Mbl variants might exhibit cross-resistance to YodL and YisK misexpression. To test for 
cross-resistance, we generated the mutant alleles in clean genetic backgrounds, and then 
introduced 3X copies of Phy-yisK into the YodL-resistant suppressors, and 3X copies Phy-
yodL into the YisK-resistant suppressors. We then assayed for the ability of the 
misexpression strains to grow on media in the presence of inducer. The results, 
summarized in Table A1.6, show that several of the variants exhibited resistance to both 
YodL and YisK. Three MreB variants, MreBN145D, MreBP147R and MreBR282S, exhibited 
specificity in their resistance to YodL compared to YisK. Three Mbl variants, MblR63C, 
MblΔS251, and MblP309L, showed specificity in their resistance to YisK over YodL. These 
results suggest that the alleles exhibiting cross-resistance to both YisK and YodL are 
likely to be general, possibly conferring gain-of-function to either MreB or Mbl activity. 
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Fig. A1.10.  Location of Mbl residues conferring resistance to YisK. The structure of B. 
subtilis Mbl, as predicted by I-TASSER (321), threaded to T. maritima MreB 
(1JCG)(279). The structure on the right is a surface prediction model. The identity and 
locations of the amino acid substitutions obtained from the YisK spontaneous suppressor 
selections are indicated on the structure, with substitutions conferring resistance to YisK 
over YodL in bold. The sequence alignment is of MreB from T. maritima, B. subtilis 
168, C. crescentus NA1000, E. coli MG1655, and V. cholera N16961. The location of 
amino acid substitutions conferring YisK resistance are indicated by black asterisks. 
Residues also previously shown to confer resistance to A22 in C. crescentus NA1000 
(274, 317) and V. cholera N16961 (319) are indicated by red and blue asterisks, 
respectively. The filled triangle corresponds to a residue shown by in vivo crosslinking 
to be important for the formation of antiparallel MreB protofilaments (322). The filled 
circle denotes the location of MreBR117G, which was identified in spontaneous suppressor 
selections conferring resistance to both YodL and YisK. MblT317I (underlined) was only 
identified in a spontaneous suppressor selection conferring resistance to YodL, although 
it exhibits cross-resistance to YisK (see Fig A1.5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 209 
 
 
 
 
 
 
 
 
Fig. A1.11.  YodL and YisK co-misexpression causes cell lysis. (A) BYD361 (Phy-
yodL, Phy-yisK) and BYD281 (2X Phy-yodL, 2X Phy-yisK) were streaked on an LB plate 
with 100 µg/ml spectinomycin and, when indicated 1 mM IPTG or 1 mM IPTG and the 
denoted concentration of MgCl2. (B) Cells were grown in LB-Lennox media at 37°C to 
mid-exponential and back-diluted to an OD600 of ~0.02. When indicated 1 mM IPTG or 
1 mM IPTG and the denoted concentration of MgCl2 were added. Cells were then 
grown for 1.5 hrs at 37°C before image capture. Membranes are stained with TMA-
DPH. All images are shown at the same magnification. 
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YodL and YisK’s cell-widening activities require MreB and Mbl, respectively 
 
The phenotypic consequences of YodL and YisK misexpression are similar but 
not identical (Fig A1.1B), suggesting that YodL and YisK might have distinct targets. 
Consistent with this idea, YodL and YisK coexpression resulted in phenotypes distinct 
from misexpression of either YodL or YisK alone. More specifically, cells co-expressing 
YodL and YisK did not grow on plates, regardless of media or MgCl2 concentration (Fig 
A1.3A and Fig A1.11A) and growth without lysis in liquid media required the presence 
of MgCl2 (Fig A1.2, Fig A1.3B, and Fig A1.11B). Importantly, the co-expressing cells 
displayed a round morphology that strongly contrasted with strains expressing either 
YodL or YisK alone (Fig A1.3B and Fig A1.11B). The round morphology was unlikely 
due to higher expression of gene products (1X Phy-yodL plus 1X Phy-yisK), since cells 
harboring two copies (2X) of either Phy-yodL or Phy-yisK did not become round (Fig 
A1.1B and Fig A1.3B).  
Based on the observation that YodL and YisK coexpression yields distinct 
phenotypes, and the fact that all of the YodL-specific suppressor mutations occurred in 
mreB (MreBN145D, MreBP147R and MreBR282S), while all of the YisK-specific suppressor 
mutations occurred in mbl (MblR63C, MblΔS251, and MblP309L), we hypothesized that 
YodL targets MreB, whereas YisK targets Mbl. To test these hypotheses, we assessed if 
MreB and Mbl are specifically required for YodL and YisK function by taking 
advantage of the fact that mreB and mbl can be deleted in a ΔponA background with only 
minor changes in cell shape (282, 293). The ΔponA strain, which does not make PBP1, 
produces slightly longer and thinner cells than the parent strain, and requires MgCl2 
supplementation for normal growth (323, 324). We generated ΔponA ΔmreB and ΔponA 
Δmbl strains and then introduced either two copies of Phy-yodL or two copies of Phy-yisK 
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into each background. We reasoned that 2X expression would provide a more stringent 
test for specificity than 1X expression, as off-target effects (if any), would be easier to 
detect. To assess the requirement of either mreB or mbl for YodL and YisK activity, 
cells were grown to exponential phase in LB media supplemented with 10 mM MgCl2, 
back-diluted to a low optical density, and induced for 90 min before images were 
captured for microscopy. Uninduced controls all appeared as regular rods, although 
ΔponA deletion strains were noticeably thinner than wildtype parents (Fig A1.12). The 
ΔponA cells became wider following YodL expression, indicating that PBP1 is not 
required for YodL activity. We also observed that the poles of the ΔponA mutant were 
less elongated and tapered than the wild-type control following YodL expression, 
suggesting that this particular effect of YodL expression is PBP1-dependent (Fig 
A1.12A). A ΔponA Δmbl mutant phenocopied the ΔponA parent following YodL 
expression (Fig A1.12A), indicating that Mbl is not required for YodL’s activity. In 
contrast, the ΔponA ΔmreB strain did not show morphological changes following YodL 
expression, and instead appeared similar to the uninduced control. We conclude that 
YodL requires MreB for its cell-widening activity.   
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Fig. A1.12.  YodL and YisK’s cell-widening activities require MreB and Mbl, 
respectively. (A) Cells harboring 2X copies of Phy-yodL in a wildtype (BAS191), ΔponA 
(BYD176), ΔponA ΔmreB (BYD263), ΔponA Δmbl (BYD259) or ΔponA Δmbl ΔmreBH 
(BAS249) background were grown at 37°C in LB supplemented with 10 mM MgCl2 to 
mid-exponential. To induce yodL expression, cells were back-diluted to an OD600 of 
~0.02 in LB with 10 mM MgCl2, and IPTG (1 mM) was added. Cells were grown for 1.5 
hrs at 37°C before image capture. Membranes are stained with TMA-DPH. All images 
are shown at the same magnification. (B) Cells harboring 2X copies of Phy-yisK in a 
wildtype (BYD074), ΔponA (BYD175), ΔponA ΔmreB (BYD262), ΔponA Δmbl 
(BYD258) or ΔponA Δmbl ΔmreBH (BAS248) background were grown at 37°C in LB 
supplemented with 10 mM MgCl2 to mid-exponential. To induce yisK expression, cells 
were back-diluted to an OD600 of ~0.02 in LB with 10 mM MgCl2, and IPTG (1 mM) 
was added. Cells were grown for 1.5 hrs at 37°C before image capture. Membranes are 
stained with TMA-DPH. All images are shown at the same magnification. 
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We performed a similar series of experiments for YisK misexpression. The 
ΔponA mutant was sensitive to YisK expression, indicating that PBP1 is not required for 
YisK-dependent cell-widening. Similarly, expression of YisK in a ΔponA ΔmreB mutant 
also resulted in loss of cell width control (Fig A1.12B), indicating that MreB is not 
required for YisK activity; however, unlike YisK expression in a wildtype or ΔponA 
background, the cells became round (Fig A1.12B), more similar to the YodL and YisK 
co-expressing cells (Fig A1.3B and Fig A1.11). In contrast, a ΔponA Δmbl mutant did 
not lose control over cell width following YisK expression (Fig A1.12B), indicating that 
YisK activity requires Mbl for its cell-widening activity. We conclude that YodL 
requires MreB, but not Mbl for its cell-widening activity, whereas YisK requires Mbl, 
but not MreB. 
 
YisK possesses at least one additional target 
 
Although YisK expression in a ΔponA Δmbl mutant did not result in cell-
widening, we observed that the induced cells appeared qualitatively shorter than the 
uninduced control, suggesting that YisK might possess a second activity (Fig A1.12B). 
Quantitation of cell lengths in a ΔponA Δmbl mutant following YisK expression 
revealed that the YisK-induced cells were ~20% shorter than the uninduced cells (Fig 
A1.13A). In contrast, YodL expression did not result in a change in cell length in a 
ΔponA ΔmreB mutant (Fig A1.13B), suggesting the the cell shortening effect is specific 
to YisK. We hypothesized that MreBH, the third and final B. subtilis MreB family 
member, might be YisK’s additional target. We hypothesized that if MreBH is the 
additional target, then the cell shortening observed upon YisK expression in a ΔponA 
Δmbl mutant strain should be lost in a ΔponA Δmbl ΔmreBH mutant background. 
 214 
 
However, we found that even when mreBH was additionally deleted, YisK expression 
still resulted in cell shortening (Fig A1.13C). We conclude that YisK likely has at least 
one additional target that is not MreB or Mbl dependent, and that this additional target 
regulates some aspect of cell length.  
 
Discussion 
 
YodL and YisK’s functional targets 
 
Misexpression of YodL during vegetative growth results in cell-widening and 
lysis, and spontaneous suppressor mutations conferring resistance to YodL occur 
primarily in mreB. MreB is also required for YodL’s cell-widening activity, whereas 
Mbl is not. By comparison, expression of YisK during vegetative growth also results in 
cell-widening and lysis, however, spontaneous suppressor mutations conferring 
resistance to YisK occur primarily in mbl. YisK’s cell-widening activity requires Mbl, 
but not MreB. The simplest interpretation of these results is that YodL targets MreB 
function, while YisK targets Mbl function. Alternatively, YodL and YisK could target 
other factors that affect cell shape and simply require MreB and Mbl for their respective 
functions. 
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Fig. A1.13.  YisK expression results in cell shortening. (A) Cells harboring 2X copies 
of Phy-yisK in a ΔponA Δmbl background (BYD262) were grown at 37°C in LB 
supplemented with 10 mM MgCl2 to mid-exponential. To induce yisK expression, cells 
were back-diluted to an OD600 of ~0.02 in LB with 10 mM MgCl2 and IPTG (1 mM) was 
added. Cells were grown for 1.5 hrs at 37°C before image capture. Membranes are 
stained with TMA-DPH. Cell lengths (n=500/condition) were measured before and after 
yisK expression and rank-ordered from smallest to largest along the x-axis so the entire 
population could be visualized without binning. The uninduced population (black) is 
juxtaposed behind the induced population (semi-transparent, gray). The difference in 
average cell length before and after Phy-yisK induction were statistically significant 
(P<0.0001). (B) Cells harboring 2X copies of Phy-yodL in a ΔponA ΔmreB background 
(BYD263) were grown, quantitated, and plotted as described above. The difference in 
average cell length before and after Phy-yodL induction were not statistically significant.  
(C) Cells harboring 2X copies of Phy-yisK in a ΔponA Δmbl ΔmreBH background 
(BAS248) were grown, quantitated, and plotted as described above. The difference in 
average cell length before and after Phy-yisK induction were statistically significant 
(P<0.0001). 
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MreB variants specifically resistant to YodL activity, MreBN145D, MreBP147R and 
MreBR282S, all result in charge change substitutions in residues previously shown to 
constitute the RodZ-MreB interaction surface (equivalent T. maritima residues are: 
MreBN140, MreBN142 and MreBR279)(279). MreBG143A, which exhibits cross-resistance to 
YisK, also maps near the RodZ-MreB interaction interface. The two remaining YodL-
resistant MreB variants occur in (MreBR117G) or near (MreBG323E) residues previously 
associated with bypass of RodZ essentiality in E. coli (Fig A1.9)(287). A simple model 
explaining both the nature of the MreB variants we obtained in the suppressor selections, 
and YodL’s MreB-dependent effect on cell shape, is that YodL acts by disrupting the 
interaction between RodZ and MreB. In this model, MreB’s RodZ-independent activities 
would remain functional, and several observations are consistent with this idea. If YodL 
were to completely inactivate MreB function, then we would expect that expressing 
YodL in a ΔponA Δmbl ΔmreBH background would generate round cells, similar to the 
phenotype observed when MreB is depleted in a Δmbl ΔmreBH mutant background 
(293), or when mreB, mbl, and mreBH are deleted in backgrounds with upregulated sigI 
expression (the triple mutant is otherwise lethal)(325). However, we observe that cells 
expressing YodL in a ΔponA Δmbl ΔmreBH mutant instead form wide rods (Fig 
A1.12A). If YodL does specifically target MreB activity, then these results suggest that 
MreB likely retains at least some of its width-maintenance function. Morgenstein et al. 
recently found that the interaction between RodZ and MreB in E. coli is required for 
MreB rotation, but that MreB rotation was not required for rod shape or cell viability 
under standard laboratory conditions (288). This study is consistent with prior findings 
indicating that RodZ is not absolutely required for maintenance of rod shape (287). 
We hypothesize that the substitutions obtained in residues near the RodZ-MreB 
interface either enhance RodZ-MreB interaction, or decrease the ability of YodL to 
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disrupt the RodZ-MreB interface. Although we did not identify YodL-resistant 
suppressor mutations in rodZ, it is possible that the requisite rodZ mutations are rare or 
lethal for the cell, thus we cannot rule out the possibility that YodL could target RodZ 
function. Similarly, although we found that MreB is required for YodL activity, we can 
envision a scenario in which a YodL-MreB interaction may be necessary to localize 
YodL to a cellular location where it can be effective against RodZ or some other cellular 
component. We think this possibility is less likely, as cells expressing YodL have a 
distinct phenotype from RodZ depletion in B. subtilis. More specifically, YodL 
expression results in cell widening and tapered poles (Fig A1.1B), whereas RodZ-
depleted cells generate wide rods (284), similar to the phenotype we observed following 
YodL expression in a ΔponA Δmbl ΔmreBH mutant (Fig A1.12A). These results argue 
against the idea that YodL could work by inactivating RodZ function completely. Future 
work aimed at characterizing the nature of the YodL resistant suppressors and the effect 
of YodL on MreB function will shed light on the mechanism underlying YodL’s 
observed activity. 
Only three Mbl variants, MblR63C, MblΔS251, and MblP309L, showed specificity in 
resistance to YisK over YodL. MblR63C, MblD153N, MblG156D, MblT158A, MblE204G, 
MreBP309L and MblA314T occur in residues that form Mbl’s predicted ATP-binding pocket 
(Fig A1.10), and substitutions in all seven of these residues have been previously 
implicated in A22 resistance (Fig A1.10)(274, 317, 319). We speculate that most, if not 
all of the substitutions in Mbl’s ATP-binding pocket are gain-of-function with respect to 
Mbl polymerization, a hypothesis that can ultimately be tested in vitro. Similarly, we 
hypothesize that the MblM51I substitution, located at the MreB head-tail polymerization 
interface (320), may overcome YisK activity by promoting Mbl polymerization. 
MreBE262 of C. crescentus, equivalent to B. subtilis MblE250 (Fig A1.10), is located at the 
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interaction interface of antiparallel MreB protofilament bundles (322). If B. subtilis 
MblE250 is also present at this interface (this has not been tested to our knowledge), then 
MblE250K could promote resistance to YodL and YisK by enhancing Mbl bundling. How 
might YisK exert its activity? One idea is that YisK disrupts Mbl bundling, possibly by 
competing for sites required for protofilament formation. An alternative possibility is 
that YisK somehow prevents Mbl from effectively binding or hydrolyzing ATP. It is 
also possible that Mbl is simply required for YisK to target one or more other factors 
involved in cell-width control.   
In addition to Mbl-dependent cell widening, YisK expression resulted in cell 
shortening, an effect that only became apparent in a ΔponA Δmbl mutant background 
(Fig A1.12B and Ap1.13A). Given the similarities of MreB, Mbl, and MreBH to each 
other, we initially hypothesized that YisK-dependent effects on MreB and/or MreBH 
might be responsible for the decrease in cell length we observed; however, we found that 
mreBH was not required for cell shortening (Fig A1.12B and Fig A1.13C). Since YisK 
expression results in a dramatic loss of cell shape in ΔmreB mutant backgrounds (Fig 
A1.12A), we were unable to confidently assess cell length changes to determine if there 
is a requirement for MreB in the cell-shortening phenotype. It is unlikely that YisK’s 
additional activity affects MreB’s role in maintaining cell width (at least not without 
Mbl), as YisK-expressing cells retain rod shape when mbl and mreBH are both deleted 
(Fig A1.12B). An exciting alternative possibility is that YisK activity affects another 
factor involved in cell length control. One attractive candidate is the cell wall hydrolase 
CwlO, a known modulator of cell length in B. subtilis (326) which recent genetic data 
also suggests depends at least in part on Mbl (297). Future experiments aimed at 
determining the identity and function of YisK’s additional target should shed light on 
how cells regulate both cell length and cell width. 
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We performed a similar series of experiments for YisK misexpression. The 
ΔponA mutant was sensitive to YisK expression, indicating that PBP1 is not required for 
YisK-dependent cell-widening. Similarly, expression of YisK in a ΔponA ΔmreB mutant 
also resulted in loss of cell width control (Fig A1.12B), indicating that MreB is not 
required for YisK activity; however, unlike YisK expression in a wildtype or ΔponA 
background, the cells became round (Fig A1.12B), more similar to the YodL and YisK 
co-expressing cells (Fig A1.3B and Fig A1.11). In contrast, a ΔponA Δmbl mutant did 
not lose control over cell width following YisK expression (Fig A1.12B), indicating that 
YisK activity requires Mbl for its cell-widening activity. We conclude that YodL 
requires MreB, but not Mbl for its cell-widening activity, whereas YisK requires Mbl, 
but not MreB. 
 
Identification of genes involved in cellular organization through a novel gene 
discovery pipeline 
 
To systematically identify and characterize novel genes involved in cellular 
organization, we developed a gene discovery pipeline that combines known regulatory 
information (14), phenotypes obtained from misexpression screening, and suppressor 
selection analysis. The ability to identify genetic targets associated with the unknown 
genes provides a key parameter beyond phenotype from which to formulate testable 
hypotheses regarding each gene’s possible function. The misexpression constructs we 
generated are inducible and present in single copy on the chromosome. We have found 
that to obtain phenotypes, our strategy works best when the unknown genes are 
expressed outside of their native regulatory context. Thus far, we have restricted our 
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gene function discovery pipeline to B. subtilis; however, the general approach should be 
broadly applicable to other organisms and diverse screening strategies. 
In this work, we describe the use of the pipeline to identify and characterize two 
B. subtilis genes, yodL and yisK, that produce proteins capable of targeting activities 
intrinsic to cell width control. Although yodL and yisK were not previously recognized 
as members of the Spo0A regulon, both genes have putative Spo0A boxes and possess 
promoters that exhibit expression patterns consistent with other Spo0A-regulated genes 
(Fig A1.4-1.6). YisK is also a member of the SigH regulon (32), and our expression 
analysis is also consistent with expression of yisK during stationary phase (Fig A1.5). If 
the putative Spo0A box we identified is utilized in vivo, then we would predict based on 
our expression profiling that yisK is transcribed during exponential and early stationary 
phase via SigH, and then repressed as Spo0A-P accumulates during early sporulation. 
Such a pattern is similar to the regulation that has been proposed for kinA (45, 316). We 
also observe expression from PyodL and PyisK is reduced in the absence of Spo0A and 
SigH (Fig A1.5D-E). The specific contributions of these global regulators to yodL and 
yisK regulation cannot be determined by analyzing the expression profiles of the sigH 
and spo0A deletion strains alone, since spo0A depends on SigH for upregulation during 
the early stages of sporulation (37, 45). Moreover, since Spo0A inhibits expression of 
the sigH repressor AbrB (327-330), a spo0A mutant is also down for sigH expression.  
A ΔyodL ΔyisK double mutant reproducibly produces ~20% less heat-stable 
spores than wildtype, suggesting that the YodL and YisK have functions that affect 
spore development (either directly or indirectly). Most studies on sporulation genes are 
biased toward factors that reduce sporulation efficiency by an order of magnitude or 
more in a standard heat-kill assay. However, even small differences in fitness (if 
reproducible) can contribute significantly to the ability of an organism to persist, 
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especially in competitive environments (331). The 20% reduction in heat-resistant spores 
we observe in cells lacking YisK and YodL would likely result in a substantial fitness 
disadvantage to cells in the environment. We do not currently understand how YodL and 
YisK might function in spore development, but the identification of MreB and Mbl as 
genetic targets suggests the proteins likely regulate some aspect of PG synthesis. Future 
studies will be aimed at understanding the molecular and biochemical basis of YodL and 
YisK activity.   
In this study, the morphological phenotypes associated with YodL and YisK 
occurred when the genes were expressed during vegetative growth. Consequently, it is 
formally possible (although we think unlikely), that the targeting of MreB and Mbl is 
simply a coincidence that is unrelated to the potential functions of the proteins during 
stationary phase or sporulation. Regardless of what YodL and YisK’s physiological roles 
turn out to be, we have already been able to utilize misexpression of the proteins to 
obtain interesting variants of both MreB and Mbl that can now be used to generate 
testable predictions regarding how MreB and Mbl function in B. subtilis. Moreover, the 
apparent specificity with which YodL and YisK appear to target MreB and Mbl, 
respectively, make them potentially powerful tools to differentially target the activities 
of these two highly similar paralogs in vivo. Of course, more studies will be required to 
determine if YodL and YisK interact directly or indirectly to modulate MreB and Mbl 
activity. In the meantime, it is exciting to speculate that many undiscovered modulators 
of MreB and MreB-like proteins exist, and that we have only just begun to scratch the 
surface regarding regulation of this important class of proteins. The identification and 
characterization of such modulators could go a long way toward addressing the 
significant gaps in our knowledge that exist regarding the regulation of PG synthesis in 
bacteria. 
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APPENDIX II 
CHARACTERIZATION OF THE EFFECTS OF B. subtilis YodL AND YisK ON 
E. coli 
 
Introduction 
 
Bacterial actin-like proteins play important roles in bacterial peptidoglycan (PG) 
synthesis (290, 332). One such protein, MreB, is conserved and essential across the 
majority of non-coccoid bacteria (269, 270). Gram negative bacteria like Escherichia 
coli often encodes only one MreB-like protein, while Gram positives often encode more 
than one paralog. B. subtilis possesses three MreB-like proteins: MreB, Mbl, and MreBH 
(289, 293). MreB interacts with other components of the elongation system including 
MreC/MreD (encoded by the genes downstream of mreB in the same operon)(333), 
penicillin binding proteins (PBPs) such as PBP1, PBP2a and PBP2b (282), the 
membrane associated cytosolic enzyme MurG (334), and the bitopic membrane protein 
RodZ (288). Depletion or inactivation of MreB leads to rounding up of rod-shaped cells 
(335), consistent with its proposed role in directing assembly of peptidoglycan-
synthesizing cell elongation complexes (270, 336). However, in several organisms 
including E. coli, MreB has also been shown to be involved in cell division, interacting 
directly with the tubulin-like protein FtsZ (269, 270). Although MreB-like proteins are 
recognized as central players in both cell growth and cell shape maintenance, relatively 
little is known about how cells regulate MreB activity. 
In a prior study we identified two previously uncharacterized gene products 
YodL and YisK, that appear to target MreB and Mbl activity in Bacillus subtilis 
(Appenidix I)(256). Misexpression of YodL or YisK prevents colony formation on 
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plates and leads to a cell-widening phenotype (Fig A1.1) that is suppressed by specific 
point mutations in mreB and mbl respectively (Table A1.6). Moreover, we showed using 
conditionally permissive deletion strains that to elicit cell-widening effects, YodL 
specifically requires MreB while YisK requires Mbl (Fig A1.2). The purpose of this 
study was to investigate the effects of YodL and YisK overexpression in an unrelated 
Gram negative organism, E. coli. Expression of YisK in E. coli did not affect overall cell 
shape. Since current data suggest YisK affects some aspect of Mbl function (Appendix 
I)(256) and E. coli does not encode mbl, this result was expected. In contrast, expression 
of YodL in E. coli did not result in cell widening as it does in B. subtilis. Instead, cells 
filamented, consistent with an inhibition of cell division. To identify possible functional 
targets associated with YodL activity in E. coli, suppressor selections were performed, 
and several mutants resistant to YodL expression were obtained. One of these mutants 
possessed a T376A substitution in E. coli FtsZ, suggesting that in E. coli YodL perturbs 
some aspect of FtsZ function. 
 
Materials and Methods 
 
General methods.   
 
E. coli strains utilized in the study are listed in Table A2.1. Plasmids are listed in 
Table A2.2. Oligonucleotide primers are listed in Table A2.3. Escherichia coli DH5α 
was used for cloning. The expression studies and suppressor selection analysis were 
performed with E. coli MG1655 (DE3). All E. coli strains were grown in LB-Lennox 
medium supplemented with 100 µg/ml ampicillin and/or 25 µg/ml kanamycin. 
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Table A2.1.  Strains used in Appendix II. 
 
Strain Description Reference 
Parental   
E. coli DH5α F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 
deoR nupG Φ80dlacZΔM15 Δ(lacZYA-
argF)U169, hsdR17(rK
- mK
+), λ–  
 
E. coli 
MG1655 
K-12 F– λ– ilvG– rfb-50 rph-1  
E. coli 
MG1655 
(DE3) 
K-12 F– λ– ilvG– rfb-50 rph-1 endA recA  
λ(DE3 [lacI lacUV5-T7p07 ind1 sam7 nin5]) 
Addgene (337) 
E. coli 
MG1655 
  
CYD642 yisK-pBAD24 (amp) This study 
CYD643 yodL-pBAD24 (amp) This study 
E. coli 
MG1655 
(DE3)  
  
CYD694 yodL-pBAD24 (amp), yodL-pET24b+ (kan) This study 
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Table A2.2.  Plasmids used in Appendix II. 
 
Plasmid Description Reference 
pYD093 yodL-pBAD24 (amp) This study 
pYD095 yodL-pET24b+ (kan) This study 
pYD187 yisK-pBAD24 (amp) This study 
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Table A2.3.  Oligonucleotides used in Appendix II. 
 
Oligo Sequence 5’ to 3’ 
OAS029 GTCAATGTCGACTGTCGTTTGTACA 
OYD209 GCATGAATTCTTATGTCGTTTGTACAATCAGACG 
OYD332 GATCGAATTCACCATGAAATTTGCGACAGGGGAAC 
OYD333 GATCCTGCAGTCAGCCAATTTGGTTTGACAGC 
OYD334 GATCGAATTCACCATGATGTTATCCGTGTTTAAAAAG 
OYD335 GATCCTGCAGTTATGTCGTTTGTACAATCAGAC 
OYD355 CTTACGCGGTTGCAAACAGG 
OYD356 GGCGGTATCCATATAAGTACG 
OYD357 ATTCGACGGCGGTGGGATTG 
OYD358 AGGGCGTAACGTCAGGGTGA 
OYD371 GAATGCTGCTGATGCATTAAG 
OYD372 ATTTCACGGACTTCATCGCC 
OYD385 AAAGATTTGGGTATCCTGACC 
OYD386 CCGTGATGTTAACCAGCACG 
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Plate growth assay   
 
E. coli strains harboring relevant plasmids were streaked on LB-Lennox agar 
plates supplemented with 100 µg/ml ampicillin and/or 25 µg/ml kanamycin. When 
indicated, inducer was added at the following concentrations: 1mM IPTG and/or 0.2% 
arabinose (w/v). Plates were incubated at 37°C overnight and images were captured on a 
ScanJet G4050 flatbed scanner (Hewlett Packard). 
 
Microscopy   
 
1 ng of pYD093 (yodL-pBAD24) or pYD187 (yisK-pBAD24) was transformed 
into E. coli MG1655 cells and plated on LB-Lennox agar (1.5% w/v) plates containing 
100 µg/ml ampicillin. For microscopy experiments, all strains were inoculated in 25 ml 
LB-Lennox medium with 100 µg/ml ampicillin in 250 ml baffled flasks and placed in a 
shaking waterbath set at.37°C and 280 rpm. At low OD600 (~0.08), 0.2% arabinose was 
added to the induced cultures. Images were captured 90 min post-induction. 1 ml culture 
was pelleted by centrifugation at 6,010 x g for 1 minute at room temperature, then pellets 
were resuspended in ~5 µl TMA-DPH (0.02 mM) before mounting on glass slides with 
polylysine-treated coverslips. Images were taken with 1 sec exposure time using a Nikon 
Ti-E microscope equipped with a CFI Plan Apo lambda DM 100X objective, Prior 
Scientific Lumen 200 Illumination system, C-FL UV-2E/C DAPI and C-FL GFP HC 
HISN Zero Shift filter cubes, and a CoolSNAP HQ2 monochrome camera.  
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Suppressor selections   
 
To reduce the chances of obtaining suppressors arising as the result of changes in 
yodL expression, two different compatible plasmids with different induction systems 
were utilized. Single colonies of E. coli harboring the IPTG-inducible plasmid PT7-yodL 
and the arabinose inducible plasmid PBAD-yodL (CYD694) were used to inoculate six 
independent 5 ml LB-Lennox cultures with 100 µg/ml ampicillin and 25 µg/ml 
kanamycin. Cultures were grown for eight hrs at 37°C and 0.3 µl of each culture was 
diluted in 100 µl LB. The entire dilution was plated on an LB-Lennox agar plate 
supplemented with 100 µg/ml ampicillin, 25 µg/ml kanamycin and 1 mM IPTG. After 
overnight growth, suppressors that arose were patched on all four plates mentioned 
below at once: (1) LB-Lennox agar plates supplemented with 100 µg/ml ampicillin and 
25 µg/ml kanamycin; (2) LB-Lennox agar plates supplemented with 100 µg/ml 
ampicillin, 25 µg/ml kanamycin and 1 mM IPTG; (3) LB-Lennox agar plates 
supplemented with 100 µg/ml ampicillin, 25 µg/ml kanamycin and 0.2% arabinose; (4) 
LB-Lennox agar plates supplemented with 100 µg/ml ampicillin, 25 µg/ml kanamycin, 1 
mM IPTG and 0.2% arabinose. The ones did not grow by patching on IPTG plates were 
excluded as false positives from the initial selection. Mutants unable to grow in the 
presence of the arabinose were eliminated to reduce the chances of obtaining mutations 
specifically associated with the PT7-yodL plasmid (eg. yodL truncations). By patching 
variants on plates with both inducers, candidates would fall into different classes because 
increasing amount of YodL could make some of them sicker than others, although in this 
round, all the candidates grew well on double-inducer plates. Genomic DNA was then 
extracted from each candidate (see Appendix I) and used as template to PCR amplify E. 
coli mreB (primer pair OYD355 and OYD356) and ftsZ (primer pair OYD357 and 
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OYD358). The PCR products were then used to as template to Sanger sequence the 
mreB and ftsZ regions from each of the suppressor. mreB was sequenced using OYD371 
and OYD372, while ftsZ was sequenced using OYD385 and OYD386.   
 
Results 
 
Overexpression YodL, but not YisK, in E. coli prevents colony formation on plates 
 
In B. subtilis, misexpression of YodL or YisK prevented colony formation on 
plates and produced irregularly shaped cells in liquid culture through targeting (directly 
or indirectly) of MreB and Mbl, respectively (Appendix I, Table A1.6, Fig A1.1, Fig 
A1.12)(256). Since MreB is a highly conserved protein, we hypothesized that YodL’s 
mechanism of action might be conserved in a heterologous system, specifically in E. 
coli. To test this idea, we expressed yodL on a plasmid from an inducible promoter in E. 
coli MG1655. Cells growing in the presence of inducer were unable to form colonies on 
plates (Fig A2.1), similar to observations with B. subtilis. We hypothesized that since E. 
coli does not encode mbl, YisK would not affect E. coli growth. Consistent with our 
hypothesis, YisK expression had no observable effect on E. coli cell growth (Fig A2.1). 
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Fig. A2.1.  Overexpression YodL, but not YisK, in E. coli prevents colony formation 
on plates. PBAD-yodL (CYD643) and PBAD-yisK (CYD642) were streaked on LB-Lennox 
plates supplemented with 100 µg/ml ampicillin and incubated at 37°C overnight. When 
indicated, 0.2% arabinose was added onto the plate to induce protein expression. 
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Fig. A2.2.  YodL inhibits E. coli cell division. PBAD-yodL (CYD643) and PBAD-yisK 
(CYD642) were grown in LB-Lennox media at 37°C to mid-exponential and back-
diluted to an OD600 of ~0.08. When indicated, 0.2% arabinose was added to induce 
protein expression. Cells were grown for 1.5 hrs at 37°C before image capture. 
Membranes were stained with TMA-DPH. All images were scaled identically. 
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YodL inhibits E. coli cell division 
 
To further characterize the effect of YodL on E. coli growth, epi-fluorescence 
microscopy was performed on E. coli cultures before and after YodL induction. 
Unexpectedly expression of YodL in E. coli resulted in cell filamentation (Fig A2.2) 
rather than the cell-widening that was observed in B. subtilis (Fig A1.1B). In contrast, 
YisK expression had no obvious effect on E. coli morphology (Fig A2.2), consistent 
with the lack of phenotype observed on plates (Fig A2.1). 
 
FtsZ is the genetic target of YodL in E. coli 
 
Overexpression of YodL in E. coli results in filamentous cells. To better 
understand the mechanism behind this phenotype, we took advantage of the fact that 
overexpression YodL prevents colony formation on plates (Fig A2.1) and performed 
suppressor selection analysis. Two YodL overexpression plasmids with different 
promoters (one IPTG-inducible and one arabinose-inducible) and different antibiotic 
resistance cassettes were transformed into E. coli. Cells were plated in the presence of 
single inducer (IPTG) and both antibiotics, and patched onto LB plates supplemented 
with antibiotics and each of the following: no inducer, IPTG (the original selective 
pressure), arabinose (the alternate inducer), and IPTG plus arabinose. This step allowed 
us to eliminate suppressors that grew due to an inability to express functional YodL in 
the presence of IPTG because they were unable to take up inducer or derepress the 
promoter, as well as those producing non-functional forms of YodL. After patching, 12 
suppressor strains were identified that were resistant following selection in the presence 
of arabinose or arabinose and IPTG. In B. subtilis, mutations in mreB confer resistance 
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to YodL (Appendix I, Table A1.6, Fig A1.12)(256), so we sequenced the mreB locus in 
each YodL-resistant suppressor strain. In addition, since the cells filamented and a prior 
relationship between MreB and FtsZ activity has been observed (269, 270), we also 
sequenced ftsZ. Eleven of the twelve YodL-resistant strains encoded wild-type versions 
of both mreB and ftsZ, indicating that the resistance was associated with a mutation 
elsewhere in the genome. One YodL-resistant suppressor encoded a substitution in the 
FtsZ, T376A. E. coli FtsZ has 383 residues, and T376 is located in the flexible C-
terminal tail (338), a region of FtsZ previously shown to be important for septum 
localization (339), regulation of Z-ring assembly (340, 341), and interaction of FtsZ with 
other cell division proteins such including FtsA (342), ZipA (343) and MinC (344). 
 
Discussion 
 
Overexpression of YodL in E. coli prevents colony formation on plates (Fig 
A2.1), suggesting that YodL is somehow toxic to E. coli cells. Consistent with this 
observation, prior attempts to overexpress and purify YodL from E. coli have been 
problematic due to very low expression levels (data not shown). The toxicity is unlikely 
to be attributable to the protein overexpression itself since the protein could be 
overexpressed successfully in a strain background harboring FtsZT376A.   
Using epi-fluorescence microscopy, it was observed that YodL expression results 
in filamentation (Fig A2.2), suggesting that in E. coli, YodL perturbs some aspect of cell 
division. Consistent with this hypothesis, the FtsZT376A variant is resistant to YodL. FtsZ 
polymerizes at the incipient cell division site (345), and recruits additional factors required 
for cell division (346). Our results suggest that in E. coli, YodL activity is disrupting FtsZ 
activity. In contrast, in B. subtilis, YodL expression results in cell-widening through 
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disruption of MreB activity, but does not affect cell division (Appendix I, Fig A1.1, Fig 
A1.12)(256).  
We propose that the distinctive phenotypes observed in E. coli and B. subtilis can 
be attributed to differences in the way MreB functions in these two organisms. In E. coli, 
MreB-FtsZ interaction is important for cell division (269, 270) and expression of a non-
interacting variant, MreBD285A inhibits cell division by locking FtsZ rings into a non-
constrictive state (269). This phenotype can be overcome by specific substitutions in FtsZ 
(269). Intriguingly, most of the YodL resistant suppressors identified in B. subtilis map to 
a region of MreB that interacts directly with RodZ (279). RodZ is broadly conserved in 
bacteria with MreB, and has been shown to regulate MreB’s dynamic behavior (288). 
Based on these observations, it was hypothesized that in B. subtilis, YodL leads to cell 
widening by changing the interaction between RodZ and MreB (256). Interestingly, the 
region of MreB possessing substitutions resistant to YodL function is the same region of 
MreB shown to interact directly with FtsZ in E. coli (Appendix I, Table A1.6, Fig 
A1.9)(256, 269). Based on these data, we propose that in E. coli, YodL binds MreB and 
prevents MreB interaction with FtsZ. This possibility could be investigated by 
determining if YodL expression in E. coli leads to disruption or “locking” of FtsZ rings as 
was observed following expression of MreBD285A (269). Another prediction of this model 
is that ftsZ alleles that allow bypass of MreBD285A (269) would also make cells more 
resistant to YodL. 
So far we have isolated one E. coli suppressor resistant to the effects of YodL, 
FtsZT376A, located in a region important for ClpXP-dependent degradation of FtsZ protein 
(347, 348). Thus it is possible that FtsZT376A overcomes the killing effects of YodL activity 
by increasing overall FtsZ levels. Determining the nature of the mutations in the other 11 
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E. coli YodL-resistant suppressors should provide additional clues regarding how YodL 
functions.  
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APPENDIX III 
INVESTIGATION OF THE ROLES OF YodL AND YisK DURING Bacillus 
subtilis SPORULATION 
 
Introduction 
 
The actin-like protein MreB is critical to bacterial peptidoglycan (PG) synthesis 
during cell elongation (269, 270). Bacillus subtilis possesses three genes encoding 
MreB-like proteins: mreB, mbl, and mreBH (290, 293). All three genes are essential 
during vegetative growth, although they exhibit different patterns of transcription (291, 
293). Peak expression of mreB and mbl occurs during transition state that occurs at the 
end of exponential phase (295). In contrast, mreBH is maximally induced during cell 
stress by the alternative sigma factor SigI (296). To our knowledge, the roles of MreB, 
Mbl, and MreBH during B. subtilis sporulation have not been investigated.  
We recently identified two proteins, YodL and YisK, that affect aspects of MreB 
and Mbl activity, respectively (Appendix I)(256). Both genes are induced in Spo0A-
dependent manner during the early phases of sporulation. yodL exhibits peak expression 
at ~2 hrs after entry into sporulation, whereas peak yisK expression is earlier (Appendix 
I, Fig A1.6)(256), consistent with its prior characterization as a member of the SigH 
stationary phase regulon (32). yisK and yodL knockout strains exhibit minor reductions 
in laboratory sporulation efficiency; a double knockout strain possesses an ~20% 
reduction in production of heat-resistant spores (Appendix I, Table A1.4)(256). Based on 
these data, it was hypothesized that YodL and YisK likely function to modify some 
aspect of MreB and Mbl function during sporulation.  
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In this study, we found that overexpression of YodL, which we previously 
hypothesized perturbs the interaction between MreB and RodZ (See Appendix II)(256), 
has no obvious effect on cell shape during sporulation. In contrast, overexpression of 
YisK during sporulation results in production of round cells. During vegetative growth, 
YisK requires Mbl to produce its cell-widening effects (Appendix I, Fig A1.12)(256), 
therefore we hypothesized that YisK affects Mbl function during sporulation as well. 
Surprisingly, strains lacking Mbl appeared relatively normal during sporulation, while 
strains lacking MreB were round, more similar to the YisK misexpression phenotype. 
Although YisK requires a functioning Mbl to elicit cell-widening during vegetative 
growth, in the context of sporulation, Mbl does not appear to play an essential role in 
cell-shape control. These data provide the first evidence that YisK’s activity may also 
affect some aspect of MreB function (directly or indirectly). The specific activities of 
YodL and YisK during sporulation remain unknown. To better understand how YodL 
and YisK function, a screen was developed to identify additional factors that act 
redundantly with YodL and YisK to support sporulation. 
 
Materials and Methods 
 
General methods.  
 
All B. subtilis strains were derived from B. subtilis 168. B. subtilis strains utilized 
in this study are listed in Table A3.1. Plasmids are listed in Table A3.2. Oligonucleotide 
primers are listed in Table A3.3. The following concentrations of antibiotics were used 
for generating B. subtilis strains: 100 µg/ml spectinomycin, 7.5 µg/ml chloramphenicol, 
0.8 mg/ml phleomycin, 10 µg/ml tetracycline, 10 µg/ml kanamycin. To select for 
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erythromycin resistance, plates were supplemented with 1 µg/ml erythromycin (erm) and 
25 µg/ml lincomycin. B. subtilis transformations were carried out as described 
previously (302).  
 
Microscopy  
 
All samples were grown in CH media overnight at room temperature to mid-
exponential, back-diluted to OD600 = 0.05 in 25 ml CH (237) in 250 ml baffled flasks, 
and grown at 37°C in a shaking waterbath set at 280 rpm for 1.5 hrs. Sporulation was 
induced by resuspension at 37°C according to the Sterlini-Mandelstam method (237). 
When indicated, 1 mM IPTG was added together with resuspension. 10mM MgCl2 was 
added into all the media when indicated. All the samples were imaged 24 hrs post-
induction and exposed. 1 ml culture was centrifuged at 6,010 x g for 1 minute at room 
temperature. The pellets were then resuspended with 5 µl TMA-DPH (0.02 mM). Cells 
were mounted on glass slides with polylysine-treated coverslips prior to imaging. The 
phase images were exposed for 0.2 sec, whereas for the membrane stain, the exposure 
time is 1 sec. 
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Table A3.1.  Strains used in Appendix III. 
 
Strain Description Reference 
Parental   
B. subtilis 
168 
Bacillus subtilis laboratory strain 168 trpC2  BGSC (1A866) 
E. coli DH5α F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 
deoR nupG Φ80dlacZΔM15 Δ(lacZYA-
argF)U169, hsdR17(rK
- mK
+), λ–  
 
E. coli TG1 glnV44 thi-1 Δ(lac-proAB) Δ(mcrB-hsdSM)5, 
(rK
–mK
–) F′ [traD36 proAB+ lacIq lacZΔM15] 
 
B. subtilis 
168 
  
CYD642 yisK-pBAD24 (amp) This study 
CYD643 yodL-pBAD24 (amp) This study 
BAS146 ponA::erm, kanΩΔmreB This study 
BAS147 ponA::erm, kanΩΔmbl This study 
BAS191 amyE::Phy-yodL (spec), yhdG::Phy-yodL 
(phleo),  
(256) 
BAS271 kanΩrpsUK34stop, amyE::Phy-yodL (spec) This study 
BAS272 kanΩrpsUK34stop, amyE::Phy-yodL (spec), 
yhdG::Phy-yodL (phleo) 
This study 
BAS273 kanΩrpsUK34stop, amyE::Phy-yodL (spec), 
yhdG::Phy-yodL (phleo), yycR::Phy-yodL (cat) 
This study 
BAS274 kanΩrpsUK34stop, amyE::Phy-yisK (spec) This study 
BAS275 kanΩrpsUK34stop, amyE::Phy-yisK (spec), 
yhdG::Phy-yisK (phleo) 
This study 
BAS276 kanΩrpsUK34stop, amyE::Phy-yisK (spec), 
yhdG::Phy-yisK (phleo), yycR::Phy-yisK (cat) 
This study 
BYD074 amyE::Phy-yisK (spec), yhdG::Phy-yisK (phleo) (256) 
BYD099 yvbJ::PcotD-lacZ (cat)   This study 
BYD172 ponA::erm This study 
BYD258 ponA::erm, kanΩΔmbl, amyE::Phy-yisK (spec), 
yhdG::Phy-yisK (phleo)   
(256) 
BYD281 amyE::Phy-yisK (spec), ycgO::Phy-yisK (tet), 
yhdG::Phy-yodL (phleo), yycR::Phy-yodL (cat)   
(256) 
BYD359 ΔyodL, ΔyisK, yvbJ::PcotD-lacZ (cat)   This study 
BYD376 kanΩrpsUTn, amyE::Phy-yisK (spec) This study 
BYD379 kanΩrpsUTn, amyE::Phy-yisK (spec), 
yhdG::Phy-yisK (phleo)   
This study 
BYD382 kanΩrpsUTn, amyE::Phy-yisK (spec), 
yhdG::Phy-yisK (phleo), yycR::Phy-yisK (cat) 
This study 
BYD384 kanΩrpsUTn, amyE::Phy-yodL (spec) This study 
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Table A3.1.  Continued. 
 
Strain Description Reference 
BYD386 kanΩrpsUTn, amyE::Phy-yodL (spec), 
yhdG::Phy-yodL (phleo) 
This study 
BYD388 kanΩrpsUTn, amyE::Phy-yodL (spec), 
yhdG::Phy-yodL (phleo), yycR::Phy-yodL (cat) 
This study 
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Table A3.2.  Plasmids used in Appendix III. 
 
Plasmid Description Reference 
pMarA TnYLB-1 (kan), mariner-Himar1 (erm) (amp) (349) 
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Table A3.3.  Oligonucleotides used in Appendix III. 
 
Oligo Sequence 5’ to 3’ 
OAS200 TTTCTTCAATCGAAGCCAGCC 
OAS201 CCTATCACCTCAAATGGTTCGCTGGGATCCTCTCTTTCCCTCCC
TCCGAAT 
OAS202 GTCCCGAGCGCCTACGAGGAATTTGTCGACGAGCAGTAAAGC
TAATCAGAATT 
OAS203 AAGAAAAATCTCAAGCAGAATGAG 
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Heat kills   
 
The formation of heat-resistant spores was quantified by growing cells in CH 
medium and performing sporulation by resuspension as described above (237). After 24 
hrs, samples were collected and the number of both total viable cells and heat-resistant 
units were enumerated. To determine colony forming units/ml, an aliquot of each culture 
was serially diluted and plated on Difco sporulation medium (DSM)(304) agar plates. To 
enumerate heat resistant spores/ml, the serial diluted cultures were subjected to a 20 min 
heat treatment at 80°C and plated on DSM agar plates. The plates were incubated at 
37°C overnight and the next day colony counts were determined. The relative 
sporulation frequency compared to wild-type was determined by calculating the 
spores/CFU of each experimental and dividing it by the spores/CFU of wild-type. The 
reported statistical significance was determined using an unpaired student’s t-test. 
 
Making the Spo+ transposon library    
 
To induce mariner-based transposon mutagenesis, 500 ng of pMarA plasmid 
(encoding a mariner transposase and the mariner transposon on a temperature sensitive 
vector) was transformed into B. subtilis 168 strain, selected on an LB-Lennox plate 
containing 10 µg/ml kanamycin, and incubated overnight at room temperature. The next 
day, a single colony was used to inoculate 2 ml LB-Lennox medium supplemented with 
10 µg/ml kanamycin. The culture was grown overnight at room temperature and 200 µl 
was used to inoculate 1.8 ml fresh LB-Lennox medium supplemented with 10 µg/ml 
kanamycin. After 6 hrs growth at room temperature, cells were pelleted by 
centrifugation at 6,010 x g for 1 min at room temperature, and resuspended in 25 mL 
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DSM liquid medium supplemented with 10 µg/ml kanamycin. Cells were grown for 
additional 36 hrs at 42°C to induce sporulation and loss of the plasmid harboring the 
transposase. The culture was subjected to a 20 min heat treatment at 80°C to kill cells 
that failed to sporulate. 5.5 ml of heat-treated culture was mixed with 3.5 ml 50% 
glycerol, and distributed into 100 µl aliquots before freezing at -80°C. It was determined 
that ~22,000 colonies would be sufficient to generate a sporulation proficient mariner 
transposon genomic library with greater than 99% coverage using the following formula:   
 
N= number of mutants needed 
P = coverage (0.99 = 99%)  
f = average gene size (890 bp)/genome size (4,214,810 bp)(350). 
To obtain genomic DNA from 22,000 independent transposon mutants, three 100 
µl aliquots of library were thawed on ice and 900 µl LB-Lennox medium was then added 
into each tube and mixed. 100 µl of the resuspended cells were plated on each of 30 LB-
Lennox agar plates containing 10 µg/ml kanamycin, then incubated overnight at 37°C. 
Plating yielded ~30,000 colonies (~1,000 colonies/plate). Each plate was flooded with 2 
ml LB-Lennox media, crudely resuspended with a sterilized inoculating loop, and 
transferred to six independent test tubes, each containing ~5 ml of the resuspension 
culture. The cultures were then grown in a roller drum at 37°C for 2 hrs. For unknown 
reasons, this growth step was important to obtain good yields of genomic DNA (see 
below). After 2 hrs, the cultures were split into two 50 ml Falcon tubes and the cells 
were pelleted at 2,576 x g for 10 min at room temperature. The supernatants were 
discarded and each pellet was then resuspended into 20 ml lysis buffer [20 mM Tris-HCl 
pH 7.5, 50 mM EDTA pH 8, 100 mM NaCl, and 2 mg/ml lysozyme] and combined. The 
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suspension was aliquoted into 1.7 ml centrifuge tubes (550 µl/tube) and placed in a 37°C 
waterbath for 30 minutes to lyse the cells. Due to the high cell density, this initial lysis 
step was not sufficient to lyse all the cells, thus a second round lysis was performed. 50 
µl lysed culture (after the initial lysis) was added into 500 µl lysis buffer and incubated 
at 37°C for 30 min. Genomic DNA was then extracted (See Appendix I for more details 
on genomic DNA purification). The aliquots of genomic DNA were frozen at -80°C 
until use. For unknown reasons, the genomic DNA prepared from the pooled mariner 
library routinely resulted in ~10-fold fewer colonies following transformation into 
competent B. subtilis than genomic DNA prepared from a strain harboring a single 
transposon insertion. 
 
Redundant factor screen   
 
To introduce the library of mariner transposon insertions, 200 ng of genomic 
DNA was used to transform a strain harboring ΔyodL ΔyisK as well as a reporter of a 
late stage in sporulation, PcotD-lacZ (BYD359). Transformations were plated on DSM 
agar plates supplemented with 10 μg/ml kanamycin to select for the transposon and 40 
μg/ml 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-Gal), to detect production 
of beta-galactosidase. Cells that were able to reach the late stage of sporulation 
expressed lacZ and were able to cleave the X-gal substrate, producing blue colonies. The 
plates were incubated at 37°C for 36 hrs and then at room temperature for another 36 
hrs. Cells that produced white or light blue colonies (compared to the non-mutagenized 
BYD359 control) were considered delayed or reduced in sporulation and streaked for 
isolation; each strain was labeled as RFL (Redundant Factors of YodL and YisK). 
Genomic DNA was then extracted from each candidate. This genomic DNA was used to 
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transform a clean genetic background of BYD359 by selecting on LB-Lennox plates 
supplemented with 10 μg/ml kanamycin. The new strains were labelled as RFL_K.  
To determine if the reduced sporulation could be attributed to the transposon as 
opposed to an unlinked mutation in the original isolate, individual colonies from the 
original RFL isolate and its corresponding RFL_K counterpart were used to inoculate 3 
ml LB-Lennox medium, and the cells were grown to exponential phase (OD600 between 
0.3 and 0.7). Samples were normalized by OD600 and five μl of each culture was spotted 
on a DSM agar plate supplemented with 40 μg/ml X-Gal. Plates were incubated at 30°C 
for 20 hrs. For each pair, the color of RFL and its corresponding RFL_K were compared. 
If the colors were consistent (both light blue or both white compared to the BYD359 
control), then the genomic DNA from the RFL genomic was used to transform BYD99 
(PcotD-lacZ) to determine if the transposon itself was responsible for the observed 
sporulation defect, or if the delay required both ΔyodL ΔyisK and the mariner insertion. 
These new strains were labelled as RFL_C. Using the spot test described above, each 
RFL_K and its corresponding RFL_C strain were then compared. Only RFL_K strains 
that appeared white or light blue compared to the BYD359 control, and also had a 
corresponding blue RFL_C strain were selected for further analysis.   
 
Inverse PCR   
 
To determine the location of the mariner insertion associated with reduced 
sporulation in the ΔyodL/ΔyisK background, inverse PCR was performed. 1 μg of 
genomic DNA isolated from the RFL strain was digested with Sau3AI (New England 
BioLabs) for 60 min at 37°C. The enzyme was inactivated by heating to 65°C for 30 
min. To circularize the genomic DNA fragments, 200 units of T4 DNA ligase were 
 247 
 
added to 200 ng of the digested DNA, and the reaction was placed at room temperature 
for 60 min. 100 ng of the ligated DNA was then used in a 31-cycle PCR reaction (98°C 
for 10 sec, 56°C for 30 sec, 72°C for 2 min) using 0.4 μM OJH232 and OJH233 as the 
primers. The cleaned PCR product was then Sanger sequenced using primer OJH233. 
The locations of the transposon insertions were determined by Blast of the BsubCyc 
database. 
 
Plate growth assay   
 
B. subtilis strains were streaked on LB-Lennox plates supplemented with 100 
µg/ml spectinomycin (for uninduced samples), or 100 µg/ml spectinomycin and 1 mM 
IPTG (for induced samples). Plates were incubated at 37°C overnight and images were 
captured on a ScanJet G4050 flatbed scanner (Hewlett Packard). 
 
Results 
 
Overexpression of YisK, but not YodL, during B. subtilis sporulation produced 
round-shaped cells 
 
Knocking-out yodL and yisK did not result in an obvious morphological 
phenotype during sporulation (Appendix I, Fig A1.8)(256). We also tested if 
overexpression of either yodL or yisK during sporulation would affect cell or spore 
morphology. Cells harboring either the Phy-yodL or Phy-yisK misexpression constructs 
were sporulated by resuspension. Inducer was added at the time of resuspension and the 
morphology of the cells was monitored over a timecourse using microscopy. Expression 
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of yodL did not result in any obvious changes in morphology compared to wild-type, 
even after 24 hrs of growth (Fig A3.1). In contrast, expression of yisK resulted in cell-
widening, which first became evident at 2.5 hrs of resuspension and eventually produced 
round cells (Fig A3.1). These results suggest that during sporulation, B. subtilis 
morphology is sensitive to the effects of YisK but not YodL. 
 
During sporulation, ΔmreB, but not Δmbl, produced round-shaped cells 
 
Cells are sensitive to the effects of YisK overexpression during sporulation, as 
evidenced by the production of round cells (Fig A3.1). Since YisK is proposed to target 
Mbl activity and YodL is proposed to target some aspect of MreB function (Appendix I, 
Table A1.6, Fig A1.12)(256), we hypothesized that the YisK and YodL overexpression 
phenotypes observed would mimic those of deleting mbl and mreB respectively. We 
generated mbl and mreB deletion strains in a ΔponA background (see Appendix I for 
details). In this background, deletion of either gene results in minimal effects on cell 
shape as long as cultures are also supplemented with excess Mg2+. 
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Fig. A3.1.  YisK overexpression produces round cells during a B. subtilis sporulation 
timecourse. B. subtilis 168 (wildtype), BYD074 (2X Phy-yisK) and BAS191 (2X Phy-
yodL) were sporulated by resuspension (237). 1 mM IPTG was added at the time of 
resuspension (T = 0 min) to induce expression of either yisK or yodL. Cells were grown 
for the indicated amount of time at 37°C before image capture. Membranes were stained 
with TMA-DPH. All images are shown at the same magnification.  
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 Cells were grown to mid-exponential phase in the presence of 10 mM MgCl2 
and sporulated by resuspension in both regular resuspension media (237), and 
resusepnsion media supplemented with 10 mM MgCl2. At the time of resuspension both 
the Δmbl and ΔmreB strains appeared similar in overall morphology (Fig A3.2). 
Unexpectedly, the Δmbl strain possessed no obvious morphological differences 
compared to the wild-type strain during sporulation (Fig A3.1 – A3.2). In contrast, the 
ΔmreB strain became round (Fig A3.2), similar to the phenotype observed upon YisK 
induction (Fig A3.1). These results suggest that during sporulation, MreB but not Mbl 
appears to function in cell shape maintenance. Moreover, these observations are 
consistent with the idea that YisK may perturb not only Mbl, but also some aspect of 
MreB activity. 
 
Deleting mbl rescues the round-cell phenotype produced by YisK overexpression 
 
In vegetative growth, YisK overexpression results in cell widening (Appendix I, 
Fig A1.1)(256), and this phenotype specifically depends on Mbl (Appendix I, Fig 
A1.12), suggesting that either YisK specifically targets Mbl, or that YisK’s cell-
widening activity depends on the presence of Mbl (256). To test if the cell-widening 
effects of YisK overexpression during sporulation were also dependent on Mbl, YisK 
was overexpressed during sporulation in a Δmbl background. Consistent with prior 
observations during vegetative growth, YisK overexpression required the presence of 
Mbl to produce its cell-widening activity (Fig A3.3). 
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Fig. A3.2.  Deletion of mreB, but not mbl, results in the production of round cells 
during a sporulation timecourse. BAS146 (ΔponA/ΔmreB) and BAS147 (ΔponA/Δmbl) 
were grown in CH media (237) supplemented with 10 mM MgCl2 at 37°C to mid-
exponential phase growth. Sporulation was induced by resuspension at 37°C according 
to the Sterlini-Mandelstam method (237). When indicated, 10 mM MgCl2 was added 
into the resuspension media (SM media). Images were captured at the indicated time, 
where resuspension = 0’. Membranes were stained with TMA-DPH. All images are 
shown at the magnification.   
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Fig. A3.3.  Mbl is required for YisK to induce cell rounding during sporulation. 
BYD258 (2X Phy-yisK, ΔponA/Δmbl) was grown in CH media (237) supplemented with 
10 mM MgCl2 at 37°C to mid-exponential phase growth. Sporulation was induced by 
resuspension at 37°C according to the Sterlini-Mandelstam method (237). 1 mM IPTG 
was used to induce yisK expression at the time of resuspension (T = 0 min). Images were 
captured 24 hrs after resuspension. All images are shown at the same magnification. The 
image of the yisK overexpression in wild-type background is the same one shown in Fig 
A3.1, and is repeated here to facilitate comparison. 
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Overexpression YodL and YisK affect sporulation efficiency 
 
In addition to testing the morphological changes associated with YodL and YisK 
overexpression during sporulation, we also investigated the effect of overexpression on 
the production of heat-resistant spores. To determine the number of heat-resistant spores 
in a sporulation culture, we quantified the number of colony forming units (CFU) 
present in cultures before (total CFU) and after a heat treatment that kills vegetative cells 
(heat-resistant CFU). These values were normalized to display the sporulation efficiency 
of the mutants relative to wildtype. Overexpression of YodL increased the relative 
sporulation efficiency by ~20% (Table A3.4), whereas overexpression of YisK 
decreased the efficiency by ~20% (Table A3.4). Overexpression of both YodL and YisK 
resulted no significant difference in relative sporulation efficiency compared to wild-
type cells (Table A3.4). No significant difference in total CFU was observed for any of 
the overexpression strains compared to wildtype, indicating that the changes in heat-
resistant spores produced were not due to changes in germination efficiency or cell 
viability before heat treatment (Table A3.4) 
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Table A3.4.  Sporulation efficiency following yodL and yisK overexpression. 
Sporulation efficiency is the number of spores/ml divided by the total cfu/ml × 100%.  
Relative sporulation efficiency is sporulation efficiency normalized to wildtype × 100%. 
The data shown is the average of three independent biological replicates. The difference 
in sporulation efficiency for wildtype compared to following YodL overexpression or 
YisK overexpression is statistically significant by an unpaired students t-test(P<0.05). 
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ΔmreB and Δmbl had severe defects in sporulation efficiency 
 
Overexpression of YodL slightly increases the relative sporulation efficiency 
while overexpression of YisK slightly reduces it (Table A3.4). Since current models 
suggest YodL and YisK inhibit MreB and Mbl activity respectively (Appendix I)(256), 
we next sought to determine if the conditionally viable ΔmreB and Δmbl strains also 
showed differences in sporulation efficiency. Unexpectedly, the Δmbl strain exhibited no 
significant difference in sporulation efficiency (97%) compared to wildtype, whereas the 
ΔmreB strain was reduced to ~40% of wildtype (Table A3.5). The total CFU for the 
Δmbl strain was slightly higher than wildtype (Table A3.5). The reduced sporulation 
efficiency of the ΔmreB strain was largely attributable to a reduction in the ability of the 
strain to form colonies prior to heat-kill. The number of cells was reduced by 
approximately half (Table A3.5). This result could be attributed to a reduced ability of 
the ΔmreB strain to germinate or to reduced cell viability. Combined with the 
observations in the microscopy experiments (ΔmreB produced round-shaped cells, 
whereas there was no difference between wildtype and the Δmbl strain)(Fig A3.2), these 
results suggest that during sporulation, MreB plays important roles in both cell shape 
maintenance as well as cell viability and/or the ability of spores to germinate. 
It has been shown that magnesium supports both viability and cell shape of mreB 
and mbl deletion mutants on non-sporulation medium (291). Therefore, we also tested 
the effect of MgCl2 supplementation on sporulation efficiency. Unexpectedly, the 
addition of 10 mM MgCl2 to the sporulation medium reduced sporulation efficiency for 
both the Δmbl and ΔmreB strains, (from 97% to 59%, and 40% to 18%, respectively) 
(Table A3.5). The total CFU of both strains showed no difference regardless of MgCl2 
addition, indicating that the reduction in sporulation efficiency was not due to lower cell 
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viability (Table A3.5). We have not yet tested the effect of MgCl2 on wild-type 
sporulation, so it is not currently possible to know if the effect observed is attributable to 
the MgCl2 itself. 
 
Identification of factors that act redundantly with YodL and/or YisK during 
sporulation 
 
yodL and yisK are expressed during early sporulation (Fig A1.4 - A1.6). 
However, even a ΔyodL/ΔyisK strain only reduced sporulation efficiency by ~20% 
(Table A1.4). We hypothesized that the modest defects might be due to the presence of 
other factors that act redundantly with YodL and YisK during sporulation. To identify 
such factors, we designed a genetic screen for mariner transposon insertions that, in a 
ΔyodL ΔyisK strain background, result in an observable block or delay in sporulation 
(for details, See Materials and Methods). The candidates identified were called RFLs for 
Redundant Factors of YodL and YisK.  
In a screen of more than 5,000 colonies containing transposon insertions, 92 were 
perturbed in sporulation. Of these, only 36 retained the sporulation defect when the 
transposon was introduced into a clean ΔyodL ΔyisK strain background. Candidates that 
exhibited sporulation defects when the transposon was introduced into a wild-type 
background were eliminated, as these sporulation defects did not require the absence of 
yodL and/or yisK. The remaining 12 candidates exhibited sporulation defects only when 
introduced into the ΔyodL ΔyisK strain and thus were deemed more likely to contribute 
to sporulation in a redundant manner. The location of the transposon insertions in these 
mutants were determined using inverse PCR (Table A3.6). 
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Table A3.5.  Sporulation efficiency of mreB and mbl mutants. Sporulation efficiency is 
the number of spores/ml divided by the total cfu/ml × 100%. Relative sporulation 
efficiency is sporulation efficiency normalized to wildtype × 100%. The data shown is 
the average of three independent biological replicates.  
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Table A3.6.  Identification of mariner transposon insertion sites that result in a 
sporulation defect in the ΔyodL ΔyisK background. The site of transposon was 
determined using inverse PCR. 
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rpsU is associated with resistance to YisK misexpression 
 
In a selection for spontaneous suppressors resistant to YisK misexpression during 
vegetative growth, we identified an rpsU mutant containing a non-sense mutation that 
resulted in a K34stop truncation for ribosomal protein S21 (encoded by rpsU)(for 
details about the suppressor selection, see Appendix I). To test whether this mutant was 
also resistant to YodL, we generated the mutant in a clean genetic background, and 
introduced 1X, 2X or 3X copies of Phy-yodL. We observed that in the presence of 
inducer, the rpsU mutant was resistant to one copy of Phy-yodL, but not to additional 
copies. In contrast, the rpsU was resistant to 1X, 2X and 3X copies of Phy-yisK (Fig 
A3.4)(see below for further discussion).  
Since we identified a transposon insertion upstream of rpsU in the redundant 
factor screen, we hypothesized that this mutant might also be resistant to YisK and/or 
YodL misexpression during vegetative growth. To test this, 1X, 2X and 3X copies of 
Phy-yisK and 1X, 2X and 3X copies of Phy-yodL were introduced into a genetic 
background otherwise harboring only the transposon insertion upstream of rpsU. In the 
presence of inducer, the strain was resistant to one copy of Phy-yisK, but not multiple 
copies (Fig A3.5). In contrast, the transposon did not confer any resistance to YodL (Fig 
A3.5). These results suggest that the transposon confers specific resistance to YisK. 
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Fig. A3.4.  An rpsU truncation mutant generating S21K34STOP is resistant to YisK 
misexpression. 1X, 2X and 3X copies of Phy-yodL and 1X, 2X and 3X copies of Phy-yisK 
were introduced into rpsU mutant background (BAS271 – BAS276, repectively). Each 
strain was streaked on LB-Lennox plates containing 100 µg/ml spectinomycin (left 
columns), or 100 µg/ml spectinomycin and 1 mM IPTG (right columns). 
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Fig. A3.5.  A mutant with a transposon insertion upstream of rpsU is resistant to 1X 
Phy-yisK misexpression. 1X, 2X and 3X copies of Phy-yisK and 1X, 2X and 3X copies of 
Phy-yodL were introduced into rpsU mutant background (BYD376, BYD379, BYD382, 
BYD384, BYD386, BYD388, repectively). Each strain was streaked on an LB-Lennox 
plate containing 100 µg/ml spectinomycin and 1 mM IPTG. Plate was incubated at 37°C 
overnight before image was captured. 
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Discussion 
 
Overexpression of YisK during sporulation produced round cells (Fig A3.1) and 
decreased the relative sporulation efficiency by ~20% (Table A3.4), whereas a yisK 
knockout has no obvious morphological defects during sporulation (Fig A1.8). These 
results suggest that the presence of too much YisK protein is detrimental for sporulating 
cells. These results are consistent with the idea that yisK is expressed during stationary 
phase and early sporulation, but might actually be repressed by higher levels of Spo0A-P 
as sporulation proceeds (256). In contrast, overexpression of YodL, which the previous 
data suggested is induced to maximal levels in a Spo0A-dependent manner (256, 308), 
did not result in any obvious morphological changes (Fig A3.1) and actually increased 
the relative sporulation efficiency by ~20% (Table A3.4). 
Previous genetic data showed that YodL depends on MreB to perturb cell shape 
(Fig A1.12), and suppressor selection analysis are consistent with MreB being YodL’s 
primary target (Table A1.6). Similarly, YisK requires Mbl to elicit its cell-widening 
effects (Fig A1.12), and YisK-resistant suppressors arise primarily in mbl (Table 
A1.6)(256). Based on these observations, we hypothesized that during sporulation, a 
ΔmreB strain would phenocopy the YodL overexpression phenotype, whereas a Δmbl 
strain would phenocopy the YisK overexpression phenotype. To our surprise, we 
observed that the ΔmreB mutant produced round-shaped cells (Fig A3.2), similar to 
YisK overexpression (Fig A3.1), while the Δmbl mutant displayed no differences 
compared to wildtype (Fig A3.2), more similar to YodL overexpression (Fig A3.1). At 
the same time, overexpression of YisK in a Δmbl background did not result in round 
cells (Fig A3.3), suggesting that even during sporulation, YisK requires the presence of 
Mbl to perform its activity. The simplest explanation of these results is that YisK is 
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capable of inhibiting some aspect of MreB or MreB and Mbl function as long as Mbl is 
present. It is also possible that the round-cell phenotype is due to YisK affecting one or 
more other factors or processes that are required for maintenance of rod-shape during 
sporulation. For example, YisK could affect the pool of PG precursors available to PG 
synthesizing proteins.  
To gain better insight regarding how YodL and YisK might function during 
sporulation, we performed a screen for factors that act redundantly with YodL and YisK 
to support sporulation. The transposon insertions identified occur both within genes and 
upstream of the genes; in the future it will be necessary to carry out further analyses to 
determine which genes are specifically responsible for the observed sporulation defects. 
Interestingly, one of the transposon insertions occurred 32 bp upstream of pgk (Table 
A3.6), an essential gene which product is involved in regulation of carbon flux through 
the glycolytic and gluconeogenic pathways (351, 352). Of note, pgk is the first gene in 
an operon that includes eno, pgm, and tpiA, other genes required for the pathway 
converting phosphenolpyruvate (PEP) to glucose-6-phosphate during gluconeogenesis. 
The first dedicated step in PG synthesis (carried out by the enzyme MurA), is the 
condensation of PEP with the PG precursor UDP-GlcNAc to generate UDP-GlcNAc-
enolpyruvate. Previous researchers have associated bypass of MreB essentiality with 
changes in flux through the gluconeogenic pathway, possibly due to a changes in the 
pools of available PG precursors (353). We do not know if the expression of pgk, pgm, 
eno, and tpiA is increased or decreased in the strain we isolated, but this could be 
determined by examining mRNA levels. Since YodL and YisK appear to negatively 
regulate MreB and/or Mbl activity, we predict that the sporulation defect we observe is 
due to upregulation of PG synthesis. One exciting possibility is that YisK regulates Mbl 
and possibly MreB activity by limiting the availability of a substrate feeding into the 
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synthesis of UDP-GlcNAc-enolpyruvate. Future investigation will be aimed at probing 
this specific hypothesis.  
Another transposon we identified in the redundant factor screen inserted 60 bp 
upstream of rpsU. We have not investigated if the insertion results in increased or 
decreased expression of rpsU since this mutant has pleotropic effects on the cell (354) 
that will likely complicate its analysis. Prior work suggested that rpsU (the gene 
encoding ribosomal protein S21) null mutant results in an enhancement of biofilms and 
the upregulation of exopolysaccharide (EPS) production (355). However, the rpsU 
mutation also suppresses defects in phospholipid synthesis (354), so multiple processes 
are likely effected. Interestingly, before obtaining this mutant, we had already observed a 
genetic link between YisK and rpsU. In a suppressor selection for mutants 
spontaneously resistant to YisK activity (see Appendix I for details), we identified an 
rpsU truncation mutant (Fig A3.4) which, based on phenotype, is loss-of-function (355). 
We also identified a transposon in the open reading frame of veg in the redundant factor 
screen (Table A3.6). A veg knockout strain exhibits a biofilm-down phenotype, 
producing less EPS (356). We hypothesize that transposon insertion in veg inactivates 
the gene and represses EPS production. Since EPS and PG compete for the same Und-P 
precursor (357), we suspect this strain exhibits more robust PG synthesis. Similar to the 
situation with the pgk mutant, we hypothesize increased and/or disregulated PG 
synthesis is detrimental during sporulation. 
It is possible that one or more of the transposons have subtle effects on 
sporulation that are unrelated to either YodL or YisK activity, but that become evident in 
the ΔyodL ΔyisK background (which itself has a subtle sporulation defect)(Table 
A1.4)(256). For example, the ssrA transposon could affect sporulation subtly, as ssrA 
has previously been shown to affect sporulation (358). We currently do not have 
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hypotheses to be tested regarding the remaining insertions. Future experiments will be 
aimed at further characterization of the mutants identified, including determining if the 
sporulation phenotypes can be recapitulated in backgrounds in which the transposon is 
present and only yodL or yisK have been deleted.    
We also observed that addition of excess Mg2+ to sporulating cultures decreased 
cell viability in both ΔmreB and Δmbl strains. This result is interesting because during 
vegetative growth, increasing Mg2+ levels in media has been shown to have a stabilizing 
effect on mutants with perturbations in PG synthesis (290, 291, 325). Although the 
reasons for this stabilization are unclear, we would like to propose based on our current 
data that Mg2+ addition somehow leads to an increase in the availability of precursors 
available for PG synthesis. In bacteria, the sugar precursors required for synthesizing 
various cell wall glycan polymers, including those required for production of EPS, 
lipopolysaccharide, techoic acid, and PG synthesis, are conjugated to a single common 
lipid carrier called Und-P (359-361). The pool of Und-P is limiting, thus fluxes toward 
one pathway result in a corresponding depletion of Und-P available for another pathway 
(357, 362). Mg2+ is known to downregulate EPS production in Bacillus (363), so one 
idea is that the decreased EPS production increases the availability of Und-P available 
for PG synthesis (362). Similarly, in B. subtilis, low Mg2+ levels result in an increase in 
synthesis of techoic acid (364); although it has not been investigated specifically, such a 
shift would be expected to shift Und-P towards to techoic acid synthesis, and would 
therefore deplete PG precursors. Reciprocally, excess Mg2+ would be predicted to lead to 
a downregulation in techoic acid biosynthesis, and a corresponding increase in the Und-
P available for PG synthesis.  
The excess Mg2+ provided during sporulation in cells lacking either mreB or mbl 
could lead to an increase in the availability of precursors for PG synthesis at a time that 
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they are actually detrimental for spore development. Since the spore cortex is largely 
composed of PG (365), it is not clear why such a defect would occur, but it is possible 
that the ability of cells to generate the cortex-specific modifications to the PG, such as 
removal of peptide side chains and conversion of N-acetyl muramic acid to muramic-
delta-lactam (365) may be perturbed in the absence of MreB and/or Mbl. Although these 
modifications have not been shown to affect the heat-stability of spores produced, they 
have a major impact on the ability of spores to germinate successfully (365). Future 
investigations will be aimed at testing these different hypotheses. 
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APPENDIX IV 
YodL DISRUPTS CELL SHAPE INDEPENDENT OF RodZ 
 
Introduction 
 
The bacterial actin-like protein MreB is critical to peptidoglycan (PG) synthesis 
in a large number of rod-shaped bacteria, including the important model organisms 
Escherichia coli and Bacillus subtilis (269, 270). MreB interacts with several other 
proteins involved in PG synthesis, including the bitopic membrane protein RodZ (279, 
283, 288). RodZ has been shown to be important for cell shape maintenance both in E. 
coli and in B. subtilis (283, 284) and a co-crystal structure of RodZ-MreB is available 
showing the N-terminus of RodZ extending into a conserved hydrophobic pocket located 
in subdomain IIA of MreB (279). Recently, Morgenstein et al. showed that RodZ 
couples MreB to PG synthesis by mediating MreB’s dynamic rotational behavior in E. 
coli (288). In E. coli, MreB rotation is required for the robustness of rod shape, but is 
also dispensable for rod-like shape determination under standard laboratory conditions 
(288).  
Current data suggest that in B. subtilis, YodL affects MreB activity (Appendix I, 
Table A1.6, Fig A1.12)(256). During vegetative growth, misexpression of YodL 
prevents colony formation on plates and results in cell widening (Fig A1.1); these 
phenotypes can be rescued by substitutions in MreB at the RodZ-MreB interface, as well 
as in residues at/near those previously associated with bypass of RodZ essentiality 
(Table A1.6, Fig A1.9). Based on these results and the fact that MreB is required for 
YodL to induce cell widening (Fig A1.12), it was hypothesized that in its native context 
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of sporulation, YodL may function by regulating the interaction between RodZ and 
MreB. 
Here, we showed that B. subtilis MreB interacts with RodZ in a bacterial two-
hybrid (B2H) assay. This assay was then used to show that the YodL resistant MreB 
variants identified previously (256) can be divided into at least two classes:  those that 
show loss of interaction with RodZ and those that show gain of interaction with RodZ. 
Furthermore, we found that contrary to prior reports (284), RodZ is non-essential in B. 
subtilis 168. The gene can be deleted with only minor effects on cell shape as long as 
expression of the essential downstream gene, pgsA, is not disrupted (366). Using the 
ΔrodZ strain, it was observed that RodZ is not required for YodL-dependent killing or 
cell shape perturbations, suggesting that YodL does not act by targeting RodZ 
specifically.  
 
Materials and Methods 
 
General methods.   
 
All B. subtilis strains were derived from B. subtilis 168. E. coli and B. subtilis 
strains utilized in this study are listed in Table A4.1. Plasmids are listed in Table A4.2. 
Oligonucleotide primers are listed in Table A4.3. Escherichia coli DH5α was used for 
cloning. All E. coli strains were grown in LB-Lennox medium supplemented with 100 
µg/ml ampicillin and/or 25 µg/ml kanamycin. The following concentrations of 
antibiotics were used for generating B. subtilis strains: 100 µg/ml spectinomycin, 7.5 
µg/ml chloramphenicol, 0.8 mg/ml phleomycin, 10 µg/ml tetracycline, 10 µg/ml 
kanamycin. To select for erythromycin resistance, plates were supplemented with 1 
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µg/ml erythromycin (erm) and 25 µg/ml lincomycin. B. subtilis transformations were 
carried out as described previously (302).  
 
Bacterial two-hybrid assay  
 
Bacterial two hybrids were performed essentially as described (241). For more 
details, see Materials and Methods in Chapter II. 
 
Plate growth assay   
 
B. subtilis strains were streaked on LB-Lennox plates containing 100 µg/ml 
spectinomycin and 1 mM IPTG. Plates were incubated at 37°C overnight and images 
were captured on a ScanJet G4050 flatbed scanner (Hewlett Packard). 
 
Microscopy   
 
All strains were grown in 25 ml LB-Lennox medium in 250 ml baffled flasks at 
37°C in a shaking waterbath set at 280 rpm for 1.5 hrs. When indicated, 1 mM IPTG was 
added to induce protein misexpression and all the samples were imaged 1.5 hrs post-
induction. 1 ml samples were spun down at 6,010 x g for 1 minute at room temperature. 
The pellets were resuspended in 5 µl TMA-DPH (0.02 mM) to stain the membrane and 
exposed for 1 sec. Cells were mounted on glass slides with polylysine-treated coverslips 
prior to imaging.  
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Table A4.1.  Strains used in Appendix IV. 
 
Strain Description Reference 
Parental   
B. subtilis 
168 
Bacillus subtilis laboratory strain 168 trpC2  BGSC (1A866) 
E. coli DH5α F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 
deoR nupG Φ80dlacZΔM15 Δ(lacZYA-
argF)U169, hsdR17(rK
- mK
+), λ–  
 
E. coli 
DHP1 
F-, cya-99, araD139, galE15, galK16, rpsL1 
(Strr), hsdR2, mcrA1,mcrB1; 
Tom Bernhardt 
B. subtilis 
168 
  
BAS191 amyE::Phy-yodL (spec), yhdG::Phy-yodL (phleo) (256) 
BAS316 rodZ::tet This study 
BAS321 rodZ::tet, amyE::Phy-yodL (spec), yhdG::Phy-
yodL (phleo) 
This study 
E. coli 
DHP1 
  
CYD217 T25-yodL (kan), T18-mreB (amp) This study 
CYD218 T25-yodL (kan), mreB-T18 (amp) This study 
CYD219 yodL-T25 (kan), T18-mreB (amp) This study 
CYD220 yodL-T25 (kan), mreB-T18 (amp) This study 
CYD221 T25-mreB (kan), T18-yodL (amp) This study 
CYD222 mreB-T25 (kan), T18-yodL (amp) This study 
CYD223 T25-mreB (kan), yodL-T18 (amp) This study 
CYD224 mreB-T25 (kan), yodL-T18 (amp) This study 
CYD340 yodL-T25 (kan), rodZ-T18 (amp) This study 
CYD341 yodL-T25 (kan), T18-rodZ (amp) This study 
CYD342 T25-yodL (kan), rodZ-T18 (amp) This study 
CYD343 T25-yodL (kan), T18-rodZ (amp) This study 
CYD344 rodZ-T25 (kan), yodL-T18 (amp) This study 
CYD345 T25-rodZ (kan), yodL-T18 (amp) This study 
CYD346 rodZ-T25 (kan), T18-yodL (amp) This study 
CYD347 T25-rodZ (kan), T18-yodL (amp) This study 
CYD394 T25-rodZ (kan), mreB-T18 (amp) This study 
CYD421 T25-empty (kan), mreB-T18 (amp) This study 
CYD422 T25-rodZ (kan), empty-T18 (amp) This study 
CYD439 T25-rodZ (kan), mreBG143A-T18 (amp) This study 
CYD440 T25-rodZ (kan), mreBR282S-T18 (amp) This study 
CYD441 T25-rodZ (kan), mreBS154R-T18 (amp) This study 
CYD442 T25-rodZ (kan), mreBP147R-T18 (amp) This study 
CYD443 T25-rodZ (kan), mreBN145D-T18 (amp) This study 
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Table A4.1.  Continued. 
 
Strain Description Reference 
CYD444 T25-empty (kan), mreBG143A-T18 (amp) This study 
CYD445 T25-empty (kan), mreBR282S-T18 (amp) This study 
CYD446 T25-empty (kan), mreBS154R-T18 (amp) This study 
CYD447 T25-empty (kan), mreBP147R-T18 (amp) This study 
CYD448 T25-empty (kan), mreBN145D-T18 (amp) This study 
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Table A4.2.  Plasmids used in Appendix IV. 
 
Plasmid Description Reference 
pKT25 T25-empty (kan) Tom Bernhardt 
pCH363 empty-T18 (amp) Tom Bernhardt 
pYD199 T25-yodL (kan) This study 
pYD200 yodL-T25 (kan) This study 
pYD201 T18-yodL (amp) This study 
pYD202 yodL-T18 (amp) This study 
pYD203 T25-mreB (kan) This study 
pYD204 mreB-T25 (kan) This study 
pYD205 T18-mreB (amp) This study 
pYD206 mreB-T18 (amp) This study 
pYD207 rodZ-T18 (amp) This study 
pYD208 T18-rodZ (amp) This study 
pYD209 rodZ-T25 (kan) This study 
pYD210 T25-rodZ (kan) This study 
pYD211 mreBG143A-T18 (amp) This study 
pYD212 mreBR282S-T18 (amp) This study 
pYD213 mreBS154R-T18 (amp) This study 
pYD214 mreBP147R-T18 (amp) This study 
pYD215 mreBN145D-T18 (amp) This study 
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Table A4.3.  Oligonucleotides used in Appendix IV. 
 
Oligo Sequence 5’ to 3’ 
OYD206 CATTGCATGCGTAACACACAGGAAACAGCTATGATGTTATCC
GTGTTTAAAAAG 
OYD207 GCATGGATCCGAACCGCTACCTGTCGTTTGTACAATCAGACG 
OYD208 GCATGGATCCGGGCAGCGGTATGATGTTATCCGTGTTTAAAA
AG 
OYD209 GCATGAATTCTTATGTCGTTTGTACAATCAGACG 
OYD210 CATTGCATGCGTAACACACAGGAAACAGCTATGTTTGGAATT
GGTGCTAGAG 
OYD211 GCATGGATCCGAACCGCTACCTCTAGTTTTCCCTTTGAAAAGA
TG 
OYD212 GCATGGATCCGGGCAGCGGTATGTTTGGAATTGGTGCTAGAG 
OYD213 GCATGAATTCTTATCTAGTTTTCCCTTTGAAAAG 
OYD266 GCATGGATCCGTAACACACAGGAAACAGCTATGTCATTGGAT
GATCTCCAAG 
OYD267 GCATGAATTCGAACCGCTACCAGATGACTTTTCTTCCTTTTTAT
TT 
OYD268 GCATGGATCCGGGCAGCGGTATGTCATTGGATGATCTCCAAG 
OYD269 GCATGAATTCTTAAGATGACTTTTCTTCCTTTTTATTT 
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Results 
 
B. subtilis MreB interacts with RodZ in a B2H assay 
 
Muchova et al. showed that in B. subtilis, the cytosolic portion of RodZ interacts 
with MreB in a pull-down assay (284). We independently tested the interaction between 
RodZ and MreB using a bacterial two-hybrid assay. A positive interaction between 
RodZ and MreB was detected that was absent in the negative controls, consistent with 
the idea that the two proteins interact (Fig A4.1). 
 
Amino acid substitutions in MreB that suppress YodL’s cell widening and killing 
effects influence MreB-RodZ interaction 
 
Misexpression of YodL during vegetative growth results in cell-widening and 
prevents colony formation on plates (Appendix I, Fig A1.1). To identify genetic targets 
associated with YodL activity, we performed suppressor selection analysis and found out 
that most YodL-resistant strains possessed point mutations in mreB (Appendix I, Table 
A1.6)(256). Interestingly, five of the MreB variants identified, MreBG143A, MreBN145D, 
MreBP147R, MreBS154R, and MreBR282S, possessed amino acid substitutions in a region 
important for mediating MreB-RodZ interaction in E. coli (Appendix I, Table A1.6 and 
Fig A1.9)(256); three of these substitutions (MreBN145D, MreBP147R, and MreBR282S) 
occur in residues that interact directly in the T. maritima MreB-RodZ structure. Each of 
these later substitutions are resistant toYodL but not YisK, and thus are less likely to be 
general MreB gain-of-function suppressors (256).  
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Fig. A4.1.  MreB interacts with RodZ by bacterial two-hybrid assay. B2H between 
RodZ and MreB (CYD394) or RodZ and each of the following MreB variants: 
MreBG143A (CYD439), MreBR282S (CYD440), MreBS154R (CYD441), MreBP147R 
(CYD442) and MreBN145D (CYD443). Negative controls: empty partner vector with 
wild-type MreB or the indicated MreB variant (left) or RodZ with the empty partner 
vector (right). 
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To test if the amino acid substitutions in MreB indeed affected MreB-RodZ 
interaction, we performed B2H using wild-type RodZ and each of the MreB variants. In 
the assay, interaction between RodZ and MreBG143A, MreBP147R and MreBS154R were not 
detectable, whereas MreBN145D exhibited a slightly weaker interaction compared to wild-
type MreB (Fig A4.1). In contrast, MreBR282S appeared to interact more strongly with 
RodZ in the B2H (Fig A4.1). These results suggest that, analogous to what was observed 
in the T. maritima RodZ-MreB co-crystal (279), MreBG143, MreBN145, MreBP147, 
MreBS154, and MreBR282 facilitate the MreB-RodZ interaction in B. subtilis. 
 
YodL-MreB and YodL-RodZ interactions are not detectable in a B2H assay  
 
We hypothesized that YodL might perturb MreB function by interacting directly 
with either MreB and/or RodZ. To test this idea, we tested for interaction between YodL 
and MreB and YodL and RodZ in a B2H assay. None of the combinations tested resulted 
in a positive interaction in the assay (Fig A4.2). However, based on this negative data, 
we do not exclude the possibility that YodL and MreB could interact directly. 
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Fig. A4.2.  YodL-MreB interaction and YodL-RodZ interaction were not detected in a 
B2H assay. (A) B2H between YodL and MreB (CYD217-224). (B) B2H between YodL 
and RodZ (CYD340-347). The plates were incubated at room temperature for 96 hrs.  
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RodZ is not required for YodL activity  
 
We hypothesized that if YodL’s cell-widening and cell-killing effects were due 
to targeting of RodZ (as opposed to MreB), then YodL would no longer be functional in 
a strain lacking RodZ. To test this idea, we constructed a ΔrodZ strain. Although prior 
reports indicated that rodZ was essential, the knockout strains were not designed to 
avoid polar effects on the downstream gene, pgsA, which is known to be essential (366, 
367). In addition, genetic complementation was not performed to show that the loss of 
viability was attributable to RodZ. Therefore, a knockout construct was designed to 
introduce a kanamycin-resistant linked rodZ deletion into the B. subtilis chromosome 
while minimizing the possibility of polar effects on pgsA. Using this strategy, rodZ 
deletion mutants were readily obtained. The ΔrodZ strain occasionally produced slightly 
twisted cells and bent or curled poles, and phenotype that was ameliorated by the 
addition of 10 mM MgCl2 (Fig A4.3). However, even in the presence of 10 mM MgCl2, 
some small membrane-bound structures were observed, reminiscent of minicells (Fig 
A4.3). To test if YodL required RodZ for its cell-widening and cell-killing 
misexpression phenotypes, Phy-yodL was introduced into the ΔrodZ background. Neither 
wildtype nor the ΔrodZ strain could form colonies on plates containing inducer, 
suggesting that RodZ was not required for YodL activity (Fig A4.4A). Similarly, RodZ 
was not required for the cell-widening, as cells expressing YodL in the ΔrodZ 
background readily rounded up and lysed (Fig A4.4B). Moreover, the ΔrodZ strain 
appeared sensitized to the presence of YodL. Taken together, these results suggest that 
RodZ is not required for YodL activity. 
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Fig. A4.3.  Phenotypic characterization of a ΔrodZ mutant grown in liquid culture. 
BAS316 (ΔrodZ) was grown in LB-Lennox media at 37°C to mid-exponential and 
back-diluted to an OD600 of ~0.02. When indicated, 10 mM MgCl2 was added. Cells 
were grown for 1.5 hrs at 37°C before image capture. Membranes were stained with 
TMA-DPH. All images are shown at the same magnification. White arrows indicate the 
“minicells” (see text above). 
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Fig. A4.4.  RodZ is not required for YodL activity. (A) BAS191 (2X Phy-yodL) and 
BAS321 (2X Phy-yodL, ΔrodZ) were streaked on an LB plate supplemented with 100 
µg/ml spectinomycin and, when indicated, 1 mM IPTG. Plates were incubated at 37°C 
overnight before image capture. (B) BAS321 was grown in LB-Lennox media at 37°C 
to mid-exponential and back-diluted to an OD600 of ~0.02. When indicated, 1 mM IPTG 
was added. Cells were grown for 1.5 hrs at 37°C before image capture. Membranes 
were stained with TMA-DPH. All images were scaled in size identically. 
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Discussion 
 
Current data suggest that YodL disrupts cell shape in a manner that requires 
MreB (Appendix I, Fig A1.12)(256). Moreover, YodL-resistant suppressor mutations 
primarily result in MreB substitutions at the interaction interface between RodZ and 
MreB (Appendix I, Table A1.6, Fig A1.9)(256). We developed a B2H assay to test if the 
YodL-resistant MreB substitutions resulted in a change of interaction between RodZ and 
MreB. MreBG143A, MreBP147R and MreBS154R appear to reduce RodZ-MreB interaction 
by B2H while MreBR282S results in stronger interaction Fig A4.1. Based on these data, we 
hypothesize that YodL directly targets MreB at the RodZ-MreB interaction interface, 
and that the loss of interaction substitutions prevent YodL from interacting with MreB 
but also disrupt the native RodZ-MreB interaction. Similarly, we propose that MreBR282S 
leads to a stronger RodZ-MreB interaction, thereby overcoming the inhibitory effects of 
YodL.  
YodL-MreB interaction was not detected in a B2H assay (Fig A4.2). We also did 
not detect an interaction between YodL and RodZ by B2H (Fig A4.2). The lack of 
interaction in the B2H may indicate that YodL does not interact directly with either 
RodZ or MreB. It is also possible that the interactions are below the level of detection in 
the assay. Alternatively, YodL may require the formation of a RodZ-MreB complex to 
create its interaction site. It is also possible that the tagged YodL expressed in the B2H is 
titrated away from forming a complex through interactions with native E. coli proteins. 
This later possibility is supported by preliminary evidence suggesting that in E. coli, 
YodL disrupts the interaction between MreB and FtsZ (see Appendix II). This last 
possibility could be tested by performing the two-hybrid analysis in yeast, a eukaryote 
that does not encode mreB, ftsZ, or rodZ. 
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When YodL is misexpressed in a ΔrodZ background, the cells appear to be 
sensitized to the cell-altering effects of YodL, producing round cells that readily lyse 
(Fig A4.4B). These results suggest that cells lacking rodZ produce less robust 
peptidoglycan, similar to what has been shown in E. coli (288). We hypothesize that this 
reduced robustness is what sensitizes the cells to YodL activity. Interestingly, the MreB 
variants we identified that showed loss of interaction with RodZ, MreBG143A, MreBP147R 
and MreBS154R were less, not more sensitive to YodL activity (Appendix I, Table 
A1.6)(256). We can envision three possibilities to explain this result. The first and 
simplest model is that YodL is no longer able to target MreB activity when these 
substitutions are present, and that the loss-of-interaction with RodZ is simply a 
byproduct of the fact that the proteins interact with the same region of MreB. A second 
possibility is that RodZ bound at MreB creates the site for YodL interaction, thus the 
loss of interaction variants would be less susceptible to YodL activity. Both of these 
results are consistent with prior observations that YodL requires MreB for activity 
(Appendix I, Fig A1.12)(256). However, if YodL’s function is simply to interfere with 
the interaction between RodZ and MreB by binding to both proteins, the misexpression 
phenotype should be similar to the RodZ-MreB loss of interaction variants and these 
variants appear relatively normal (data not shown). The third possibility is that RodZ has 
additional functions in maintaining rod shape that become favored when the interaction 
between RodZ and MreB is perturbed. For example, it is possible that RodZ also 
regulates Mbl function (this has not been tested formally) and that some of the MreB 
variants may shift RodZ toward interaction with Mbl. MreBG143A is a good candidate for 
this class because, although it is located at the RodZ-MreB interaction interface, it is also 
highly resistant to YisK, a protein hypothesized to target Mbl (Appendix I, Table A1.6, 
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Fig A1.12)(256). Future experiments will be aimed at testing these different possibilities 
with the ultimate goal of determining YodL’s mechanism of action. 
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APPENDIX V 
MISEXPRESSION OF YisK CAUSES FtsEX-DEPENDENT CELL 
SHORTENING 
 
Introduction 
 
Bacterial cells have an external cell wall composed of peptidoglycan (PG) that 
provides structural rigidity to the cell, maintaining shape and protecting cells from 
osmotic lysis. PG is a macromolecular meshwork assembled from the glycan strands 
cross-linked to each other by short peptides (368, 369). In order for the cells to grow or 
divide or for cell the existing glycan bonds need to be broken (PG hydrolysis), thus 
allowing newly synthesized glycan strands to be inserted into the covalently network 
(PG synthesis)(332, 370, 371). Numerous studies have been performed to investigate the 
mechanisms of PG synthesis; however, the mechanisms underlying PG hydrolysis and 
its regulation remain largely mysterious. 
In the Gram negative model organism Escherichia coli, PG hydrolases have been 
shown to be particularly important during cell division, and are required for septal PG 
splitting (372-374). It has been shown that the ABC transporter protein complex FtsEX 
regulates the PG binding protein EnvC. In turn, EnvC activates the PG amidases AmiA 
and AmiB, leading to the hydrolysis of the PG crosslinks and septal splitting during cell 
division (375, 376). In the Gram positive bacterium Bacillus subtilis, FtsEX complex 
also plays an important role in PG hydrolysis, somehow regulating the activity of the cell 
wall hydrolase CwlO (a DL-endopeptidase)(326, 377-379). However, in contrast to E. 
coli, an ftsEX mutant exhibits no defects in cell division; instead, the mutant is shorter 
than wildtype, phenocopying a cwlO knockout (326, 377). These results indicate that 
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FtsEX/CwlO complex plays an important role in the regulation of cell elongation. In the 
complex, FtsE is the cytoplasmic ATPase and FtsX is the transmembrane component, 
which associates with the PG hydrolase CwlO (326, 377). The ATP binding and 
hydrolysis activity of FtsE is required for CwlO function (326). FtsX is also needed for 
CwlO function, although it is unclear if FtsX is required for association of CwlO with 
the cell membrane (326, 377).   
In addition to CwlO, B. subtilis has another DL-endopeptidase called LytE (378, 
379). LytE interacts with the actin-like protein MreBH and that this interaction is 
required for LytE’s localization around the cell periphery (290). Moreover, Dominguez-
Cuevas et al. demonstrated genetically that another actin-like protein, Mbl, is crucial for 
FtsEX/CwlO function (377). Although neither LytE nor CwlO are essential, a double 
mutant is non-viable (326, 377), suggesting that these factors act redundantly to carry 
out essential functions activity during cell growth. 
We have shown that Mbl is a genetic target of YisK activity (Appendix I, Table 
A1.6, Fig A1.12)(256). Misexpression of YisK during vegetative growth causes cell 
widening and this phenotype is dependent on Mbl (Appendix I, Fig A1.1, Fig 
A1.12)(256). In addition, YisK misexpression also leads to cell shortening in a manner 
that is independent of both Mbl and MreBH (Appendix I, Fig A1.13)(256). Here we 
show that YisK interacts with FtsE directly in a bacterial two-hybrid. Moreover, we 
observe that the cell-shortening but not the cell-widening phenotypes associated with 
YisK activity are dependent on the FtsEX complex. Our results support the idea that 
YisK activity targets not only Mbl, but also the Mbl-dependent FtsEX complex. 
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Materials and Methods 
 
General methods.   
 
All B. subtilis strains were derived from B. subtilis 168. E. coli and B. subtilis 
strains utilized in this study are listed in Table A5.1. Plasmids are listed in Table A5.2. 
Oligonucleotide primers are listed in Table A5.3. Escherichia coli DH5α was used for 
cloning. All E. coli strains were grown in LB-Lennox medium supplemented with 100 
µg/ml ampicillin and/or 25 µg/ml kanamycin. The following concentrations of 
antibiotics were used for generating B. subtilis strains: 100 µg/ml spectinomycin, 7.5 
µg/ml chloramphenicol, 0.8 mg/ml phleomycin, 10 µg/ml tetracycline, 10 µg/ml 
kanamycin. To select for erythromycin resistance, plates were supplemented with 1 
µg/ml erythromycin (erm) and 25 µg/ml lincomycin. B. subtilis transformations were 
carried out as described previously (302). 
 
Bacterial two-hybrid assay  
 
Bacterial two hybrids were performed essentially as described (241). For more 
details, see Materials and Methods in Chapter II. 
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Table A5.1.  Strains used in Appendix V. 
 
Strain Description Reference 
Parental   
B. subtilis 
168 
Bacillus subtilis laboratory strain 168 trpC2  BGSC (1A866) 
E. coli DH5α F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 
deoR nupG Φ80dlacZΔM15 Δ(lacZYA-
argF)U169, hsdR17(rK
- mK
+), λ–  
 
E. coli 
DHP1 
F-, cya-99, araD139, galE15, galK16, rpsL1 
(Strr), hsdR2, mcrA1,mcrB1; 
Tom Bernhardt 
B. subtilis 
168 
  
BAS319 ftsEX::tet This study 
BJH407 lytE::cat David Z. Rudner 
BJH408 kanΩmblD153N, lytE::cat This study 
BJH410 kanΩmblD153N, lytE::cat, amyE::Phy-yisK (spec) This study 
BJH412 kanΩmblD153N, lytE::cat, amyE::Phy-yisK 
(spec), yhdG::Phy-yisK (phleo) 
This study 
BJH413 kanΩmblR63C, lytE::cat This study 
BJH415 kanΩmblR63C, lytE::cat, amyE::Phy-yisK (spec), 
yhdG::Phy-yisK (phleo) 
This study 
BJH416 kanΩmblR63C, lytE::cat, amyE::Phy-yisK (spec), 
yhdG::Phy-yisK (phleo), ycgO::Phy-yisK (tet) 
This study 
BJH417 kanΩmblR63C, lytE::cat, amyE::Phy-yisK (spec) This study 
BJH418 kanΩmblD153N, lytE::cat, amyE::Phy-yisK 
(spec), yhdG::Phy-yisK (phleo), ycgO::Phy-yisK 
(tet) 
This study 
BYD074 amyE::Phy-yisK (spec), yhdG::Phy-yisK (phleo) (256) 
BYD262 ponA::erm, kanΩΔmreB, amyE::Phy-yisK 
(spec), yhdG::Phy-yisK (phleo)   
(256) 
BYD468 cwlO::cat, amyE::Phy-yisK (spec), yhdG::Phy-
yisK (phleo) 
This study 
BYD476 ftsEX::tet, amyE::Phy-yisK (spec), yhdG::Phy-
yisK (phleo) 
This study 
BYD480 ponA::erm, kanΩΔmreB, ftsEX::tet, amyE::Phy-
yisK (spec), yhdG::Phy-yisK (phleo)   
This study 
E. coli 
DHP1 
  
CYD962 ftsE-T25 (kan), yisK-T18 (amp) This study 
CYD966 yisK-T25 (kan), ftsX-T18 (amp) This study 
CYD967 yisK-T25 (kan), T18-ftsX (amp) This study 
CYD968 T25-yisK (kan), ftsX-T18 (amp) This study 
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Table A5.1.  Continued. 
 
Strain Description Reference 
E. coli 
DHP1 
  
CYD969 T25-yisK (kan), T18-ftsX (amp) This study 
CYD970 ftsX-T25 (kan), yisK-T18 (amp) This study 
CYD971 ftsX-T25 (kan), T18-yisK (amp) This study 
CYD972 T25-ftsX (kan), yisK-T18 (amp) This study 
CYD973 T25-ftsX (kan), T18-yisK (amp) This study 
CYD974 yisK-T25 (kan), ftsEX-T18 (amp) This study 
CYD982 yisK-T25 (kan), empty-T18 (amp) This study 
CYD984 empty-T25 (kan), yisK-T18 (amp) This study 
CYD985 ftsE-T25 (kan), empty-T18 (amp) This study 
CYD986 empty-T25 (kan), ftsEX-T18 (amp) This study 
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Table A5.2.  Plasmids used in Appendix V. 
 
Plasmid Description Reference 
pKNT25 empty-T25 (kan) Tom Bernhardt 
pKT25 T25-empty (kan) Tom Bernhardt 
pCH363 empty-T18 (amp) Tom Bernhardt 
pCH364 T18-empty (amp) Tom Bernhardt 
pYD216 yisK-T18 (amp) This study 
pYD217 T18-yisK (amp) This study 
pYD218 yisK-T25 (kan) This study 
pYD219 T25-yisK (kan) This study 
pYD220 ftsE-T25 (kan) This study 
pYD221 ftsX-T25 (kan) This study 
pYD222 T25-ftsX (kan) This study 
pYD223 ftsX-T18 (amp) This study 
pYD224 T18-ftsX (amp) This study 
pYD225 ftsEX-T18 (amp) This study 
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Table A5.3.  Oligonucleotides used in Appendix V. 
 
Oligo Sequence 5’ to 3’ 
OYD245 AGAAGCGGCCGCTTATTCTG 
OYD246 CTTCGTATAATGTATGCTATACGAACGGTACTCACTTTTTATA
TCCTCCCTTTTAC 
OAS247 CTTCGTATAGCATACATTATACGAACGGTATAATAAATATGAC
AAGGGCCTTCT 
OAS248 TCATCCGTCTGAAGCACAC 
OAS251 TACCGTTCGTATAGCATACATTATACGAAGTTATCATACGGCA
ATAGTTACCCTTAT 
OAS252 TACCGTTCGTATAATGTATGCTATACGAAGTTATGGAGCTGTA
ATATAAAAACCTTC 
OAS253 TACCGTTCGTATAGCATACATTATACGAAGTTATGATTTTATG
ACCGATGATGAAGA 
OAS254 TACCGTTCGTATAATGTATGCTATACGAAGTTATAACTCTCTC
CCAAAGTTGATC 
OAS255 ATCGGAGAGCATTGGAAGAAA 
OAS256 ATAACTTCGTATAATGTATGCTATACGAACGGTAATCATGAAA
TCACCTAATCTTTTA 
OAS257 ATAACTTCGTATAGCATACATTATACGAACGGTATAAAGTGA
AAAAGCCGTTCCGT 
OAS258 TTTAATGTCTCTGCAGTGCGA 
OYD206 CATTGCATGCGTAACACACAGGAAACAGCTATGATGTTATCC
GTGTTTAAAAAG 
OYD298 GCATGGATCCGTAACACACAGGAAACAGCTATGAAATTTGCG
ACAGGGGAAC 
OYD299 GCATGAATTCGAACCGCTACCGCCAATTTGGTTTGACAGCGTT 
OYD300 GCATGGATCCGGGCAGCGGTATGAAATTTGCGACAGGGGAAC 
OYD301 GCATGAATTCTTAGCCAATTTGGTTTGACAGCGTT 
OYD475 GCATGGATCCGTAACACACAGGAAACAGCTATGATAGAGATG
AAGGAAGTATAT 
OYD476 GCATGAATTCGAACCGCTACCATCATATGAACCATACTCCCC 
OYD479 GCATGGATCCGTAACACACAGGAAACAGCTATGATTAAAATT
CTCGGGCGC 
OYD480 GCATGAATTCGAACCGCTACCTACTCGCAGAAACTTGCGGA 
OYD481 GCATGGATCCGGGCAGCGGTATGATTAAAATTCTCGGGCGC 
OYD482 GCATGAATTCTTATACTCGCAGAAACTTGCGGA 
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Microscopy   
 
All strains were grown in 25 ml LB-Lennox medium in 250 ml baffled flasks at 
37°C in a shaking waterbath set at 280 rpm for 1.5 hrs. When indicated, 1 mM IPTG was 
added to induce protein misexpression and all the samples were imaged 1.5 hrs post-
induction. 1 ml samples were spun down at 6,010 x g for 1 minute at room temperature. 
The pellets were resuspended in 5 µl TMA-DPH (0.02 mM) to stain the membranes. 
Cells were mounted on glass slides with polylysine-treated coverslips prior to imaging 
(generally 1 sec exposures). Fluorescence microscopy was performed with a Nikon Ti-E 
microscope equipped with a CFI Plan Apo lambda DM 100X objective, Prior Scientific 
Lumen 200 Illumination system, C-FL UV-2E/C DAPI and C-FL GFP HC HISN Zero 
Shift filter cubes, and a CoolSNAP HQ2 monochrome camera. Images were captured 
with NIS Elements Advanced Research (version 4.10), and processed with NIS Elements 
Advanced Research (version 4.10) and ImageJ64 (240). 
 
Plate growth assay   
 
B. subtilis strains were streaked on LB-Lennox plates containing 100 µg/ml 
spectinomycin and 1 mM IPTG. Plates were incubated at 37°C overnight and images 
were captured on a ScanJet G4050 flatbed scanner (Hewlett Packard). 
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Results 
 
FtsEX is required for YisK causing cell shortening phenotype 
 
We have shown that misexpression of YisK leads to cell shortening (Appendix I, 
Fig A1.13)(256). Since ftsEX and/or cwlO mutants also produced shorter cells (326, 
377), we hypothesized that YisK might cause cell shortening by disrupting the function 
of the FtsEX/CwlO protein complex. 
To test this idea, we measured cell lengths in a ΔponA Δmbl ΔftsEX mutant 
before and after YisK expression. The ΔponA Δmbl background was used as the cell-
shortening effect of YisK is more quantifiable when the cells are not additionally 
perturbed in overall shape as occurs when YisK is expressed in a strain expressing 
functional Mbl (Appendix I, Fig A1.1)(256). Even without YisK expression, the ΔponA 
Δmbl ΔftsEX mutant was slightly shorter than the ΔponA Δmbl mutant (Fig A5.1); this 
result was expected, as the ΔftsEX mutant itself produces shorter cells (326, 377). 
Following YisK induction, the ΔponA Δmbl ΔftsEX strain showed no significant 
difference in cell length compared to the uninduced control (Fig A5.1B). In contrast, and 
as previously observed, the ΔponA Δmbl strain was ~20% shorter than the uninduced 
control when YisK was induced (Fig A1.13, Fig A5.1A)(256). These results suggest that 
FtsE and/or FtsX are required for mediating cell shortening via YisK.  
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Fig. A5.1.  Cell shortening phenotype by YisK misexpression is dependent on FtsEX 
complex. Cells harboring 2X copies of Phy-yisK in a ΔponA Δmbl background 
(BYD262)(A) or a ΔponA Δmbl ΔftsEX background (BYD480)(B) were grown at 37°C 
in LB supplemented with 10 mM MgCl2 to mid-exponential. To induce yisK expression, 
cells were back-diluted to an OD600 of ~0.02 in LB with 10 mM MgCl2 and IPTG (1 
mM) was added. Cells were grown for 1.5 hrs at 37°C before image capture. Membranes 
are stained with TMA-DPH. Cell lengths (n=500/condition) were measured before and 
after yisK expression and rank-ordered from smallest to largest along the x-axis so the 
entire population could be visualized without binning. The uninduced population (black) 
is juxtaposed behind the induced population (semi-transparent, gray). The difference in 
average cell length before and after Phy-yisK induction was only significant in the ΔponA 
Δmbl background (P<0.0001)(A). The data presented in (A) is the same as shown in Fig 
A1.13A. 
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Fig. A5.2.  YisK interacts with FtsEX by bacterial two-hybrid assay. (A) B2H between 
YisK and FtsE (CYD962) or FtsEX in which only FtsX is tagged (CYD974). Negative 
controls: YisK with the empty partner vector (CYD984 or CYD982) (middle column) or 
empty partner vector with FtsE (CYD985) or FtsEX (CYD986) (right column). (B) B2H 
between YisK and FtsX (CYD966---CYD973). All eight different tagged combinations 
are shown here. 
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Fig. A5.3.  FtsEX is not required for YisK activity. (A) BYD074 (2X Phy-yisK), 
BYD476 (2X Phy-yisK, ΔftsEX) and BYD468 (2X Phy-yisK, ΔcwlO) were streaked on an 
LB plate supplemented with 100 µg/ml spectinomycin and, when indicated, 1 mM 
IPTG. Plates were incubated at 37°C overnight before image capture. (B) BYD476 and 
BYD468 were grown in LB-Lennox media at 37°C to mid-exponential and back-diluted 
to an OD600 of ~0.02. When indicated, 1 mM IPTG was added. Cells were grown for 1.5 
hrs at 37°C before image capture. Membranes were stained with TMA-DPH. All images 
are shown at the same magnification 
 
 296 
 
YisK interacts with FtsE, but not FtsX, in a B2H assay 
 
We have shown that FtsE and/or FtsX required for YisK-dependent cell 
shortening (Fig A5.1). To test if YisK might interact directly with FtsE and/or FtsX, we 
performed a bacterial two-hybrid (B2H) assay between YisK and FtsE, YisK and FtsX, 
and YisK and FtsEX. 
As shown in Fig A5.2A, YisK could interact with both FtsE alone and FtsEX 
complex when FtsX was the tagged partner. However, no interaction between YisK and 
FtsX alone was detected, suggesting the interaction observed in the FtsEX complex is 
primarily mediated through FtsE (Fig A5.2B). Taken together, these results are 
consistent with they hypothesis that YisK targets FtsE activity in vivo to cause cell 
shortening.  
 
FtsEX/CwlO is not required for YisK’s cell widening activity  
 
We have shown that FtsEX is required for the YisK-dependent cell shortening 
phenotype (Fig A5.1) and that YisK can interact directly with FtsE in a B2H assay (Fig 
A5.2). To test if the cell-widening and cell killing phenotypes previously observed 
following YisK misexpression (Appendix I, Fig A1.1)(256) also required FtsE and/or 
FtsX, we repeated the misexpression experiments in an ΔftsEX mutant. YisK 
misexpression in ΔftsEX mutant still prevented colony formation on plates (Fig A5.3A), 
similar to a wildtype background. Using epifluorescence microscopy, we also observed 
that YisK misexpression still resulted in the production of irregularly shaped cells (Fig 
A5.3B). Moreover, the ΔftsEX strain appeared sensitized to the presence of YisK, as 
cells were more round and lysed more readily. Cells lacking CwlO, which acts in the 
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same genetic pathway as FtsEX (326, 377), appeared similarly to ΔftsEX mutant (Fig 
A5.3). Taken together, these results suggest that YisK possesses two distinct activities: 
cell shortening mediated through FtsEX and CwlO and cell widening, which depends on 
the presence of Mbl.  
 
The FtsEX complex retains some activity following YisK misexpression  
 
It has been shown that the simultaneous inactivation of FtsEX and LytE or CwlO 
and LytE is synthetically lethal (326, 377). These results suggest that these proteins carry 
out a redundant function in the cell that is essential. Our data suggest that YisK targets 
FtsEX (Fig A5.1, Fig A5.2), so we hypothesized that misexpression of YisK in ΔlytE 
mutant would also result in a synthetically lethal phenotype. To test this hypothesis, we 
transformed genomic DNA from a ΔftsEX::tet strain into a ΔlytE mutant. Consistent 
with the prior observations, we were unable to obtain viable ΔlytE ΔftsEX transformants 
(Fig A5.4A). We then transformed the ftsEX::tet genomic into several strains harboring 
the YisK misexpression construct. Since misexpression of YisK in wild-type 
background leads to cell death (Appendix I, Fig A1.1), the strain backgrounds included 
allelic replacements of wildtype mbl with mutants encoding either the MblR63C or 
MblD153N variants (which are resistant to YisK-dependent killing)(Appendix I, Table 
A1.6)(256). Surprisingly, in each of these backgrounds, the ΔlytE strains could still grow 
on plates, even with multiple copies of Phy-yisK (Fig A5.4B). To test if the non-killing 
phenotype we observed could be attributed to the mbl mutations themselves, we 
attempted to introduce the ftsEX::tet into a ΔlytE strain harboring either MblR63C or 
MblD153N; and no viable transformants could be obtained (Fig A5.4A). Taken together, 
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these results suggest that YisK either incompletely inactivates FtsEX function, or that 
YisK targets an FtsEX function that is not redundant with LytE. 
 
Discussion 
 
Our previous results showed that misexpression of YisK produced irregular 
shaped cells and this phenotype depends on Mbl (Appendix I, Fig A1.1, Fig 
A1.12)(256). In addition, we observed that YisK misexpression also led to cell 
shortening (Fig A1.13)(256). Since FtsEX and CwlO depend at least in part on Mbl for 
function (297) and the ΔftsEX and ΔcwlO mutants are shorter than wildtype (326, 377), 
we hypothesized that YisK might be inhibiting the FtsEX/CwlO protein complex to 
cause cell shortening. Consistent with this hypothesis, we observed that YisK can no 
longer shorten cells in the absence of FtsEX (Fig A5.1). As we also observe that YisK 
and FtsE interact in a B2H assay (Fig A5.2), we hypothesize that YisK causes cell 
shortening by targeting and perturbing FtsE function. 
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Fig. A5.4.  YisK misexpression does not inhibit growth of a ΔlytE mutant. (A) 
Genomic DNA from BAS319 (ftsEX::tet) was used to transform BJH407 (ΔlytE ), 
BJH408 (ΔlytE, MblD153N) or BJH413 (ΔlytE, MblR63C). Cells were plated on LB-
Lennox agar plates supplemented with 10 µg/ml tetracycline and incubated at 37°C 
overnight before image capture. (B) BJH417 (1X Phy-yisK, MblR63C, ΔlytE), BJH415 
(2X Phy-yisK, MblR63C, ΔlytE), BJH416 (3X Phy-yisK, MblR63C, ΔlytE), BJH410 (1X Phy-
yisK, MblD153N, ΔlytE), BJH412 (2X Phy-yisK, MblD153N, ΔlytE) and BJH418 (3X Phy-
yisK, MblD153N, ΔlytE) were streaked on LB plates supplemented with 100 µg/ml 
spectinomycin and, when indicated, 1 mM IPTG. Plates were incubated at 37°C 
overnight before image capture. 
 
 300 
 
In order for bacterial cells to elongate, both PG hydrolysis and PG synthesis are 
essential (332, 370, 371). We have shown that YisK is mainly expressed during 
stationary phase and early sporulation (Appendix I, Fig A1.4 – A1.6)(256), at a time 
when cell growth is downregulated. Since cell elongation is expensive, we raised up an 
idea that as an inhibitor of cell elongation, YisK targets and prevents both PG hydrolysis 
and PG synthesis, in order to surely turn off cell elongation. We do not observed an 
obvious difference in cell length during either stationary phase or sporulation (data not 
shown and Appendix I)(256), therefore we propose that YisK’s physiological role is not 
to regulate cell length. Instead, YisK may perform a more subtle function, such as fine-
tuning the activities of proteins important for PG synthesis, such as Mbl, FtsEX, and 
CwlO.   
Two sets of data suggest that YisK has the capacity to affect cell length and cell 
width independently. First, Mbl is not required for YisK-mediated cell shortening 
(Appendix I, Fig A1.13)(256). Second, neither FtsEX nor CwlO are required for YisK to 
disrupt cell shape (Fig A5.3).   
Garti-Levi et al. showed that ftsEX mutants are slightly delayed for entry into 
sporulation (380), a result that was confirmed by others (326). Garti-Levi et. al. also 
showed that after overnight growth, an ftsE mutant produces round cells and less ovoid 
spores (380). We also observed this phenotype in strains deleted for mreB (256) as well 
as those expressing artificially high levels of YisK during sporulation (Fig A3.1 and Fig 
A3.2, Appendix III). These results suggest that during sporulation, YisK, FtsEX, CwlO, 
and MreB may act in a common pathway to regulate processes that effect cell width and 
spore morphology, and provide an avenue for future investigation.   
Simultaneous inactivation of lytE and ftsEX or lytE and cwlO is synthetically 
lethal in B. subtilis (326, 377). Surprisingly, although our data suggest that YisK 
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inactivates the aspect of FtsEX function responsible for preventing cell shortening, 
misexpression of YisK in ΔlytE mutant backgrounds resistant to YisK’s cell-widening 
function are not synthetically lethal (Fig A5.4), even when YisK is expressed at higher 
levels. The simplest explanation for this result is that YisK does not inactivate all 
functions of FtsE, only those related to cell length control. FtsE mutants that cannot bind 
or hydrolyze ATP are also synthetically lethal in a ΔlytE mutant background (326). 
Therefore, we think it is unlikely that YisK Affects FtsE’s ATP binding and/or 
hydrolysis activities. Although we cannot exclude the possibility that YisK is simply a 
poor inhibitor of this activity, the lack of an intermediate phenotype (for instance, poor 
growth) following YisK misexpression in a ΔlytE argues against this possibility. It is 
also possible that YisK effects FtsE-FtsX interaction by targeting FtsE and causing some 
conformational changes, so that FtsE can still bind to FtsX but not as tight as before, 
thus YisK does not completely abolish the FtsEX/CwlO complex’s function, but make it 
inefficient. We do not exclude any other possible mechanisms that YisK might affect 
FtsEX/CwlO protein complex. 
 
 
